Modelling the Role of Nitric Oxide in Cerebral Autoregulation by Catherall, Mark
Modelling the Role of Nitric Oxide in
Cerebral Autoregulation
Mark Catherall
University College
Supervisor: Prof. S. J. Payne
PUMMA Research Group
Department of Engineering Science
University of Oxford
Thesis submitted for the degree of
Doctor of Philosophy
October 2014
ar
X
iv
:1
51
2.
09
16
0v
1 
 [q
-b
io.
TO
]  
30
 D
ec
 20
15
Abstract
Malfunction of the system which regulates the bloodflow in the brain is a major cause
of stroke and dementia, costing many lives and many billions of pounds each year in
the UK alone. This regulatory system, known as cerebral autoregulation, has been the
subject of much experimental and mathematical investigation yet our understanding of
it is still quite limited. One area in which our understanding is particularly lacking is
that of the role of nitric oxide, understood to be a potent vasodilator. The interactions
of nitric oxide with the better understood myogenic response remain un-modelled and
poorly understood. In this thesis we present a novel model of the arteriolar control
mechanism, comprising a mixture of well-established and new models of individual
processes, brought together for the first time. We show that this model is capable of
reproducing experimentally observed behaviour very closely and go on to investigate its
stability in the context of the vasculature of the whole brain. In conclusion we find that
nitric oxide, although it plays a central role in determining equilibrium vessel radius,
is unimportant to the dynamics of the system and its responses to variation in arterial
blood pressure. We also find that the stability of the system is very sensitive to the
dynamics of Ca2+ within the muscle cell, and that self-sustaining Ca2+ waves are not
necessary to cause whole-vessel radius oscillations consistent with vasomotion.
2Nomenclature
A area
ABP arterial blood pressure
Ca calcium
CBFV cerebral blood flow velocity
cGMP cyclic guanosine monophosphate
CICR calcium induced calcium release
C compliance
Cw concentration of NO in vessel wall
∆X difference in X between two places
 error between target and response
η dimensionless variance
eNOS endothelial nitric oxide synthase
f viscous friction coefficient
F force
hw NO wall transport coefficient
IP3 inositol 1,4,5-triphosphate
k constant or iteration counter
K rate constant
λ normalized cell length
L length
mmHg millimetres of mercury
µb viscosity of blood
n number or exponent constant
NO nitric oxide
P pressure
pX log10(X)
q flow or constant
Q flow
r radius or decay rate
R resistance to flow
σ stress
§ section
sw NO production rate in vessel wall
SERCA sarco-(endo)plasmic reticulum calcium ATPase
SR sarcoplasmic reticulum
τ shear stress
τx time constant for variable denoted by subscript x
tw vessel wall thickness
v speed
Vx volume of compartment x
VSMC vascular smooth muscle cell
wc cell width
ωn natural frequency
3x¯ equilibrium value of x
x˙ first time derivative of x ( dx
dt
)
x¨ second time derivative of x ( d
2x
dt2
)
XL Lower value of X
XU Upper value of X
Xz± ion of element X with charge ±z
[X] concentration of X
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Chapter 1
Introduction
1.1 The Problem
Stroke and dementia are between them responsible for approximately 68,000 deaths
per year in the England and Wales alone [76, 4]. The cost to the UK of stroke and
dementia combined is an estimated £24.6 billion per year [5, 2]. Stroke can be either
haemorrhagic (caused by bleeding in the brain), or ischaemic (caused by insufficient
blood flow to a part of the brain). There are several different types of dementia; one
of them, called vascular dementia, occurs due to insufficient blood supply within the
brain, just as in ischaemic stroke, only on a much smaller scale. Ischaemia damages
the brain because when brain tissue does not receive enough blood it is not supplied
with enough oxygen to respire (a condition known as hypoxia), this in turn leads to a
build up of toxic chemicals within the cell and ultimately to the death of the cell. The
volume of cells that die during an ischaemic episode is called the infarct. In the case
of ischaemic stroke, the infarct is relatively large, comparable to the size of a golf ball,
and this can cause loss of a specific mental function, e.g., speech or control of a limb.
In the case of dementia, rather than an acute ischaemic attack that leads to a large
infarct, chronic slight ischaemia causes many small infarcts to accrue over months and
years. These infarcts are very small, of the order of 1mm across, and do not lead to
the sudden loss of a specific mental function, but rather to a general degradation of
cognitive ability, affecting the reasoning and memory of those afflicted. Dementia can
then be thought of as a chronic condition brought about as the result of an ongoing
series of tiny strokes, each one occurring over a short time scale.
1.2 The Brain and its Blood Supply
The brain consumes more oxygen than any other organ (in a resting state), with around
15% of the total cardiac output (blood flow) going to the brain [3]. Brain tissue is also
much more sensitive than most tissues to ischaemia; a leg can be deprived of blood flow,
and hence oxygen, for up to two hours without damage, in contrast, the brain can suffer
irreversible damage after only 4 minutes of oxygen deprivation at normal temperatures
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[1]. There are biological control systems that exist to maintain the brain’s blood supply
at a constant level in order that the oxygen sensitive tissue of the cerebral cortex is
never without oxygen. The combination of all such systems is known as cerebral
autoregulation. An impaired cerebral autoregulatory system will affect the brain’s
vascular response to changing conditions and so will affect the progress of ischaemic
stroke and vascular dementia. If we can better understand the mechanisms of cerebral
autoregulation we may be able to prevent or slow down the onset of cerebral ischaemia,
furthermore, we may be able to propose improvements to post infarction treatment
based on a better understanding of the brain’s own response to the event.
The primary mechanisms by which the flow of blood through the brain is regulated are
vasodilation and vasoconstriction – the enlargement or narrowing of the blood vessels.
Various substances interact in the tissue comprising the blood vessels to cause these
changes in radius. One such substance, the role of which is not yet well understood, is
nitric oxide (NO).
1.3 The Value of Mathematical Modelling
Mathematical modelling provides direction for clinical experimentation. It serves to in-
terpolate between the observed behaviours of a system and so suggest fruitful avenues of
further investigation. It can also serve as a quick and cheap test-bed for new treatment
ideas – the alternative clinical trials are very costly and time-consuming and it would
be very wasteful to embark upon such a venture without the best possible guidance as
to the target of the investigation. Mathematical models provide such guidance. In the
limit, where a completely faithful mathematical reconstruction of a biological system
were available, there would be no need for speculative clinical investigation to discover
new treatments, nor for long clinical trials to evaluate efficacy and safety. Without
mathematical modelling we are limited to very simple hypotheses, and so are limited
in our understanding to only those things which are simple in nature. Mathematical
modelling allows us to extend our understanding to complex systems and enables us
to make useful predictions about such systems.
1.4 Objective
In this thesis we will answer two principle questions; the first relates to the role of
NO within the cerebral autoregulatory system, in particular some experimental work
carried out by Ide et al. [40] (described in § 2.3.3) produced results which could not
properly be explained within the current understanding of the role of NO in cerebral
autoregulation; we aim to build a mathematical model of the regulating blood vessels
and use this to elucidate the results of [40]. The second is concerned with a phenomenon
known as vasomotion and the mechanism by which is arises. Vasomotion could play
a role in protecting tissue from transient ischaemia by enhancing oxygen delivery - we
will use our blood vessel model to replicate vasomotion and examine the conditions
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under which is arises. Both the experiments and results of [40] and the phenomenon
of vasomotion are described in more detail in chapter 2 in order that they may be
understood in the wider biological context.
1.5 Overview
This thesis is presented in several chapters, each relating to a distinct phase of our
investigations into the subject, here we provide an overview of the thesis and the
contents of each chapter:
In chapter 2 we review some background physiology of which the reader should be
aware to put the subsequent discussion into context. The experimental work that has
led to the current understanding of the cerebral autoregulatory system is then reviewed
and commented upon before we move on to reviewing the mathematical modelling and
theoretical literature relevant to our thesis.
Chapter 3 presents the equations, and origins thereof, that constitute our novel model
of the cerebral arteriole. The model presented is an agglomeration of parts of previous
models and original elements.
Chapter 4 introduces the experimental data which we will use to validate our model
and details the optimization process through which parameter values are found which
enable the model to best reproduce the behaviour represented in the data. The results
of this optimized fitting process are presented and insights are gained into the nature
of the system. Also presented here is an analysis of the sensitivity of the response of
the system to variations in its parameter values.
In Chapter 5 we integrate the fitted arteriole model into a representation of the vascu-
lature of the whole brain. We then modify this model to better fit the balance between
venous and arterial blood volume observed in vivo. Finally we examine the frequency
response of the combined model and draw conclusions about the autoregulatory system
as a whole, its possible pathologies and methods of diagnosis.
Chapter 6 details further modifications made to the autoregulatory model of chapter 5
in search of both greater physiological fidelity and, crucially, the development of insta-
bility and spontaneous oscillation representative of vasomotion. We identify features
of the dynamics of the vessel which are sufficient to cause spontaneous oscillations and
examine the limits and possible triggers of such oscillations.
Finally, in Chapter 7, we summarise what we have found through this iterative mod-
elling, fitting, and examination process. We reflect on the successes and limitations
of our investigation and make suggestions for future work to address these limita-
tions.
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Chapter 2
Literature Review
In this chapter we will first review some of the fundamental material which underpins
our current understanding of bloodflow in the brain before going on to review the more
focussed research which is directly relevant to cerebral autoregulation. Finally we will
review existing mathematical models of relevant elements of the system.
2.1 The Cardiovascular System
In order to function and to stay alive, all cells of the body require energy, and this energy
is provided by respiration, which requires oxygen. Consequently all cells of the body
require oxygen. The absorption of oxygen from the air and its distribution throughout
the body is taken care of by the cardiovascular system. The heart pumps blood through
the lungs wherein it absorbs oxygen, chiefly through binding to haemoglobin (Hb)
molecules found in red blood cells. The oxygenated blood returns to the heart where
it is pumped once again, this time through the rest of the body via the system of
blood vessels known as the vasculature. As the blood passes through the vasculature,
oxygen is transferred from the blood to the tissue surrounding the blood vessel. By
the time the blood is returned to the heart it has lost much of the oxygen it formerly
carried.
2.1.1 Blood Vessels
The vessels which carry the blood through the body form an intricate network. The
network can be thought of as having two sides, both tree like in structure: the arterial
side takes oxygenated blood leaving the heart through the aorta and distributes it
throughout the body; the venous side collects the blood from throughout the body
and returns it to the heart. Whereas the arterial side starts in one large vessel (the
aorta) and divides repeatedly into smaller vessels, the venous side starts in a multitude
of small vessels and, through repeated confluence, ends up in one large vessel (the
vena cava). The junction of the two systems is the capillary bed, a very fine mesh of
blood vessels which themselves are only just wide enough for one red blood cell to pass
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through. It is through the capillary bed that most of the oxygen delivery takes place.
Capillaries have very thin walls (only one cell thick) to allow easy diffusion of oxygen
from the blood to the surrounding tissue.
The generation of blood vessels which immediately precedes the capillaries is made
up of arterioles. It is predominantly these arterioles which change size in order to
modulate flow through the tissue. Whereas the walls of capillaries are only one cell
thick, the walls of arterioles have two layers of cells: the first is the same as that which
the capillaries have, a single-cell-thick layer of endothelial cells; the second, outer,
layer is a one or two cell thick layer of muscle cells. It is these muscle cells (vascular
smooth muscle cells or VSMCs) which enable the arterioles to change size and so to
regulate the flow of blood through the tissues. The structure of an arteriole is shown
in fig. 2.1.
Vascular Smooth Muscle Cells
(which moderate vessel radius)
Endothelial Cells
(which produce NO)
Lumen
(through which the blood flows)
Figure 2.1: Structure of an arteriole.
Because they carry blood at such different pressures, arteries and veins have very
different structures. Arteries have thick, elastic walls with substantial layers of muscle
to contain blood at high pressures relative to the surrounding tissue, and to smooth out
highly pulsatile flow, whereas veins have thin, inelastic walls and are easily collapsed
between pulses.
2.1.2 Blood Pressure
Blood flows through the vasculature because the heart raises the blood pressure suf-
ficiently. The amount of pressure drop along a vessel is a function of the viscosity of
the blood, the vessel radius, and the vessel length; taken together these constitute the
overall resistance to flow of the system. As the cardiovascular system generally acts to
maintain constant blood flow throughout the vasculature, an increase in the resistance
to flow is generally followed by an increase in arterial blood pressure (ABP). This can
be achieved through increased heart rate and/or increased stroke volume of the heart.
For example, when the blood vessels constrict due to mental stress [47], or are partially
occluded by cholesterol build up [56], ABP necessarily rises to achieve sufficient blood
flow through the vasculature.
Blood pressure in the aorta is necessarily higher than anywhere else in the body (cor-
recting for elevation). As blood progresses through the arterial tree, and overcomes
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the resistance of each vessel in turn, its pressure falls. By the time the blood returns
to the heart via the vena cava it is at a similar pressure to that of the surrounding
tissue.
2.1.3 Blood Flow
As mentioned in §1.2, the tissue of the brain is particularly sensitive to hypoxia (lack of
oxygen) and so the supply of blood to the brain must be critically controlled. The flow
through a vessel is determined by the difference in blood pressure from one end of the
vessel to the other and the internal radius of the vessel. Smaller vessels present greater
resistance and so admit less flow than larger vessels, for the same driving pressure.
This relationship is normally assumed to be governed by the Poiseuille equation for
flow through cylindrical vessels:
R =
8µL
pir4
=
∆P
Q
(2.1)
where R is the resistance of the vessel, µ is the viscosity of the fluid, L is the length of
the vessel, r is the radius of the vessel, ∆P is the difference in fluid pressure between
the ends of the vessel, and Q is the volumetric flow rate through the vessel.
By varying the radius, and thus the resistance to flow, of the blood vessels in the brain,
the autoregulatory system can prevent fluctuations in blood pressure from causing
fluctuations in bloodflow which might otherwise lead to lack, or excess, of oxygen in
the brain tissue, both of which would be damaging.
2.2 Cells
2.2.1 Cell Structure
The cells of animals all have a similar structure; the cell is contained by a membrane
made from two layers of lipid (fat) molecules containing a phosphorus atom. The
phosphorus atom at one end of the molecule polarises the bonds surrounding it, thus
enabling affinity with other polar molecules, such as water; This end is known as the
hydrophilic end (liking water). The other end is a chain (or two) of carbon atoms
surrounded by hydrogen atoms, much like in alkanes, or oils. This end of the molecule
does not have polarised bonds and so does not have any electrostatic affinity with other
polar molecules; this is known as the hydrophobic end.
During cell formation these phospholipids become arranged so that there are two layers,
facing in opposite directions, all of the hydrophobic ends are in the middle while all
the hydrophilic ends face outwards, and are in contact with the watery solution that
makes up both the fluid between cells and the fluid within the cell. Because the centre
of this membrane is hydrophobic, polar species, including charged ones such as metal
ions cannot readily diffuse across it. This makes the membrane electrically insulating,
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which means that the electrical potential on one side can be different from that on the
other.
Differences in potential can arise through different concentrations of charged species on
either side of the membrane (i.e., inside and outside the cell). The potential difference
across the membrane is known as membrane potential and is usually noted by Vm.
The membrane is not entirely insulating however; embedded in the membrane are
transmembrane proteins that can act as channels to allow certain species to cross the
membrane, and thereby enter or leave the cell. These protein channels come in various
forms, some require energy to operate, some swap one ion with another, some must be
activated by the binding of some species on side or the other before they allow another
species to cross the membrane, and some are activated by the membrane potential. It
is these channels that allow the regulation of ionic concentrations within the cell which
in turn can allow the cell to change its behaviour, or to affect other cells.
The volume enclosed by the cell membrane is called the lumen, and is filled mainly
with a watery solution of ions and other molecules called the cytoplasm. Floating
about in the cytoplasm there are various other structures and molecular machines,
depending on the type of cell. One such structure is the sarcoplasmic reticulum, or SR.
This sub-compartment is contained by its own membrane, which is very similar to the
cell membrane in structure and it too has transmembrane proteins that regulate the
passage of polar species across the membrane. The SR contains Ca2+ ions at a much
higher concentration than in the cytoplasm, this will be important later. Figure 2.2
shows the basic structure of an animal cell.
SR
Extracellular space
Cell membrane
Sarcoplasmic reticulum membrane
Trans-membrane proteins (channels)
Cytoplasm
Figure 2.2: Schematic diagram of a cell showing only those structures and compartments
that are relevant. SR denotes the Sarcoplasmic Reticulum.
2.2.2 Smooth Muscle Cells
Smooth muscle cells contain molecules of myosin and actin, both of which form thin
strands which lie parallel to one another. Contraction is achieved through the globular
heads of myosin filaments (which protrude from the sides of the filament) attaching to
the actin filaments and then changing angle, pulling the actin filaments past the myosin
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filaments as they do so. The attached myosin head, or cross-bridge, then detaches and
tilts back to its original position where it can attach to another site on the actin
filament. This process of attachment, dragging past, detachment and repositioning of
the myosin heads is called cross-bridge cycling. Figure 2.3 shows the action of cross-
bridge cycling pulling the myosin filament past the actin filament.
1 2
actin filament
myosin filament
attached cross-bridge
Figure 2.3: Schematic diagram of a cross bridge pulling an actin filament past a myosin
filament; the cross bridge attaches in position 1, then tilts so that the actin filament is drawn
past, as in position 2. The cross bridge will then detach and reposition, the repeated process
is known as cross-bridge cycling.
Myosin heads cannot attach to the actin filaments until they have been activated by
phosphorylation. Phosphorylation requires an enzyme called myosin light-chain kinase,
or MLCK, which is in turn activated by a complex formed from Ca2+ and a molecule
called calmodulin, called the calcium-calmodulin complex. This activation chain has
the consequence that the contraction of smooth muscle is chiefly modulated by the
concentration of free Ca2+ ions in the cytoplasm (which is where the actin-myosin
filament structures are found). Bundles of overlapping actin and myosin filaments
are joined in chains across the smooth muscle cell and attached to the cell walls such
that the cycling of cross-bridges throughout the cell causes the cell to contract. Each
myosin filament has many heads that can form attached cross-bridges along its length;
the maximum force that can be created by this cross-bridge cycling is therefore related
to the amount of overlap between actin and myosin filaments. One pair of overlapping
actin and myosin filaments is known as a sarcomere.
2.3 Autoregulation
2.3.1 Myogenic Response
The automatic contraction of arterioles in response to elevated blood pressure is known
as the myogenic response. First discovered by Bayliss in 1902 [9], it was not until
isolated vessel experimental techniques were developed in 1981 that the mechanisms
behind the response began to be uncovered. Experiments involving stretching isolated
VSMCs bathed in various solutions [35, 36], and cannulated isolated arterioles [45, 81,
26], have lead to the consensus that the myogenic response is driven by a force-sensitive
element in-line with the contractile elements (actin and myosin filaments) of the VSMC;
this is known as the wall tension hypothesis. These experiments have repeatedly shown
that the myogenic response is dependent on the availability of Ca2+. In cases where the
fluid surrounding the experimental preparation does not contain Ca2+, the myogenic
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response is not observed. This observation is consistent with the idea that Ca2+ is a
vital part of the pathway to activation of MLCK and subsequent phosphorylation of
myosin heads which leads to increased vascular tone.
2.3.2 The Role of Nitric Oxide
Nitric oxide (NO) has now been identified as the formerly enigmatic Endothelium-
Derived Relaxing Factor, or EDRF as it was known. NO is produced primarily in
the endothelium by an enzyme called endothelial nitric oxide synthase, or eNOS. It
acts on VSMCs in the opposite way to Ca2+, through an intermediary molecule, cyclic
guanosine mono-phosphate (cGMP) [23], acting to de-phosphorylate myosin heads and
to cause a reduction in smooth muscle tone. The action of cGMP is twofold: firstly it
reduces Ca2+ concentration in the VSMC via various mechanisms [16], primarily the
activation of the Ca2+ ATPase, an enzyme which actively pumps Ca2+ out of the cell
[66]; and secondly it indirectly stimulates myosin light-chain phosphatase (MLCP) [50],
which does the opposite to MLCK and de-phosphorylates myosin heads, thus reducing
smooth muscle tone.
Inhibition of eNOS causes significant vasoconstriction and a subsequent increase in
blood pressure [67], suggesting that there is some baseline production of NO by eNOS.
NO produced in the endothelium diffuses either into the blood or into the VSMCs sur-
rounding the endothelium. The decay rate of NO is quite fast as it is not a particularly
stable diatom. Decay or absorption of NO in whole blood is very rapid due to uptake
by haemoglobin in place of oxygen. For this reason approximately 90% [12] of the NO
produced in the endothelium is carried away in the blood.
It has been found using endothelial cells grown on the surface of small glass beads
[13] that NO production is stimulated in response to shear stress at the surface of the
endothelial cells in contact with the blood. This suggests that the action of NO in
autoregulation could be antagonistic to that of the myogenic response. Whereas a rise
in pressure would cause the myogenic response to contract the arteriole, the accom-
panying rise in flow and therefore shear stress would cause an increased production of
NO which would act antagonistically, moderating the contraction due to the myogenic
mechanism or overriding it and causing dilation.
2.3.3 Interactions of NO and Myogenic Mechanisms
After removing arterioles from rat skeletal muscle, Falcone et al.[26] modulated the
pressure of the fluid in the arterioles and observed the ensuing changes in the vessels’
diameter. They found that over a mid range of intramural pressures the arterioles
contracted in response to elevated pressure. Critically they did this before and after
removing the endothelium from the vessels, thus establishing that the myogenic re-
sponse is independent of the endothelium. However, they did go on to point out that
this result may not hold true for cerebral arterioles. In fact Table 2 in [26] summarises
previous studies on arterioles isolated from different tissues and highlights the fact that
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studies [33, 34, 42, 70] using cerebral vessels tend to find that the myogenic response of
these vessels is dependent on an intact endothelium, although some of these studies use
vessels larger than arterioles, which may be significant. The role of shear-stress-induced
NO production in this case is ruled out not only by the removal of the endothelium
but also by the absence of flow through the vessel during the experiment.
In his review of mechanisms underlying the myogenic response [21], Davis makes the
observation that in experiments on arterioles in which arterial and venous pressures are
raised equally, as in [57], the contribution of the myogenic response to autoregulation
is much greater than in experiments where flow increases as well. This may be due to
a mitigating effect of flow-induced NO production. He also refers to the wall tension
hypothesis (see § 2.3.1) which posits that the myogenic response is mediated by some
tension sensing element in the VSMC in series with the contractile element. This is
supported and taken further in [81] where it is concluded that wall tension not only
mediates Ca2+ release but also modulates [Ca2+] sensitivity.
In order to separate the effects of flow and intramural pressure, Kuo et al. [45] iso-
lated coronary arterioles from a pig and subjected them both to a range of intramural
pressures and to a range of pressure differences between the ends (thus a range of flow
rates). They found similar results to [26] for the no-flow case and observed significant
vasodilation in response to flow. This flow-induced dilation was not present after the
introduction of NG–monomethyl–L–arginine (L-NMMA), which is an eNOS inhibitor,
thus supporting the idea that shear-stress-induced release of NO is the driver behind
flow-induced vasodilation. They also found that the vasodilation in response to flow
was endothelium-dependent, i.e., when the endothelium was removed, the flow-induced
dilation was no longer observed. In addition to the aforementioned steady-state exper-
iments, Kuo et al. did a series of dynamic experiments, subjecting an isolated arteriole
to step changes in intramural pressure and flow and observing the response of the vessel
over time.
In the study which provided the motivation for this thesis, Ide et al. [40] recorded the
ABP and cerebral blood flow velocity (CBFV) of several patients over ten minute pe-
riods under different conditions. One of these conditions was infusion with L-NMMA.
To record a baseline for comparison with similar ABP to the L-NMMA condition (L-
NMMA causes significant vasoconstriction and hence elevated ABP, see § 2.3.2) the
experimenters used an α-adrenergic agonist called phenylephrine. This stimulates the
release of Ca2+ from the SR via a molecule called inositol triphosphate, or IP3. The
correlation between ABP and CBFV is often used as an indicator of autoregulatory
function – after all it is the function of the autoregulatory system to control CBFV in
spite of fluctuations in ABP. We would expect then that this ABP-CBFV correlation
would be quite different under the influence of L-NMMA (if NO is involved in autoreg-
ulation) than in the baseline condition with an equally high ABP (the phenylephrine
condition). Wavelet analysis of the ABP-CBFV data shows that in fact no discernible
difference can be observed between the two cases [8]. This surprising result raises
questions about the role that NO plays in the cerebral autoregulation, which seems
unaffected by its absence.
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2.3.4 Other Autoregulatory Mechanisms
Whilst the NO mechanism is the primary focus of this investigation, and the myogenic
response is the primary autoregulatory mechanism, the autoregulatory system includes
several other mechanisms by which the flow of blood is controlled. These include
but are not limited to: metabolic mechanisms, through which the consumption of
resources, e.g. oxygen, in surrounding tissue feeds back to the blood vessel; neural
control, whereby nervous stimulation of the VSMCs affects tone; cell-to-cell conducted
response, in which responses are propagated from cell to cell along the vessel walls
via gap junctions; ATP release from red blood cells, shear stress within the blood can
cause ATP to be released from red blood cells which then binds to the endothelium
and stimulates release of NO; and, over longer timescales, capillary recruitment - the
process by which new capillaries are created in response to ongoing demand for higher
perfusion. Most of these responses will not be explicitly included in this investigation,
instead we will keep our model as simple as possible whilst still providing enough detail
and verisimilitude to provide insight into our key questions.
2.4 Vasomotion
Arterioles in vivo have been found to exhibit oscillations in vascular tone under certain
conditions, typically low arterial pressure and hence hypo-perfusion [74, 58, 71]. This
oscillation in vascular tone manifests as a rhythmic contraction and dilation of the
arteriole known as vasomotion. Although vasomotion has been frequently observed ex-
perimentally, the biochemical mechanisms driving the rhythmic oscillations in smooth
muscle tone are still unclear [6]. There is however consensus that vasomotion requires
the coordination of all of the VSMCs in the vessel to contract in synch, and that this
coordination is achieved through the electrical coupling of the cells. Experiments by
Gustafsson [29] and Hill [37] found that the membrane potentials of all VSMCs in an
arteriole exhibiting vasomotion oscillate with the same frequency as that of the va-
somotion, and with a slight phase lead. Whereas Gokina [27] and Lamb [48] found
that each arterial contraction was accompanied by a burst of action potentials from
the VSMCs. Peng et al. [64] showed that oscillations in VSMC membrane potential
are caused by oscillations in Ca2+ concentration in the cytoplasm, and further that the
synchronisation of these oscillations between VSMCs requires either an endothelium
or the external introduction of cGMP. The action of cGMP in this study suggests a
further link between NO and the autoregulatory system.
The purpose, if there is one, of vasomotion is also the subject of some debate; the
suggestion that vasomotion may benefit oxygenation of adjacent tissue is one that has
received much attention. Hapuarachchi et al. demonstrated mathematically in [32]
that oxygen transport from blood to surrounding tissue is enhanced in a vessel which
oscillates in radius compared to a stable vessel of the same mean radius. This conclusion
is corroborated by the experimental work of Ru¨cker et al. [71] who measured tissue
oxygenation in rat hindlimbs with and without vasomotion and found that vasomotion
did indeed increase the perfusion of oxygen into the adjacent muscle tissue.
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The combination of findings suggesting that vasomotion occurs only in pathophysiolog-
ical conditions (such as hypo-perfusion) and that vasomotion may increase the delivery
of oxygen from the blood to the adjacent tissue has lead to the hypothesis that va-
somotion is an evolved response to keep tissue alive during periods of vascular strain.
If this is the case then vasomotion may be of particular importance when considering
dementia. Brain tissue is exceptionally sensitive to hypoxia and it may be that va-
somotion could prevent the death of cells during brief periods of localised ischaemia
which would otherwise form an infarct and contribute to the degradation of mental
function that characterises the disease.
2.5 Mathematical Models in the Literature
What follows is a review of models that have been proposed previously, and that
are relevant to our investigation. We shall thus be mainly looking at models of the
electrochemistry of the smooth muscle cell, models of the interaction between chemical
concentrations and smooth muscle contraction, models of the mechanics of smooth
muscle, and models of the production and transport of NO.
2.5.1 Hodgkin and Huxley
In 1952 Hodgkin and Huxley published a series of five papers which described and
validated an electrical equivalent circuit model of the activity of the cell membrane.
Specifically they sought to model the generation and propagation of action potentials
in the squid giant axon (a long nerve). An action potential is a short electrical pulse in
which the membrane potential of a cell rapidly rises and falls. An action potential is
used to transmit information along a cell, in the case of neurons, or in the case of muscle
cells, to trigger a series of processes that result in muscular contraction. Although the
exact electrical equivalent circuit used is adapted to suit the cell or behaviour being
modelled, many models of cell electrochemistry are based on Hodgkin and Huxley’s
approach. Figure 2.4 is taken from [38] and shows the circuit that was used to model
the activity of the cell membrane from the axon of a squid.
MEMBRANE CURRENT IN NERVE
the sodium and potassium conductances to time and membrane potential.
Before attempting this we shall consider briefly what types of physical system
are likely to be consistent with the observed changes in permeability.
Outside
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Fig. 1. Electrical circuit representing membrane. RB =l/gNa; RK= l/9K; RI= 1/#1. RNw andRK vary with time and membrane potential; the other components are constant.
The nature of the permewablity change8
At present the thickness and composition of the excitable membrane are
unknown. Our experiments are therefore unlikely to give any certain informa-
tion about the nature of the molecular events underlying changes in perme-
ability. The object of this section is to show that certain types of theory are
excluded by our experiments and that others are consistent with them.
The first point which emerges is that the changes in permeability appear to
depend on membrane potential and not on membrane current. At a fixed
depolarization the sodium current follows a time course whose form is inde-
pendent of the current through the membrane. If the sodium concentration
is such that ENaB<E, the sodium current is inward; if it is reduced until
ENa > E the current changes in sign but still appears to follow the same time
course. Further support for the view that membrane potential is the variable
controlling permeability is provided by the observation that restoration of the
normal membrane potential causes the sodium or potassium conductance to
decline to a low value at any stage of the response.
The dependence of 9Na and g9 on membrane potential suggests that the
permeability changes arise from the effect of the electric field on the distribu-
tion or orientation of molecules with a charge or dipole moment. By this we
do not mean to exclude chemical reactions, for the rate at which these occur
might depend on the position of a charged substrate or catalyst. All that is
intended is that small changes in membrane potential Would be most unlikely
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Figure 2.4: Schematic of the equivalent circuit used in the Hodgkin-Huxley model. Taken
from [38].
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Hodgkin and Huxley were considering a travelling action potential, of the sort that
transmits information through nerves and derived from their model the following:
dV
dt
= − 1
Cm
(
g¯Kn
4 (V − VK) + g¯Nam3h (V − VNa) + g¯l (V − Vl)
)
+
z
K
(2.2)
where V is the membrane potential, VK , VNa and Vl are the equilibrium potentials for
the various species (see below), gi represents the conductance of the i channel while
m, n and h are parameters representing the number and activation of the channels,
z = d
2V
dt2
and K is a variable related to the speed of propagation. If we assume that the
cell in question is small, or that the speed of propagation is infinite (or at least very
large compared to other speeds and processes) then K tends to infinity and the last
term tends to zero. What we have then is an equation which expresses the membrane
potential in terms of the ionic currents into and out of the cell, the ionic currents being
given in the form IX = gX (V − VX).
The parameters m, n and h control the number of channels open to a particular ion,
these parameters vary with membrane potential and it is through this feedback of
membrane potential (potential determines m, n and h which determine ionic currents
which affect membrane potential) that the system is capable of generating action po-
tentials.
The equilibrium potential VX for the species X is the membrane potential which would
arise if there were zero flux of that ion across the membrane, i.e., the concentrations of
that ion inside and outside the cell were in equilibrium. The mathematical expression
for this potential was first formulated by Walther Nernst [59]:
VX =
RT
FzX
· log
(
[X]o
[X]i
)
(2.3)
where R, T , and F are the ideal gas constant, the absolute temperature, and the Fara-
day constant respectively, zX is the charge on the ion X, and [X] is the concentration
of ion X with the subscipts o and i standing for outside the cell and inside the cell,
log here representing the natural logarithm.
2.5.2 DeBoer
There are several different frequencies present in the subsystems that make up the
cardiovascular system, some are very obvious, such as the frequency of the heart beat
and the frequency of respiration. Some are less obvious and do not arise from a single
oscillatory source but from the interplay between system components and their feed-
back control mechanisms. For example, the heart rate is controlled in part by feedback
from blood pressure sensors in the neck. Feedback from these pressure sensors (barore-
ceptors) comes in two forms of nervous activation, vagal and sympathetic. A model
first published by DeBoer [22] shows that the difference in speed between the vagal
and sympathetic nervous systems, or more accurately the slowness of the sympathetic
nervous system, can lead to a 0.1Hz oscillation in blood pressure. The frequency of
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0.1Hz from DeBoer’s model is purely emergent from the feedback system, it is not a
reflection of some other frequency such as heart rate or breathing but a property of
the system as a whole.
Debate continues as to whether such oscillations in actual subjects are the result of a
feedback instability, as in DeBoer’s model, or come from an oscillator within the vagal
nervous system itself. It is sufficient for our purposes to know that, as a consequence of
autoregulatory systems, there can be periodic oscillations in blood pressure and blood
flow. The important feature of these oscillations is that they reflect the contributions
of all parts of the autoregulatory system; as highlighted in [55], all parts of a feedback
system contribute to its gain and natural frequency, so the removal of one element will
change the behaviour of the system as a whole. It is for this reason that we would expect
to see a change in the autoregulatory system reflected in a change in the correlation
between ABP and CBFV, hence why the result from [40] is intriguing.
2.5.3 Yang
In a 2003 paper [82] Yang describes a model of the VSMC including three main parts:
the electrochemical processes of ions entering and leaving the cell, the kinetics of phos-
phorylation of myosin cross bridges, and the mechanical interactions that ultimately
determine the force sustained by the VSMC. This model contains several of the key
elements that we are interested in modelling here.
Yang’s electrochemical model is a lumped-parameter Hodgkin-Huxley type represen-
tation which accounts for changes in membrane potential via the equation:
dVm
dt
= − 1
Cm
(ICa,L + IK + IK,Ca + IKi + IM + INa,Ca + INa,K + ICa,P + IB) (2.4)
where Vm is the cell membrane potential, Cm is the capacitance of the cell membrane,
and IX,Y is generally the current attributable to the flow of an ion through a particular
channel. Crucially, IM is the total stretch-sensitive current across the membrane, a
current which increases with increasing strain on the VSMC.
This electrochemical model goes together with a fluid compartment model that includes
one compartment for the cytoplasm, one compartment for the extracellular space and
another compartment for the sarcoplasmic reticulum, which serves an important role in
buffering the concentration of Ca2+. Through the coupling of this fluid compartment
model and the electrochemical model, it is possible to keep track of all of the ionic
currents between the compartments and therefore the concentrations of each species
within each compartment and hence the potential of the cell membrane.
The second element of Yang’s model is taken from Hai and Muphy [31] and comprises
a 4-state kinetic model describing the attachment and phosphorylation of actin and
myosin filaments; this provides the molecular basis for smooth muscle contraction.
The important feature of this representation is the way in which it links the electro-
chemical model and the mechanical model of the cell. The link to the electrochemical
model is through the rate constants for phosphorylation of myosin filaments which
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is represented as having a sigmoidal dependance on the concentration of the calcium-
calmodulin complex, which in turn is strongly related to the concentration of free Ca2+.
The force generated by the myosin filaments depends on the number of them which
are in particular states (attached, phosphorylated). In this way the concentration of
Ca2+ in the cytoplasm, which is an output of the electrochemical model, affects the
force generated by the myosin filaments in the cell.
The final part of Yang’s model is a mechanical, spring-and-damper type of model rep-
resenting the passive stiffness of the whole cell, the stiffness of latched myosin filaments
and the tension generated by the cycling cross-bridges actually pulling the actin and
myosin strands past each other. There is also a term modulating the active force by
the amount of overlap between the actin and myosin filaments. Overall this part of the
model takes, as inputs, the states of the kinetic model and translates them into the
length of the VSMC.
Yang has combined three models to produce a viable, and near complete, model of the
smooth muscle cell, and validated several aspects of it against experimental data. One
thing that is conspicuous by its absence however is any mention of NO.
Furthermore the implementation of the myogenic response in Yang’s model is flawed.
Whereas this model includes a stretch-sensitive leakage current, it is well established
that the myogenic response is driven by stress, not stretch. In fact due to the negative
relationship between stress and stretch found in the autoregulating regime, a stretch-
sensitive leakage current would act in the opposite sense to that which is observed –
only limiting dilation rather than causing constriction.
2.5.4 Stalhand
A slightly modified version of Yang’s mechanical model of the VSMC is combined with
Hai and Murphey’s 4-state kinetic model in an energy based treatment of the system
given by Stalhand [75]. In his work a general expression of the mechanochemical model
is given and it is then shown that the model of Yang is recovered by a linearisation of
the general model in the case of small strains. Stalhand’s formulation is somewhat more
thorough than Yang’s and its generality, especially over larger strains, is an advantage
when seeking to build a vessel model in which radius may increase by a factor of
two.
2.5.5 Abatay
In the last chapter of his thesis [8], Abatay attempted to take the model proposed by
Yang [82] and modify it to include the mass transport and vasodilatory effects of NO.
In fact Abatay presents several different models in his thesis; when a reference is made
here to ‘Abatay’, the model presented in chapter 6 is meant. This adaptation comprises
of several changes, firstly the electrochemical model is replaced by a much simplified
version that only includes the Ca2+ dynamics, ignoring the other ions; secondly a
2.5 Mathematical Models in the Literature 25
model of NO mass transport is included, and thirdly the stretch-sensitive currents are
removed.
The electrochemical model used by Abatay is taken from Gonzalez-Fernandez, 1994
[28] and has only three states, the open probability of a Ca2+ -sensitive K+ channel,
the internal concentration of Ca2+, and the membrane potential. This model also has
the feature that it oscillates in its ‘steady-state’. In other words, the electrochemi-
cal model does not reach a single equilibrium state but rather tends towards a stable
oscillation involving the release and re-uptake of Ca2+ . This baseline oscillation in
[Ca2+] could be thought of as representing what is known as vasomotion; the spon-
taneous oscillation in vascular tone that is found in many mammals under certain
conditions, and is of myogenic origin [60]. Myogenic means ‘generated by the muscle’
and in this context refers to the fact that vasomotion is not a response to oscillatory
nervous stimulation, rather it is a result of the feedback mechanisms inherent in muscle
cells themselves. Vasomotion is thought to enhance oxygen transport under conditions
of reduced flow [60, 32]. It is debatable whether a model of the effects of NO should
include an oscillatory electrochemical model. Certainly the use of a model which is
capable of spontaneous [Ca2+] oscillations under certain circumstances is desirable, in
order to provide verisimilitude, but it should not necessarily exhibit this behaviour
under normal, baseline conditions.
Abatay’s NO model builds on that presented in [63] by also including the concentration
of NO in the blood. Production of NO is assumed to be proportional to shear stress
at the vessel wall, which means that in steady-state NO production is proportional
to pressure gradient and vessel radius. The vasodilatory effect of NO is modelled
through a sigmoidal relationship between the dephosphorylation rate of the 4-state
kinetic model and the concentration of NO in the vessel wall1. This means that [NO]
has an effect converse to that of [Ca2+]; NO facilitates dephosphorylation of myosin
chains while Ca2+ facilitates phosphorylation. Whilst proportionality with shear stress
is consistent with the current knowledge of NO production [13], it means that NO
acts as a form of positive feedback on the system: if the vessel dilates, shear stress
rises (as flow velocity rises) and so more NO is produced which causes the vessel to
dilate further. The system doesn’t actually tend towards dilation indefinitely due to
the passive stiffness of the VSMC, but an increase in ABP in the model leads to a
greater increase (proportionally) in blood flow.
A key feature which is lacking from the Abatay model is the myogenic response. In
order to properly include the myogenic response however, a different electrochemical
model is necessary.
2.5.6 Rowley-Payne
Another candidate for the electrochemical model is that proposed by Payne and Rowley
[69]. This model is a Hodgkin-Huxley type model of the cell membrane including
1It is assumed that NO diffuses perfectly throughout the vessel wall so that even though it is
produced in the endothelium, it is present in identical concentration in the VSMC.
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single currents for Ca2+ , K+ and Na+ that only depend on membrane potential and
a stretch-sensitive leakage current as described in [82]. This stretch-sensitive current
is a problem as mentioned in relation to Yang’s model. Additionally this simplified
model is not capable of spontaneous, vasomotion-generating oscillations under any
circumstances.
2.5.7 Jacobsen
Jens Jacobsen from the University of Copenhagen developed a model of the VSMC
for his investigations into the effect of cGMP on calcium waves/oscillations in vascular
smooth muscle [41]. Jacobsen was interested in the transition from a state where
waves of high [Ca2+] travelled from one end of a cell to the other to a state where
[Ca2+] in the whole cytoplasm oscillates as one. His work was undertaken with a
view to understanding the process by which [Ca2+] waves in cells transition to whole-
cell [Ca2+] oscillations and so go on to synchronised oscillations amongst all VSMCs,
resulting in vasomotion. As mentioned in §2.4, the role of cGMP in this process may be
critical to the transition from [Ca2+] waves to whole-cell [Ca2+] oscillations. Jacobsen’s
model of the VSMC describes a cell divided along its length into many finite elements,
through which substances diffuse at a finite rate. If these spatial variations are ignored,
i.e., no division of the cell and instant diffusion, then the resulting model is complex
enough to enable vasomotion-generating oscillations in [Ca2+].
The model is similar to Yang’s in that there are three fluid compartments, the cy-
toplasm, the sarcoplasmic reticulum (SR) and the extracellular space. Although the
currents for all of the ions are included in the model, the actual concentrations of
all but Ca2+ are assumed to be constant within the cytoplasm because their native
concentrations are so high that the small flux across the cell membrane makes very
little difference. The currents are included because of their important influence on
membrane potential. Another important feature is that both the cytoplasm and the
SR contain a Ca2+ buffer, this is a substance that binds to Ca2+ in proportion to
[Ca2+] and has the effect of maintaining [Ca2+] in a smaller range than would be the
case in its absence. The elements of the cell which are represented in Jacobsen’s model
are shown in fig. 2.5.
The first stage of Jacobsen’s test of his model is to see what happens if all of the cur-
rents across the cell membrane are switched off and so only the interaction between the
cytoplasm and the SR remains. The result (under certain conditions) is an oscillation
in cytoplasmic [Ca2+] and an inverse oscillation in the SR. The reason that this system
oscillates, rather than settling at a single steady-state, is that there is a fast acting pos-
itive feedback mechanism that reinforces Ca2+ release from the SR into the cytoplasm
once a threshold level of Ca2+ has been reached in the cytoplasm, this mechanism is
referred to as Calcium-Induced Calcium Release, or CICR. There is a higher thresh-
old of cytoplasmic [Ca2+] beyond which the SR calcium release channel is inhibited
rather than activated, but the binding of Ca2+ to the inactivation site is somewhat
slower than binding to the activation site. Once enough Ca2+ has been released and
enough time has passed to allow the binding of Ca2+ to the inactivation sites on the
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Figure 2.5: Schematic of the cell model in [41], the labelled structures are: 1) Na+ - K+
ATPase, 2) Na+ - Ca2+ exchanger, 3) cell membrane Ca2+ ATPase, 4) SR Ca2+ ATPase,
5) SR Ca2+ release channel, 6) cytosol Ca2+ buffer, 7) SR Ca2+ buffer, 8) cGMP sensitive,
Ca2+ dependent Cl− channel, 9) voltage dependent, Ca2+ sensitive K+ channel, 10) voltage
dependent Ca2+ channel (L-type channel). Background leakage and stretch sensitive ion
channels are not shown.
SR Ca2+ release channels, the channels become inactive and the cytoplasmic Ca2+ is
pumped back into the SR, against the concentration gradient, by a calcium-ATPase.
An ATPase is a pump that transports ions across a membrane against their natural
concentration gradient, so named because they require the energy available from ATP
(adenosine-triphosphate) to do so. The restoration of Ca2+ to the SR takes enough
time for the unbinding of Ca2+ from the inactivation sites and the cycle can start again
with the slow leakage of Ca2+ into the cytoplasm from the SR.
Another feature of Jacobsen’s model is that it includes the influence of a substance
called inositol-1,4,5-triphosphate, or IP3. This may well be useful in an advanced
stage of investigation because it is through the production of IP3 that phenylephrine
effects vasoconstriction, so its inclusion in the model may make it possible to directly
compare the effects of eNOS inhibition and α-adrenergic stimulation (application of
phenylephrine).
2.5.8 Cornelissen and Carlson
A model consisting of 10 resistance compartments in series, each with different reac-
tances to flow, pressure, and metabolic factors, is presented by Cornelissen et al. in
[19]. The responses of the different generations of vessels were fitted primarily to data
from Liao and Kuo [46, 53]. Although the responses are fitted to these data, the func-
tions defining them are not derived from a physical model. The authors tuned the
relative strengths of the three mechanisms (myogenic, flow-induced, and metabolic) in
the different generations of blood vessels to replicate the tone and pressure distribu-
tions seen in the data. Whilst very instructive in the higher level interactions of these
mechanisms, the lack of a physical model underlying the response curves limits the
usefulness of this approach for the purposes of understanding the processes leading to
vessel behaviour.
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A very similar model to that of [19] was developed by Carlson in [15]. This model
comprises of only 7 segments in series and includes the three mechanisms of myogenic
response, shear-induced vasodilation, and metabolic influence acting on all of the seg-
ments, to varying degrees. Again the modelling of the variation of wall tension due
to these factors is non-physical; no mechanical, kinetic, or biochemical mechanisms
inside the VSMC or endothelial cells are described. The equations representing the
three mechanisms are selected for their ability to re-create experimentally observed
behaviour.
2.5.9 Koenigsberger
In an investigation into the role of the endothelium on vasomotion [43], Koenigsberger
et al. model a population of VSMCs coupled to a population of endothelial cells. Their
model sought to explain the apparently contradictory experimental data on the role
of the endothelium in arterial vasomotion, some of which suggested that vasomotion
was abolished by the endothelium [73] or arose in its absence [73, 30, 49], some of
which suggested that the endothelium was necessary for vasomotion to occur [29, 39,
64, 61]. Through their model it was found that the action of the endothelium, in
reducing intracellular [Ca2+] in the VSMCs, could move [Ca2+] either into or out of the
range in which whole-cell [Ca2+] oscillations are sustainable, depending on the initial
concentration of Ca2+ . In other words, because there is only a finite range of [Ca2+] in
which whole-cell [Ca2+] oscillations can be sustained, the lowering of [Ca2+] by the
endothelium can either bring [Ca2+] down into that range, or lower [Ca2+] below that
range.
In a subsequent paper [44] Koenigsberger et al. use the same model to investigate
the effect of wall stress on the occurrence of vasomotion. They find that wall stress is
the principal determinant of intracellular Ca2+ in the VSMC (through the myogenic
response) and hence can either induce or abolish vasomotion similarly to the production
of cGMP by the endothelium.
2.6 Conclusions
Much has been discovered about the nature and mechanisms of vascular regulation,
and of the structure of the arteriole. The role of Ca2+ has been shown to be crucial in
modulating smooth muscle tone, and NO has been unveiled as the flow-induced relaxing
agent which antagonises the myogenic response. The endothelium has been identified as
the source of this NO release. Mathematical models have successfully reproduced many
aspects of the behaviour of the components of the arteriole, such as the smooth muscle
cell, although no physically based model has yet combined the myogenic response and
the influence of NO to successfully reproduce the behaviour observed in [45]. In fact,
several models have mistakenly modelled the myogenic response as a stretch-dependent
phenomenon, when in reality the observed response of arterioles to persistent increases
in intramural pressure could only be produced by a stress-dependent mechanism.
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The phenomenon of vasomotion has been observed and modelled and some understand-
ing of the conditions under which it occurs has been gained. It has been suggested by
mathematical modelling of coupled groups of cells that there is a range of pressures
and flow states outside which vasomotion cannot arise.
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Chapter 3
A Model of Vascular Regulation
3.1 Introduction
As stated in § 1.4, this study is concerned with explaining the lack of impact of eNOS
blockade on blood pressure oscillations, presented in [40] and described here in § 2.3.3,
which we believe to be linked to cerebral autoregulation. We begin by hypothesising
about the lack of apparent change in ABP-CBFV correlation after inhibition of eNOS.
Some possibilities are:
1. NO is not involved in cerebral autoregulation at all, so inhibiting the enzymes
that produce it has no effect on the ABP-CBFV correlation.
2. Cerebral autoregulation is not, in fact, reflected by changes in ABP-CBFV cor-
relation.
3. Stimulation of α-adrenoreceptors by phenylephrine overrides the influence of NO,
so that instead of comparing an NO depleted condition with a normal condition
but with matching ABP, what is actually being compared is a case where NO is
depleted and a case where NO is abundant but ineffective.
4. There is still enough NO after inhibition of eNOS to regulate the blood flow by
the same proportion as before.
5. Some other vasodilatory mechanism takes over from NO release when eNOS is
inhibited maintaining the same correlation between ABP and CBFV.
Number 1 seems very unlikely; NO is a vasodilator found in the arterioles of the brain
and as such must be either used in autoregulatory mechanisms or compensated for
by those mechanisms, either way removing it would have an effect on autoregulation.
Number 2 is possible, although again it seems unlikely; we may not be able to predict
the actual nature of the change in ABP-CBFV correlation that we would expect to
see for any given change in cerebral autoregulation but, as explained in § 2.5.2, we
would expect to see a change of some kind. Number 3 is a strong contender, the
mechanism by which phenylephrine causes the VSMCs to contract is certainly not
independent from that by which NO causes them to relax; it could well be the case
that the introduction of phenylephrine inhibits autoregulation just as much as the
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depletion of NO. Possibility 4 also has potential, and it could be a significant effect
either a) because the inhibition of eNOS by L-NMMA is not as complete as assumed
and/or the rate of decay of existing NO is lower than thought, both leading to more NO
remaining after eNOS blockade than was assumed, or b) the amount of NO remaining
after eNOS blockade is small but because the blood vessel is in a contracted state,
the amount of NO required to modulate the bloodflow according to the demands of
autoregulation is also small, so although there is little NO available, there is more
than enough to maintain autoregulation around the new, low radius, operating point.
Number 5 is another possibility, although it seems that if any of 1-4 can be shown
to be feasible then this explanation should be discarded on the grounds of excessive
complexity.
To continue investigations into the viability of proposals 3 and 4 it is clear that a model
of the system is required. The model must include the production of NO and factors
affecting the rate of that production, e.g., the effect of shear stress on the production of
NO in the endothelium; the release and uptake of Ca2+ in the smooth muscle cells; the
relationship between the concentrations of the species in the VSMC and the contraction
of the same; the effects of each species on the interactions of the others, e.g., the effect
of NO on the dephosphorylation of myosin cross bridges [63].Essentially the model
needs to be sufficiently complex that it can eventually provide some insight into the
results shown in [40] and hence give us some better understanding of what might be
going on. Here, and indeed as should be the case in all mathematical models, we aim
to construct the simplest model possible which can shed light on the role of NO and
it’s interactions with the myogenic response. For this reason some parts of the model
will be necessarily complex - to reflect the true action of the VSMC - whilst some
parts can very simple. For instance, it is considered necessary to include the kinetics
of myosin phosphorylation and attachment, and the subsequent mechanical effects of
myosin cross-bridge cycling in order to accurately represent the effects of Ca2+ and
NO on the vessel radius - this being the key interaction under investigation. Similarly,
the production and transport of NO through the system should be given its proper
physical basis in the equations. In contrast, the full complexity of the NO-cGMP
pathway need not be represented explicitly - it is sufficient to put in place a reasonable
approximation to the mapping that an enzyme mediated pathway produces between
NO and cGMP. Nor is the complexity of a full biochemical model of the VSMC (with
all the associated ionic currents and channel activations) considered to be justified by
this investigation. It is sufficient that [Ca2+] is a state of the model and that the
overriding influence on [Ca2+] is the stress in the vessel wall, as per the myogenic
response. Further elaborations on the work presented here may seek deeper insight
into the particulars of the processes which we have represented simply, but here we
constrain ourselves to the simplest model which can produce insights of value.
Such a model as described above is presented here, consisting of several sub-models
connected by shared states, as shown in fig. 3.1. The NO model calculates the rate of
change of NO concentration in the vessel wall dependent on ABP and the given vessel
radius. The [NO] – [cGMP] relationship converts [NO] into [cGMP]. The myogenic
response model uses ABP and cell length, λ, to calculate stress in the vessel wall,
and hence the rate of change of [Ca2+] . The 4-state kinetic model uses [Ca2+] and
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[cGMP] to calculate the phosphorylation and attachment of the myosin cross-bridges
in the VSMC. Finally the mechanical model calculates the rate of change of VSMC
length, which is then converted into the rate of change of vessel radius – thus completing
the feedback loop.
NO Model
Vessel 
Equilibrium 
Equations
Myogenic 
Response 
Model
NO-cGMP 
Relationship
4-State Kinetic 
Model
Mechanical 
Model
Figure 3.1: Model schematic; boxes represent sets of equations and lines represent states as
they are propagated through the model. ABP is set externally.
3.2 Model Equations
3.2.1 NO model
The NO model has two compartments: the vessel wall, and the blood in the vessel
lumen. NO is produced in the vessel wall at a constant rate, sw, supplemented by a
shear-stress-dependent production, kτ
τˆ
Aw
, where kτ is a constant and τˆ is the normalised
shear stress at the inner vessel wall surface. The cross-sectional areas of the lumen and
the vessel wall are Ab and Aw respectively. The area of the wall, Aw, is assumed not to
deviate from its value at baseline conditions. This is equivalent to a constant volume
assumption for the vessel wall. Diffusion into the blood from the wall is assumed to
be proportional to the relative concentration difference between the two compartments
with constant of proportionality hw. Blood entering the upstream end of the vessel
has an NO concentration of Cin; as it progresses downstream more NO is accumulated
in the blood from the vessel wall. The NO concentration in the vessel wall, Cw, is
assumed to be constant along the length of the vessel. NO decays in both the wall
and the blood with time, although the decay rate in the blood, rdb, is much higher
than that in the wall, rdw, due to NO scavenging by haemoglobin. Thus the governing
equation for the NO concentration in the blood, Cb, at a downstream distance, x, from
the entrance to the arteriole is:
dCb(x)
dx
=
1
Q
· (hw (Cwe − Cb(x))− rdbAbCb(x)) (3.1)
where Q is the volumetric blood flow rate given by Poiseuille’s law (eq. (2.1)) and Cwe
is the effective NO concentration in the vessel wall, given by:
Cwe =
Cw
γwb
(3.2)
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such that when Cw = γwbCb, i.e., Cwe = Cb, there will be no transport of NO between
the vessel wall and the blood. In the absence of other processes, the equilibrium
concentration of NO in the wall would be greater than that in the blood by a factor of
γwb.
The spatially averaged NO concentration in the blood over a distance L from the
upstream end of the vessel is calculated from the solution to eq. (3.1) to give:
C¯b =
(
hwCwe
hw + rdbAb
− Cin
)
·
(
1− Q
(hw + rdbAb)L
·
(
1− e−(hw+rdbAb) LQ
))
+ Cin (3.3)
The rate of change of [NO] in the vessel wall is then calculated using this spatial average
concentration, C¯b. Thus assuming that the net effect of NO transfer to the blood on the
NO concentration in the wall can be approximated by using the difference between the
spatially homogenous NO concentration in the vessel wall and the spatially averaged
concentration in the blood, we can write the following equation for the conservation of
mass of NO:
dCw
dt
=
−hw
Aw
· (Cwe − C¯b)− rdwCw + sw + kτ τˆAw (3.4)
The normalised shear stress is given by:
τˆ =
∆P
∆P0
· r
r0
(3.5)
3.2.2 [NO] – [cGMP] relationship
The mapping from [NO] to [cGMP] assumed here is that the logarithm of [cGMP] is a
sigmoidal function of [NO]. This is done so that the range of [NO] values from the NO
model corresponds with the active range of [cGMP] values from [50] and to reflect the
fact that the pathway by which cGMP production is stimulated by NO is limited by
the availability of soluble guanylate cyclase in the VSMC [23]. We define:
p[cGMP ] = log10([cGMP ]) (3.6)
which is given by a sigmoidal function of [NO]:
p[cGMP ] = p[cGMP ]L +
p[cGMP ]U − p[cGMP ]L
1 + e−
[NO] −zhalf
kz
(3.7)
where p[cGMP ]L and p[cGMP ]U are constants representing the lower and upper bounds
on [cGMP] respectively and zhalf and kz are functions of similar bounds on [NO] given
by:
zhalf = [NO]L +
[NO]U − [NO]L
2
(3.8)
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and:
kz =
[NO]L − [NO]U
2 ln
(
1
0.95
− 1) (3.9)
The definition of a sigmoid in this fashion may seem obscure at first but actually it
allows a better intuitive grasp of the active range of the function; the four parameters
defining the relationship are the two saturation limits of the output, and the two input
values at which the function reaches 5% and 95% transition respectively from the
lower output saturation value to the higher. It is from this formulation that eq. (3.9)
is derived; a graphical representation is given in fig. 3.2.
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Figure 3.2: [NO] – p[cGMP] relationship. The coordinates of the two black circles are given
by the parameters defining the function: ([NO]L, p[cGMP ]L) and ([NO]U , p[cGMP ]U )
The [NO] – [cGMP] relationship is assumed to reach equilibrium instantly, or at least
to be much faster than the rest of the system and so to have negligible dynamics. This
assumption is made in the context of an NO model of tuneable speed, thus the overall
speed of the feedback between flow and VSMC tone via the NO model is still free in
the model as a whole.
3.2.3 Myogenic Response Model
Despite full implementation and testing of the electrochemical models described in
§ 2.5 [82, 8, 41, 69], we decided that a full electrochemical model of the cell was an
unnecessary introduction of complexity at an early stage in the investigation. For the
initial stage of replicating behaviour in the absence of vasomotion it is only necessary
to model behaviour in line with the wall tension hypothesis of the myogenic response.
The ability of an electrochemical model to replicate spontaneous vasomotion may be
necessary at a later stage, in which case one of the more complex biochemical models
may be re-inserted.
For the present implementation then, we have only to define a function relating stress in
the vessel wall, σ, to equilibrium [Ca2+], [Ca2+]; for this we will use a sigmoidal function
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of exactly the same form as that of the [NO] – [cGMP] relationship of § 3.2.2:
p[Ca2+] = p[Ca2+]L +
p[Ca2+]U − p[Ca2+]L
1 + e−
σ−zhalf
kz
(3.10)
where, as before,
p[Ca2+] = log10
(
[Ca2+]
)
(3.11)
and in which zhalf and kz are functions of the bounds of the active region of σ given
by:
zhalf = σL +
σU − σL
2
(3.12)
and:
kz =
σL − σU
2 ln
(
1
0.95
− 1) (3.13)
In this context, σ does not strictly signify stress in the vessel wall, rather force per unit
vessel length, being defined as:
σ =
Pr
tw
(3.14)
where P is intramural pressure, r is vessel internal radius, and tw is thickness of the
vessel wall. The concentration of Ca2+ is assumed to tend towards its equilibrium value
[Ca2+] with first order dynamics dictated by the time constant τCa:
d[Ca2+]
dt
=
1
τCa
(
[Ca2+]− [Ca2+]
)
(3.15)
3.2.4 4-state Kinetic Model
The 4-state kinetic model from [31] describes the attachment and phosphorylation of
myosin cross-bridges. The proportions of the total number of cross-bridges are: M ,
myosin cross-bridges; Mp, phosphorylated cross-bridges; AMp, phosphorylated and at-
tached cross-bridges; and AM , attached, non-phosphorylated cross-bridges. Rate con-
stants, K, govern the transitions between states (i.e., phosphorylation/dephosphorylation
and attachment/detachment) such that the state derivatives are given by:
d
dt

M
Mp
AMp
AM
 =

−K1 K2 0 K7
K1 −K2 −K3 K4 0
0 K3 −K4 −K5 K6
0 0 K5 −K6 −K7
 ·

M
Mp
AMp
AM
 (3.16)
subject to:
M +Mp+ AMp+ AM = 1 (3.17)
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Figure 3.3: The four state kinetic system of myosin cross-bridges, adopted from Hai and
Murphy, [31].
The phosphorylation and dephosphorylation rate constants are assumed to depend on
[Ca2+] and [cGMP] in order that the effects of MLCK and MLCP respectively can be
simulated. It is via these rate constants that the myogenic response and the NO model
exert their influence on the mechanical model, and so on the behaviour of the vessel.
The phosphorylation rates are modulated by the concentration of Ca2+ :
K1 = K6 =
[Ca2+]nCa1
[Ca2+]nCa1 + k
nCa1
Ca1
(3.18)
whereas the de-phosphorylation rates are negatively modulated by [Ca2+] and posi-
tively modulated by [cGMP]:
K2 = K5 = 0.55 + 2 · [cGMP ]
ncGMP
[cGMP ]ncGMP + kncGMPcGMP
· k
nCa2
Ca2
[Ca2+]nCa2 + k
nCa2
Ca2
(3.19)
3.2.5 Mechanical Model
The mechanical model is based on those of Yang [82] and Stalhand [75]. The elastic
extension of myosin cross bridges has been omitted here as their stiffness is so high that
the error introduced by assuming that the cross bridges are rigid is negligible. Thus the
model consists of two parallel elements, one active element representing the overlapping
actin and myosin filaments, and one passive element, representing the passive stiffness
of the cell, fig. 3.4.
The force in the active element is determined by the viscous friction coefficients f1 and
f2 (for phosphorylated and un-phosphorylated attached myosin cross bridges respec-
tively):
Fa = l0
(
f1AMp
(
vˆ + λ˙
)
+ f2AMλ˙
)
e−(λ−λopt)
2
(3.20)
where normalised cross-bridge cycling speed vˆ = v/l0 and normalised cell length λ =
lcell/l0. The passive element takes the form of an exponential spring-like element, giving
38 A Model of Vascular Regulation
3.5 Mechanical Model 27
of two parallel elements, one active element representing the overlapping actin and myosin
filaments giving an active force:
Fa = l0
(
f1AMp
(
vˆ + λ˙
)
+ f2AM λ˙
)
e−(λ−λopt)
2
(3.15)
and one exponential spring-like element, giving a passive force:
Fp = q1
(
eq2(λ−1) − 1) (3.16)
where vˆ = v/l0 and λ = lcell/l0. Figure 3.3 shows the contributions of the passive and active
sides of the mechanical model to total force in the cell over a range of cell lengths for a fixed
phosphorylation state. Note that the peak active force is reached when λ = λopt = 1.4; this is
when the overlap between myosin and actin filaments is maximal.
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Figure 3.3: Contributions of the parallel passive and active elements of the mechanical muscle cell
model at high phosphorylation for a range of cell lengths: Fa - dot-dashed - force generated in the
active element by the friction of cycling (phosphorylated and attached) cross-bridges, equation (3.15);
Fp - dashed - force generated by the passive element, equation (3.16); FCell - solid - total force in the
cell, the sum of passive and active contributions, equation (3.19).
Normalised cell length is related to radius with:
r =
1
2
(
λl0nc
π
− tw
)
(3.17)
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π
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where nc is the number of VSMCs end-to-end around the circumference of the vessel and tw is
the vessel wall thickness. The expansive force of the blood pressure can be equated with the
contractive force of the muscles, for a single cell of width wc:
FCell = wc · P · r (3.19)
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Figure 3.4: Schematic of the mechanical model showing the active force generating sarcomere
(upper) and the passive non-linear spring element (lower).
a passive force:
Fp = q1
(
eq2(λ−1) − 1) (3.21)
The sum of the active and passive forces gives the total force in the cell:
FT = Fa + Fp (3.22)
Figure 3.5 sh ws the contributions of the passive nd active sides of the mechanical
model to total force in the cell over a range of cell lengths for a fixed phosphorylation
state. Note that the peak active force is reached when λ = λopt = 1.4 here; this is when
the overlap between myosin and actin filaments is maximal.
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Figure 3.5: Contributions of the parallel passive and active elements of the mechanical muscle
cell model at high phosphorylation for a range of cell lengths: Fa - red, dot-dashed - force
generated in the active element by the friction of cycling (phosphorylated and attached) cross-
bridges, eq. (3.20); Fp - blue, dashed - force generated by the passive element, eq. (3.21); FCell
- black, solid - total force in the cell, the sum of passive and active contributions, eq. (3.24).
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Normalised cell length is related to radius by:
r =
1
2
(
λl0nc
pi
− tw
)
(3.23)
where nc is the number of VSMCs end-to-end around the circumference of the vessel
and tw is the vessel wall thickness. The expansive force of the blood pressure can be
equated with the contractive force of the muscle from eq. (3.22), for a single cell of
width wc:
FT = FCell = wc · P · r (3.24)
where P denotes intramural pressure; the difference in pressure between the blood
within the vessel and the tissue surrounding the vessel.
3.3 Solution of the Model in the Steady-State
The model has been presented as a series of ODEs and algebraic equations. In order to
solve for the equilibrium state of the model it is necessary to set the state derivatives
to zero and rearrange the equations to be explicit in terms of the equilibrium state
values, rather than the state derivatives. In the equilibrium case, the model has inputs:
intramural pressure, P , and pressure drop along the vessel, ∆P ; the outputs are the
equilibrium states of the system, principally the radius of the vessel, or rather length
of the cell, which is related to the vessel radius by eq. (3.23). The overall form of the
steady-state model is then:
x =
 [Ca2+]Cw
λ
 = f(P,∆P ) (3.25)
where x is the state vector in the steady-state case, i.e., x = x when x˙ = 0. The follow-
ing sections detail the method of solution for each part of the model under equilibrium
assumptions.
3.3.1 NO
Let us simplify our notation for brevity and define:
ψ = 1− Q
(hw + rdbAb)L
·
(
1− e−(hw+rdbAb) LQ
)
(3.26)
such that eq. (3.3) becomes:
C¯b =
(
hwCwe
hw + rdbAb
− Cin
)
· ψ + Cin (3.27)
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We then rearrange eq. (3.4) for Cw after setting
dCw
dt
= 0 to get:
Cw =
hw
Aw
C¯b + sw + kτ
τˆ
Aw
hw
Awγwb
+ rdw
(3.28)
Into which we can substitute eq. (3.27) and rearrange to yield the equilibrium equa-
tion:
Cw =
hw
Aw
Cin (1− ψ) + sw + kτ τˆAw
hw
Awγwb
+ rdw − h2wAw(hw+Abrdb)γwbψ
(3.29)
3.3.2 Myogenic Response
The myogenic response model is trivial to solve in the steady-state, we simply rearrange
eq. (3.15) with d[Ca
2+]
dt
= 0 to get:
[Ca2+] = [Ca2+] (3.30)
3.3.3 4-state Kinetic
Let the vector of states in the 4-state kinetic model be denoted by:
[M,Mp,AMp,AM ]T = α (3.31)
and its equilibrium value by α, then setting the derivatives to zero, eq. (3.16) be-
comes:
0 =

−K1 K2 0 K7
K1 −K2 −K3 K4 0
0 K3 −K4 −K5 K6
0 0 K5 −K6 −K7
 ·α (3.32)
This matrix, K, is rank-deficient and so non-invertible. To solve for the equilibrium
state vector α we replace one line of eq. (3.32) with eq. (3.17), yielding an invertible
matrix and so the equilibrium solution:
α =

−K1 K2 0 K7
K1 −K2 −K3 K4 0
0 K3 −K4 −K5 K6
1 1 1 1

−1
·

0
0
0
1
 (3.33)
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3.3.4 Mechanical
To solve the mechanical model in the steady-state we set λ˙ = 0 in eq. (3.20), giving
the relation:
FT = Fp + Fa|λ˙=0 = q1
(
eq2(λ−1) − 1)+ l0f1α3vˆe−(λ−λopt)2 (3.34)
Here force in the cell is a function only of its current length and the proportion of cycling
cross-bridges (α3 = AMp, as per eq. (3.31)). The value of λ at which FT = FCell from
eq. (3.24) is then found by solving:
0 = Fp + Fa|λ˙=0 − FCell (3.35)
0 = q1
(
eq2(λ−1) − 1)+ l0f1α3vˆe−(λ−λopt)2 − wcP 1
2
(
λl0nc
pi
− tw
)
(3.36)
Unfortunately there is no analytical solution to eq. (3.36), instead it must be solved
numerically, in this case a modified Newton-Raphson method was used.
3.4 Solution of the Dynamic Model
In the dynamic case the equations of the model remain as they are presented in § 3.2.
The driving inputs to the model are P (t) and ∆P (t), both of which are functions of
time. The states of the model are the concentration of Ca2+ in the vessel wall, the
concentration of NO in the vessel wall, and the normalized length of the VSMCs which
constitute the vessel wall, as in eq. (3.25), and so the system of ODEs governing these
states, given by eqs. (3.4), (3.15) and (3.20) respectively, takes the form:
x˙ = f(x, P (t),∆P (t)) (3.37)
This system is solved using either a custom fixed-step solver or one of MATLAB’s built-
in ODE solvers, depending on which is more appropriate for the specific task.
3.5 Assumptions
As with any mathematical representation of a physical system, a number of assumptions
have been made and the principle ones shall be discussed here, grouped by the part of
the model to which they relate.
NO
1. The diffusion of NO is calculated using volume-averaged concentrations.
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2. The transport of NO between the blood and the endothelial cells is assumed to
be linear, whilst the transport of NO from the endothelium into the VSMCs is
assumed to be perfect.
3. The relationship between pressure and flow is assumed to follow Poiseuille’s law,
despite the presence of red blood cells and other bodies in the blood meaning
that it is not a Newtonian fluid.
4. The relationship between [NO] and [cGMP] is assumed to be sigmoidal and to
equilibrate instantly.
5. The concentration of NO in the blood entering the vessel is assumed to be zero.
Myogenic
1. The myogenic mechanism is assumed to be sensitive only to circumferential stress
in the vessel wall, not to any other factors.
2. The myogenic mechanism is assumed to have the sole effect of raising [Ca2+] levels.
3. The dynamics of the myogenic response are assumed to be first order.
Kinetic
1. Phosphorylation and dephosphorylation rates of myosin cross-bridges are as-
sumed to be independent of attachment.
2. The dependance of phosphorylation and dephosphorylation rates on Ca2+ and
cGMP respectively are both assumed to be sigmoidal.
Mechanical
1. Force from sliding of cycling cross-bridges and latch (attached, non-cycling)
bridges is assumed to be linear with sliding velocity; given the complex inter-
action between myosin and actin in smooth muscle filaments it is highly unlikely
that the friction force is simply proportional to the sliding speed.
2. Extracellular pressure is assumed to be constant, despite expansion of the blood
vessel to compress extracellular tissue. This assumption will vary in its validity
depending on the proximity of one vessel to another.
3. Supply pressure of the blood is assumed not to vary with vessel radius; whilst
this is valid for the variation in radius of an individual vessel, if the behaviour
of the vessel being modelled is representative of the behaviour throughout the
brain then the arterial blood pressure will be affected by changes in peripheral
resistance in the brain.
4. Forces in the vessel wall are assumed to be in equilibrium at all times, i.e., there
is no inertia associated with changes in vessel radius, what’s more, the changes
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in flow resulting from changes in vessel radius displacing blood volume are not
considered.
Most of these assumptions are reasonable approximations, and necessary for the con-
struction of a compact model. Some are more gross than others, and these may be
addressed in the future according to how severely they inhibit the ability of the model
to replicate the behaviour of the physiological system.
3.6 Conclusions
In this chapter we have presented a new model of the arteriole. This model includes
the myogenic response and the flow-induced release of NO from the endothelium. The
effects of these mechanisms on the contraction of the VSMC are modelled and thus
the feedback loop from vessel radius influencing flow and stress, to flow and stress
influencing vessel radius is completed. We have noted the simplifications that are
possible when the model is solved in the steady-state, and we have outlined the general
form of the model in the dynamic case. Although several aspects of the model as
presented are hypothetical approximations, the aim is to identify the nature of the
relationships that are necessary to accurately recreate experimental observations. To
this end it is thought better to start with simple relationships and complicate them as
necessary than to start with great complexity and later attempt to extract that which
is essential.
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Chapter 4
Fitting and Analysis of Vascular
Regulation Model
4.1 Introduction
Before our model can be used to make useful predictions about the behaviour of the
cerebral vasculature, first the parameter values must be determined. This is done here
by tuning the parameter values such that the behaviour of the model is as close as
possible to some experimental measurements of the behaviour of a real arteriole. In
this chapter we will first present the data to which we have chosen to fit the model.
We will then describe the fitting method before presenting the results of the model
fitting, both static and dynamic. Finally we will analyse the sensitivity of the model
to variance in the values of its parameters – highlighting those parameters which have
the greatest influence on the behaviour of the system.
4.2 Model Fitting Data
Ideally quantitative data would be available for all processes in our model, allowing
each process to be fitted individually before being compiled into a completely fitted
model. Unfortunately very few quantitative data are available for most of the processes
included in the model, and those quantitative results which are available often do not
come from a common tissue type or experimental condition. Where data are available
for low level structures and processes they invariably do not come from humans, espe-
cially not the brain. We are forced therefore to use data from other tissues, and indeed
other mammals, in the hope that a model built on such data can provide answers
to questions concerning the human cerebral vasculature. If we cannot build a useful
model on data from other animals then we might revisit the question of applicability
of data across species. A key exception to the general lack of low level quantitative
data (from any animal) is the work of Lee et al. [50] which does provide quantitative
data with which to fit the parameters of the 4-state kinetic model. For this reason
the parameters of the 4-state kinetic model will be fitted to the data of [50] before the
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other parameters of the model are fitted to the data of Kuo at al. [45] and Falcone et
al. [26]. The results presented in [45] are particularly suited to our purpose as they
include the steady-state responses of arterioles over a range of intramural pressures,
both with and without flow; they also include the dynamic responses of the same or
similar arterioles to step changes in pressure and flow, thus in theory providing enough
information to separate these two effects.
4.2.1 Fitting the 4-State Kinetic Model
Lee et al. [50] use the cGMP analogue 8-bromo-cGMP (8Br-cGMP) to investigate the
effect of cGMP on the phosphorylation of myosin light chains (myosin heads) and the
force subsequently generated by the VSMC. Although Lee’s results were obtained from
VSMCs extracted from rabbit femoral arteries, it is a reasonable working assumption
that the biochemistry of MLCK and MLCP is similar in VSMCs found in all mam-
mals; indeed we are forced to make this assumption due to the lack of experimental
data relating to isolated muscle cells, or even isolated arterioles, from humans. The
phosphorylation and dephosphorylation rates of the 4-state kinetic model have there-
fore been determined such that the phosphorylation of the model at varying levels of
[Ca2+] and [cGMP] agrees with the data presented in [50]. The phosphorylation rate,
eq. (3.18), depends solely on [Ca2+]. The dephosphorylation rate, eq. (3.19), depends
on [Ca2+] and on [cGMP]. Figure 4.1 shows the total phosphorylation of the 4-state ki-
netic model alongside the data from [50], to which the sigmoidal functions in eqs. (3.18)
and (3.19) were fitted; fitting was manual, by inspection.
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Figure 4.1: Proportion of maximum phosphorylation as a function of [Ca2+]. Hollow circles
are data from [50] for the control condition, [8Br-cGMP] = 0M. Filled circles are the data
from [50] for the [8Br-cGMP] = 2µM condition. Dashed lines are the values of relative
phosphorylation (AMp + Mp) from the 4-state kinetic model for values of [cGMP] between
0.1nM and 10µM.
Figure 4.2 shows the relative force generated by the cell at varying concentrations
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of cGMP and a fixed [Ca2+] of 1µM. The reason that the fitted sigmoid does not
exactly overlay the data is that there is an experimental discrepancy in [50]; the two
sets of experimental data shown in figs. 4.1 and 4.2 have slightly different values of
phosphorylation/force at their common point, [Ca2+] = 1µM, [cGMP] = 2µM, shown
by the magenta triangle in figs. 4.1 and 4.2, making it impossible to exactly fit both
data sets. Figures 4.1 and 4.2 can be thought of as perpendicular planar sections
through the same three dimensional surface, with dimensions phosphorylation/force,
[Ca2+], and [cGMP].
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Figure 4.2: Relative force developed by the VSMC against [cGMP]. Circles show data from
[50] for [Ca2+] = 1µM, dashed lines show the results of the 4-state kinetic model (converted
from phosphorylation to force using the equation given in the caption of Figure 3 of [50])
for values of [Ca2+] between 10nM and 100µM. The unmarked solid line represents model
behaviour at [Ca2+] = 1µM; this is the same condition at which the data were recorded.
The initial parameter values of the [NO] – [cGMP] relationship given in §3.2.2 are also
determined in part by the data of [50], the range of [cGMP] chosen was between 10−9M
and 10−7M, to coincide with the region of greatest sensitivity of force to [cGMP] in
fig. 4.2. The values of the 4-state kinetic model parameters are given in table 4.1:
some values have been taken from the original model presentation by Hai and Murphy
[31], whereas those relating to the effects of Ca2+ and cGMP have been found through
fitting outlined above.
4.2.2 Data to Fit the Model Overall
Here we will present the results of Kuo et al. [45] and Falcone et al. [26] and discuss
their significance in terms of the fitting of the present model before going into the detail
of the fitting process itself in §§ 4.3 and 4.4.
Figure 4.3 is reproduced from fig. 4 in [45] and shows the equilibrium diameter of
an arteriole across a range of intramural pressures in three different cases. The ‘Pas-
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Parameter Description Value Units Source
K3 phosphorylated attachment rate constant 0.4 1/s [31]
K4 phosphorylated detachment rate constant 0.1 1/s [31]
K7 non-phosphorylated detachment rate constant 0.01 1/s [31]
kCa1 phosphorylation Ca
2+ sensitivity constant 3× 10−6 M fit to [50]
nCa1 phosphorylation Ca
2+ sensitivity constant 0.85 – fit to [50]
kCa2 dephosphorylation Ca
2+ sensitivity constant 8× 10−7 M fit to [50]
nCa2 dephosphorylation Ca
2+ sensitivity constant 1.5 – fit to [50]
kcGMP dephosphorylation [cGMP] sensitivity constant 3× 10−8 M fit to [50]
ncGMP dephosphorylation [cGMP] sensitivity constant 1 – fit to [50]
Table 4.1: 4-state kinetic model parameters. Here and elsewhere in this thesis, M stands for
molar, or mol/L
sive’ case relates to an arteriole bathed in nitroprusside, which prevents Ca2+ from
being available to the VSMCs, whereas in the other cases the arteriole is bathed in a
Ca2+ containing solution; there is no flow in the passive case. In the ‘With flow’ case
∆P = 4cmH2O and the pressure quoted on the x -axis is the mean pressure. In the
‘Without flow’ case the pressure at each end of the vessel is equal. Diameters have
been normalized to the diameter in the passive case at a pressure of 60cmH2O.
Figure 4.3: The steady-state response of an arteriole to changes in intramural pressure (re-
produced from fig. 4 in [45]).
The dynamic responses of arterioles to step changes in P and ∆P are presented in
fig. 4.4, reproduced from fig. 2 in [45]. In the first subplot, A, it can be seen that in
response to a step increase in intramural pressure the arteriole first passively dilates
under the increased stress, then the myogenic response causes an increase in muscular
tone and the vessel gradually contracts down to a new steady-state diameter which is
smaller than the diameter before the step change in pressure. The second event in this
plot is the onset of flow through the vessel, which causes a dilation of the vessel. The
flow is short lived however, and the vessel returns to its previous baseline diameter
soon (but not immediately) after flow has ceased.
The steady-state results of Falcone et al. are shown in fig. 4.5. All of Falcone’s
experiments were conducted with the same pressure at each end of the isolated arteriole,
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MYOGENIC AND FLOW-INDUCED RESPONSES H1709 
1 min. 
FIG. 2. Example of interaction between pressure-induced myogenic responses and flow-dependent dilations in 
isolated subepicardial arterioles. A: myogenic constriction was inhibited by an increase in flow. B: myogenic dilation 
was potentiated by flow. C: flow-induced dilation was attenuated by elevating pressure. D: flow-induced dilation was 
potentiated by lowering pressure. 
responses to substance P (lo-l6 to lo-l2 M), indicating 
that the endothelial-dependent function was not affected 
by perfusion with ink-gelatin (Fig. 1). 
Protocol 1. Figure 2 shows examples of the interaction 
of pressure- and flow-induced responses in isolated cor- 
onary arterioles. The effect of flow on pressure-induced 
constriction and dilation is shown in Figs. 2, A and B, 
respectively. The pressure changes shown here caused 
submaximal constriction or dilation. When IP was in- 
creased from 60 to 80 cmH20, the arteriole initially 
distended but regained tone and constricted further from 
its original diameter of 69 to 61 pm (Fig. 2A). This 
pressure-induced myogenic constriction was reversed by 
flow (when AP was increased from 0 to 4 cmH20), with 
diameter increasing from 61 to 76 pm. When flow was 
stopped (AP = 0 cmH20), vasoconstriction occurred and 
the diameter gradually returned to its preflow value (Fig. 
2A). Figure 2B shows that a myogenic dilation (IP de- 
creased from 60 to 40 cmH20) was potentiated by an 
increase in flow, producing vasodilation from its initial 
value of 69 to 96 pm. Upon the cessation of flow, the 
vessel returned to the diameter that occurred during the 
myogenic dilation (from 96 to 85 pm). 
Figure 2, C and D show the effects of pressure-induced 
responses on vessels with flow. Under control conditions 
(IP = 60 cmH20, AP = 0 cmH20), vasodilation occurred 
when flow was initiated (AP = 4 cmH20), but the in- 
crease in diameter was attenuated by elevating luminal 
pressure (IP = 80 cmH20) (Fig. 2C). In contrast, my- 
ogenic relaxation (IP decreased from 60 to 40 cmH20) 
potentiated the vasodilatory effect of flow (Fig. 20). 
The effect of myogenic tone on flow-induced dilation 
is summarized in Fig. 3. Flow-induced responses were 
studied at low, intermediate, and high levels of myogenic 
tone by setting IP at 20,60, and 100 cmH20, respectively. 
Under zero flow conditions (AP = 0 cmH20), vessels 
developed myogenic tone, which was directly related to 
the level of IP. A graded vasodilation was observed when 
AP, and thus flow, was increased in a stepwise manner. 
Generally, flow-induced dilation reached its plateau 
when AP = 20 cmH20. The magnitude of the flow- 
induced dilation was greatest at intermediate tone (IP = 
60 cmH20) but was significantly attenuated (P < 0.05) 
at lower and higher levels of tone. 
The effect of flow on pressure-induced myogenic re- 
sponses is summarized in Fig. 4. Under zero flow condi- 
tions, myogenic constrictions and dilations were ob- 
served when IP was increased (~60 cmH20) and de- 
creased (~60 cmH20), respectively. When flow was 
established (AP = 4 cmH20), the vessels exhibited lower 
Figure 4.4: Four dynamic responses of arterioles to step changes in P and ∆P (reproduced
from fig. 2 in [45]). Each of the four subplots represents a different experiment. Each subplot
shows he response of vessel d ameter (top line) to changing intramural pressure (middle line)
and pressure gradient (bottom line).
therefore no flow is present and so we expect the active response to be largely unaffected
by the removal of the endothelium (as long as the shear-stress induced production of
NO is much greater than the baseline production). This is seen in the results with the
exceptio of the highest pressure wh re the two active curve do diverge. Similarly
to Kuo, Falco e’s passive response was achieved through bathing the pr paration in a
solution devoi of Ca2+, although F lcone also introduced adenosine, which is an eNOS
activating compound. This additional activation of eNOS is shown to have no effect
on the present model in the absence of Ca2+ in § 4.3.1.
4.3 Steady-State Response
The first stage of the fitting process for our model is to replicate the steady-state
response of the arteriole. For this we will optimize the parameters present in the
steady-state equations of § 3.3 to achieve the closest possible match to the data of
fig. 4.3. It is desirable for the purposes of accuracy to isolate the effects of parameters
from each other as far as possible during fitting. To this end we will first optimize those
parameters which affect only the passive response of the arteriole (i.e., in the absence
of Ca2+) to fit the passive response curve of fig. 4.3. In this way we can fit the subset of
parameters involved in the passive response without affecting those parameters which
appear only in the equations for the active case. Secondly we will fit the active response
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ENDOTHELIUM AND THE MYOGENIC RESPONSE H133 
0 Endothellum-Intact Arterioles 
120 T l Endothellum-Denuded Arterioles n=ll n Passive Arterioles 
40 
0 20 40 60 80 100 120 140 160 180 
PRESSURE 
(cmH20) 
FIG. 1. Collective data showing means Z!Z SE (n = 11) of steady- 
state arteriolar diameters during static flow as a function of intralu- 
minal pressure. Passive arterioles were made passive with 10m4 M 
adenosine in a Ca*+-free solution. *P < 0.05, endothelium-intact and 
endothelium-denuded arteriolar diameters vs. passive diameters. 
[7 Endothelium-Intact Arterioles 
m Endothelium-Denuded Arterioles 
* 
L 
CONTROL ACH (10-6M) ADS(10-4 M) 
SUFFUSION CONDITION 
(at 90 cmH20) 
FIG. 2. Arteriolar diameters in response to an endothelium-depend- 
ent vasodilator, acetylcholine (ACh), and an endothelium-independent 
dilator, adenosine (ADS). Values reported are normalized means f SE. 
* P < 0.05 vs. control; § P < 0.05 denuded vs. intact. 
DISCUSSION 
Two important findings regarding the myogenic re- 
sponse of skeletal muscle arterioles are demonstrated in 
this study. The first is that the endothelium is not 
responsible for the myogenic response or basal tone 
under the present experimental conditions. The second 
is that the endothelium does not release a vasoactive 
factor(s) in response to static changes in intraluminal 
pressure that modulate vascular tone of the myogenic 
response. 
Isolated arteriolar viability and reactivity were impor- 
tant factors that were verified and monitored in each 
FIG. 3. Transmission electron micrographs comparing arterioles be- 
fore (A) and after (B and C) removal of endothelium. After mechanical 
rubbing with a glass micropipette there was a noted disruption (B) or 
absence (C) of endothelial cells lining the arteriolar lumen (B). Note 
that after endothelial denudation procedure, basement membrane and 
vascular smooth muscle are still intact. E, endothelium; BM, basement 
membrane; VSM, vascular smooth muscle. 
experiment. For all our studies we only used arterioles 
that satisfied criteria previously described for isolated 
vessels considered to be functional and active (3, 4, 20). 
These criteria included the development of spontaneous 
tone, reactivity in response to vasoactive pharmacologi- 
cal compounds, and some degree of myogenic reactivity 
to altered intravascular pressure. The arterioles we used 
maintained a spontaneous level of tone between 30 and 
50% of maximum diameter during the course of an 
experiment. These isolated arterioles were initially re- 
sponsive to the endothelium-dependent and endothe- 
lium-independent vasodilators acetylcholine and adeno- 
sine, respectively, and to the vasoconstrictor norepineph- 
rine. They also demonstrated myogenic responses to both 
increases and decreases in intraluminal pressure under 
the conditions of static flow. After physical denudation 
of the endothelium the dilatory response to acetylcholine, 
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Figure 4.5: The steady-state response of an arteriole to changes in intramural pressure (re-
produced from fig. 1 in [26]).
in the absence of flow, so as to achi ve approxima e y accurate parameter values for
the myogenic and mechanical elements of the model without the complication of the
flow-induced NO response. Lastly we will use the values already obtained as a starting
point to combine the flow and no-flow cases and optimize a combined set of parameters
in order to achieve the best fit to both cases simultaneously.
4.3.1 Fitting the Passive Response
The passive case shown in fig. 4.3, where the arteriole was bathed in a solution contain-
ing nitroprusside, can be simulated in our model by omitting the myogenic response
and setting the concentration of Ca2+ to zero, effectively replacing eq. (3.30) with
[Ca2+] = 0. This leads to a solution to the 4-state kinetic model of α = [1, 0, 0, 0]T ,
which in turn leads to zero active force thanks to the factor of α3 in the active force
term of eq. (3.36). This reduces the entire steady-state model to a single equality, con-
veniently isolating the values of q1, q2, and l0 to be optimized by fitting to the passive
curve of fig. 4.4:
0 = q1
(
eq2(λ−1) − 1)− wcP 1
2
(
λl0nc
pi
− tw
)
(4.1)
By extracting the data points from fig. 4.3 and interrogating our model at the sam
values of P , with ∆P = 0 and [Ca2+] = 0, we can compute the root-mean-squared
(rms) error between o r model’s predictions of passive resp nse and the dat . By
formulating the problem such that this error is expressed as a function of the parameter
values then we can use an optimization function to find the set of parameter values
which minimizes the error between the model predictions and the data. In other words,
if the problem is expressed as:
 = f(q1, q2, l0) (4.2)
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where  is the rms error between the data and the model prediction, then we can use
an optimizer to find the parameter values which minimize this error, i.e., to find:
arg min
q1,q2,l0
f(q1, q2, l0) (4.3)
or, more generally, we optimize sets of parameters to fit a certain target dataset by
finding:
arg min
p
f(p) (4.4)
where the rms fitting error  = f(p), and p is a vector of the parameter values to be
optimized. The optimizer used in this case is the Matlab built-in function fmincon
which finds the minimum of the given function subject to constraints. The constraints
imposed here are simple bounds on the parameter values. This was done to bound the
domain of the optimizer and so to enable it to solve the problem more quickly. It is
important when doing this that we ensure that the optimum solution is not actually
resting on one of the bounds; if that were the case the arbitrary value of the bound
would have affected the solution, rather than just simplifying the optimizer’s search
for the unconstrained minimum of the objective function.
After an initial optimization, the solution with the model in the form of eq. (4.1) was
found not adequately to fit the passive data of fig. 4.3. The rate of stiffening with cell
elongation was found to be insufficient to match the curvature of the response curve in
the data. To remedy this, another parameter, q3, was introduced to exponentiate the
length term in eq. (3.21), leading to a new equation for passive force, and hence a new
expression for the model in the passive case:
0 = q1
(
eq2(λ
q3−1) − 1)− wcP 1
2
(
λl0nc
pi
− tw
)
(4.5)
With this modification the optimization was able very closely to fit the passive response
of fig. 4.4. This optimization was then applied to the fitting of the Falcone data with
the exception that the results for pressures below 30mmHg were omitted from the
fitting. This was done because the function given in eq. (4.5) was not capable of fitting
this section of the curve and because it is possible that at very low pressures there is
another mechanical element which comes into play. The element would be less stiff than
that in eq. (4.5) but have a hard end-stop when it reached full extension, somewhat
like a shorter elastic band in parallel with a longer stiff cord. Given that we are chiefly
concerned with the autoregulatory regime, we decided not to model this additional
element. The results of the optimized fitting to both Kuo and Falcone data are shown
in fig. 4.6, together with the original data which have been extracted and re-normalized
for comparison.
Of the terms in eq. (4.5), only four are optimized parameters, one is a variable, one
is an input, and the rest are physiological parameters which have been reliably exper-
imentally determined and so are treated as fixed. The values of all terms in eq. (4.5)
after optimal fitting to each set of data are given in table 4.2.
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Figure 4.6: The steady-state data from [45] have been extracted and are shown here in blue,
the extracted data from [26] are shown in grey. The red points and line show the fit achieved
after optimization of the parameter values q1−3 to minimize the rms error between the model
and the data, i.e., to achieve the closest fit between the red and uppper blue lines. The
normalized diameter of both sets of original data has been transposed to an absolute radius
about a set point of r = 60µm when intramural pressure P = 60mmHg in the active, no-flow
case from [45].
Parameter Description Kuo Falcone Units Source
q1 passive stiffness coefficient 26.4× 10−9 61.4× 10−9 N Fitting
q2 passive stiffness coefficient 8.38 8.27 – Fitting
q3 passive stiffness coefficient 1.06 0.619 – Fitting
l0 relaxed length of cell 77.5× 10−6 64.3× 10−6 m Fitting
wc effective width of muscle cell 2.67× 10−6 m [82]
nc number of cells around vessel 6 – [82]
tw thickness of vessel wall 15× 10−6 m [82]
Table 4.2: Parameters of the model fitted to the passive (no Ca2+ ) case. As can be seen
from fig. 4.6, the passive response in the Kuo data is stiffer than that found in the Falcone
data; although the coefficient q1 is smaller in the Kuo case, q2 and q3 are larger and these
coefficients have a stronger effect.
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4.3.2 Fitting the Active Response
Having found optimal values for those parameters which are involved in the passive
response, we now turn our attention to the active cases, the lower blue and grey lines in
fig. 4.6. Initially only the no-flow case was considered from the Kuo data; the problem
is formulated exactly as for the passive case, eq. (4.3), except that the parameters given
in table 4.2 are now fixed and the error is a function of all of the other parameters of
the model. The purpose of considering first only the no-flow case is to again remove
as many of the unknowns as possible whilst finding at least approximate values for a
subset of the parameters. When optimizing over all remaining parameters to fit only
the no-flow data it is possible (results not shown) to exactly match the model response
to the data. However, an exact fit to the no-flow data can only be achieved by setting
the parameters such that the NO concentration is extremely low, so low that using
these parameter values (optimized on the no-flow case only) for the flow case gives a
very poor fit to the flow data. Therefore, once good starting values for the parameters
had been found from the fitting to no-flow only, the objective function was changed to
equal the sum of the rms errors of the fit to both flow and no-flow cases. With this
combined objective function the optimizer was not driven to overfit one case at the
expense of the other, but rather to find the best set of parameter values to fit both
cases at the same time.
As with the passive fitting, it was found that the model as described above is not
sufficiently flexible to adequately fit all of the data. Specifically the reaction of the
vessel to the onset of flow was found to be too large, this was caused by the sensitivity of
active force to vessel length being too low1. To remedy this another slight modification
was introduced, this time into the active side of the mechanical model. A variance term
was added to the Gaussian describing the amount of overlap between actin and myosin
filaments in the cell. The addition of this variance term changes eq. (3.20) to:
Fa = l0
(
f1AMp
(
vˆ + λ˙
)
+ f2AMλ˙
)
e
−(λ−λopt)2
2η (4.6)
and eq. (3.36) similarly becomes (incorporating the extra parameter, q3, from eq. (4.5)):
0 = q1
(
eq2(λ
q3−1) − 1)+ l0f1α3vˆe−(λ−λopt)22η − wcP 1
2
(
λl0nc
pi
− tw
)
(4.7)
where η represents the variance of the distribution of sarcomeres in the VSMC, previ-
ously fixed to an implicit value of 1/2. The results of the fitting after inclusion of this
extra term are shown in figs. 4.7 and 4.8 and the corresponding parameter values given
in table 4.3.
1See gradient of muscle force lines at intersection with equilibrium force lines in fig. 4.9.
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Figure 4.7: The steady-state data from Kuo [45] have been extracted and are shown here in
blue. The model responses are shown in black (passive) and magenta (active).
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Figure 4.8: The steady-state data from Falcone [26] have been extracted and are shown here
in blue. The model responses are shown in black (passive) and magenta (active).
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Parameter Description Kuo Falcone Units Source
hw NO wall transport coefficient 7.61× 10−9 – m2/s Fitting
sw production rate of NO in vessel wall 69.2× 10−9 – M/s Fitting
γwb baseline wall:blood [NO] ratio 7.27 – – Fitting
rdb decay rate of NO in blood 89.5 – 1/s Fitting
rdw decay rate of NO in vessel wall 9.51 – 1/s Fitting
kτ shear stress NO production coefficient 248× 10−15 N/A m2M/s Fitting
Cin upstream (incoming) [NO] in the blood 0 M § 3.5
µb viscosity of blood 4.37× 10−3 Ns/m [68]
∆P0 baseline arterial blood pressure 60 mmHg Typical
r0 baseline internal vessel radius 60× 10−6 m Typical
L length of arteriole 1× 10−3 m Typical
[NO]L lower edge of [NO] active region 780× 10−12 – M Fitting
[NO]U upper edge of [NO] active region 36.5× 10−9 – M Fitting
p[cGMP ]L lower bound of p[cGMP ] in muscle cells −9.57 – – Fitting
p[cGMP ]U upper bound of p[cGMP ] in muscle cells −8.29 – – Fitting
σL lower edge of σ active region −8.16× 103 11.3× 103 N/m Fitting
σU upper edge of σ active region 52.4× 103 47.3× 103 N/m Fitting
p[Ca2+]L lower bound of p[Ca
2+] in muscle cells −8.50 −8.84 – Fitting
p[Ca2+]U upper bound of p[Ca
2+] in muscle cells −6.94 −7.57 – Fitting
f1 friction from cycling cross-bridges 9.34× 10−6 98.7× 10−6 Ns/m Fitting
f2 friction from latch bridges 500× 10−3 N/A Ns/m Fitting
λopt normalized cell length at max overlap 1.49 1.79 – Fitting
v cross bridge cycling velocity 9.71 8.99 m/s Fitting
η variance of distribution of sarcomeres 264× 10−3 217× 10−3 – Fitting
Table 4.3: Parameter values of the model after optimization to fit active steady-state data of
Kuo [45] and Falcone [26]. Note that the parameters of the NO model were not re-optimized
for the Falcone data as they have negligible effect when no flow is present.
4.3.3 Discussion
Whilst the magenta lines of the model response in figs. 4.7 and 4.8 do not overlay
exactly with the blue lines of the experimental results, the form of both sets of curves
is the same: both exhibit active autoregulation over the given range of intramural
pressures in the presence of Ca2+ and fail to do so in the absence of Ca2+. It is clear,
from the model’s emulation of the Kuo data, that the impact of flow is to significantly
reduce the vasoconstriction caused by the myogenic response, exactly as observed in
[21]. Figure 4.9 shows the relationship between the forces in the vessel wall and the
pressure of the fluid in the vessel for the model as optimized to fit the Falcone data. It
is clear from this figure how the myogenic response moves the force curve of the muscle
upward and hence the equilibrium radius decreases. Table 4.3 shows that the primary
difference between the parameter values for the two fitting cases is in the friction
associated with cycling cross-bridges, f1. The lesser passive stiffness of the vessel in
the Falcone data, as shown in fig. 4.6, necessitates a stronger active component of the
VSMC to achieve the same level of autoregulatory response. The sensitivity of the
model to the values of its parameters will be further examined in § 4.5.
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Figure 4.9: The relationship between force required to resist the blood pressure, dashed blue
line, blue text, and the force available from the muscle cell, solid red. Responses shown are
a result of fitting to the Falcone data. Open circles on the right show the equilibrium points
of the passive response, solid circles in the centre show the equilibria of the active response –
as intramural pressure increases, the myogenic response makes more Ca2+ available and the
resulting phosphorylation of myosin cross-bridges moves the muscle force curve upward and
the equilibrium radius is reduced.
4.4 Dynamic Responses
We now turn our attention to the dynamic responses to various steps in pressure and
flow presented in fig. 2 of [45] and reproduced here in fig. 4.4. In order to simulate a
dynamic response with our model, we return to the fully dynamic equations presented
in § 3.2. This introduces the additional parameter τCa which will require tuning to
achieve good agreement with the data. The first part of fig. 4.4A is the dynamic
response of the system to a step change in pressure under no-flow conditions, this is
the ideal experiment against which to tune the value of τCa without the dynamics of
the NO model interfering. Figure 4.10 shows the data from this experiment, together
with two model responses. For the first 239s of this experiment there is no pressure
difference between the ends of the vessel and so no flow along it. The initial response of
the vessel to the step increase in intramural pressure is to dilate elastically towards the
passive equilibrium radius at the new pressure; this occurs between 51 and 60s. The
secondary, slower, response is a gradual contraction down to a new active equilibrium
radius which is smaller than the initial radius. The speed of the myogenic response is
governed by τCa as per eq. (3.15); the response shown by the dashed line in fig. 4.10
was obtained with a value of τCa = 230s, chosen by visual inspection. Clearly this value
fits the slow response to the pressure step between 60 and 239s quite well, however,
the model response to the brief period of flow is distinctly different from the data. The
equilibrium radius of the model during the period of flow is actually quite close to the
level of the plateau seen in the data, this is not evident in the dashed line of fig. 4.10
because the myogenic response (with a time constant of 230s) is too slow to achieve
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the very quick saturation at the new equilibrium level shown in the data, in fact radius
has only just started to decrease back towards equilibrium when the flow stimulus is
removed. If the time constant for the myogenic response is reduced at the onset of flow
then it is possible to closely match the shape of the data. The solid line in fig. 4.10 is
the model response when the value of τCa follows, the lower value again being chosen
by visual inspection to match the data:
τCa =
{
230s if t < 239,
1s if t ≥ 239. (4.8)
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Figure 4.10: Data from fig. 2A in [45] (fig. 4.4) shown with two model responses: the dashed
line is given by τCa = 230s throughout, the solid line is given when the value of τCa is reduced
from 230s to 1s at the onset of flow. Radius values from data have been normalised to match
initial value from the model.
Once the myogenic response is speeded up, the model can closely match the behaviour
seen in the data in its response to the onset of flow. There is a significant delay seen in
the data between the removal of the flow stimulus and the reaction of the vessel. This
is achieved in the model through a combination of the saturation of the NO – cGMP
relationship with the slow response of NO; when flow begins the level of NO in the
vessel wall rises rapidly and the NO – cGMP sigmoid quickly saturates at the maximum
level of [cGMP], the effect of the cessation of flow is not felt by the model until the
NO concentration falls back below the cGMP saturation level and the concentration
of cGMP begins to fall, and with it the vessel radius. Because of the exponential
sawtooth shape of the NO response there is a significant delay between cessation of
flow and the de-saturation of the NO – cGMP sigmoid. The result is the desired delay
between the cessation of flow and the resultant reduction in vessel radius. Although it
is not known whether this is the actual mechanism for delay which occurs in reality, it
seems likely that the delay in vessel response to cessation of flow is the result of one
of the species in the NO pathway reaching saturation whilst the concentration of its
progenitor continues to increase – the slow decay of the progenitor then causing the
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delay in the reaction of the saturated species. The states of the model throughout the
period of this simulation are shown in fig. 4.11, the dashed line in the middle panel
indicates [NO]U , the concentration of NO at which cGMP reaches 95% of its maximum
value. The tuning of this delay was done manually by adjusting the speed of the NO
model. This is possible without changing the steady-state behaviour of the model
because eq. (3.29) has a degree of freedom; the values of hw, rdw, sw, and kτ can be
scaled by a common factor without affecting the result. These are the coefficients for
each of the four terms in eq. (3.4), transport into the blood, decay in the wall, baseline
production in the wall, and shear-stress-induced production in the wall. Their scaling
thus affects the speed of the model without changing its steady-state behaviour. The
common factor by which they were all scaled is 0.005, resulting in the values given in
table 4.4:
Parameter Description Value Units Source
hw NO wall transport coefficient 38.0× 10−12 m2/s Fitting
rdw decay rate of NO in vessel wall 47.6× 10−3 1/s Fitting
sw production rate of NO in vessel wall 346× 10−12 mol/Ls Fitting
kτ shear stress NO production coefficient 1.24× 10−15 m2mol/Ls Fitting
Table 4.4: Parameter values of the coefficients of eq. (3.4) after manual tuning to fit the delay
observed in fig. 4.4A. These are the values in table 4.3 scaled by a common factor of 0.005.
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Figure 4.11: The states of the model during the experiment shown in fig. 4.10. The dashed
line in the middle panel shows the level of [NO] at which the cGMP concentration is 95%
saturated. The peak of the sawtooth in the NO concentration curve marks the cessation
of flow – its slow return to below the level of the dashed line gives rise to the delay in the
response of cGMP, and hence radius.
Having found from this first dynamic simulation that a variation in the speed of the
myogenic response was necessary to match the data of fig. 4.4A, we proceeded to
apply the same approach to matching the responses of the model to the remaining
three dynamic experiments presented in [45]. In order to maintain a credible ability to
hypothesise about the possible physical mechanism for such changes in speed, the time
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constant was only changed at points in the experiments when the conditions (either P
or ∆P ) change. The results of all four simulations are shown in figs. 4.12 to 4.15 and
the time constants used are summarised in table 4.5. Radius values from the data have
been normalised to match the initial radius from the model. The values of these time
constants were again chosen manually to provide a close fit to the data, the response
to the drop in pressure in fig. 4.15 requires a time constant of 5s, rather than the
previously used 1s, in order to replicated the brief passive contraction seen in the data
before the active expansion.
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Figure 4.12: Data from fig. 2A in [45] (fig. 4.4) in blue, shown with the model response in
red.
Experiment Start time (s) End time (s) τCa (s)
A 0 239 230
239 end 1
B 0 end 1
C 0 117 1
117 267 210
267 end 1
D 0 123 1
123 end 5
Table 4.5: Values of the myogenic response time constant, along with corresponding epoch
start and end times, used to obtain the model simulation results presented in figs. 4.12 to 4.15.
All values are given in seconds.
It is suspected that the experimental data of the second experiment, fig. 4.13, contains
an error; the instant dilation of the arteriole in response to the drop in pressure at
the beginning of the experiment not only exhibits no initial elastic contraction but
it goes on to an equilibrium of much greater radius than would be expected given
the steady-state results presented in the same paper. It is possible that some kind of
experimental or recording error occurred coincident with the drop in pressure which
caused the results to be shifted upward from then on.
60 Fitting and Analysis of Vascular Regulation Model
0 50 100 150 200 250 30020
40
60
P 
(m
m
Hg
)
0 50 100 150 200 250 3000
2
4
∆
 P
 (m
m
Hg
)
0 50 100 150 200 250 30065
70
75
80
85
90
95
100
time (s)
ra
diu
s (
µ m
)
B
 
 
Data
Model
Figure 4.13: Data from fig. 2B in [45] (fig. 4.4) in blue, shown with the model response in
red.
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Figure 4.14: Data from fig. 2C in [45] (fig. 4.4) in blue, shown with the model response in
red.
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Figure 4.15: Data from fig. 2D in [45] (fig. 4.4) in blue, shown with the model response in
red.
It should also be noted that the discrepancies between the data and the model responses
during periods of constant radius (i.e., plateaus in the traces) are not a feature of the
dynamic response per se, but rather a combined feature of the fitting inaccuracies of
the steady-state model, fig. 4.7, and disagreement between the steady-state and dy-
namic data of [45]. Shape, relative magnitude, and timescales provide more meaningful
comparisons between the data and the model responses than absolute values.
4.4.1 Hypothesis/Justification for a Variable Ca2+ Time Con-
stant
Whilst at first it might seem physiologically unjustifiable to allow tuning of the myo-
genic response time constant in an ad hoc manner to fit the available data, there is
actually a viable physiological mechanism that could cause such an effect. Ca2+ ions
can be admitted to the cell cytoplasm from two sources: the extracellular fluid, and the
sarcoplasmic reticulum, or SR, see fig. 2.2. Influx of Ca2+ from the extracellular fluid
is relatively slow due to the fact that the concentration of Ca2+ in the extracellular
fluid is relatively low. Conversely, the SR contains fluid at a very high concentration
of Ca2+ relative to the cytoplasm. Some processes lead to Ca2+ being released from
the SR, causing a rapid rise in the cytoplasmic Ca2+ concentration; one such process
is calcium-induced calcium release, or CICR, which is thought to be a vital part of
the generation of rhythmic action potentials within VSMCs, leading to vasomotion. So
there is actually a plausible physical basis for the duality in Ca2+ response times, in the
slow cases the Ca2+ could be coming through the cell membrane from the extracellular
fluid, in the fast cases it could be coming from the SR.
Another hypothesis for the physical basis of the apparent need for a varying Ca2+ time
constant is suggested when examining the conditions under which the time constant is
62 Fitting and Analysis of Vascular Regulation Model
very large. Only when the intramural pressure is stepped up do we see that the time
constant must be significantly greater than in all other situations. When intramural
pressure suddenly increases the vessel is forced to dilate quickly by the imbalance of
forces, this sudden elongation of the VSMCs may well cause phosphorylated attached
cross-bridges to be forcibly detached from their actin filaments. If myosin heads so
detached took some time to recover and regain attachment, perhaps to dephosphorylate
and re-phosphorylate, then this could explain the slowness of the myogenic response
in the case of sudden pressure increase. In no other circumstance are VSMCs forcibly
elongated, and in no other circumstance is the Ca2+ time constant required to be
large.
Looking at the τCa values in table 4.5 and the experimental conditions of figs. 4.12
to 4.15, it can be seen that the only two occasions on which the Ca2+ response is
required to be very slow are the only two occasions on which the vessel is reacting to
a step increase in intramural pressure. It could be that some aspect of the vessel’s
initial passive dilation in response to these step increases of pressure causes the influx
of Ca2+ to the cytoplasm from the SR to be inhibited, resulting in a much slower
than ‘usual’ myogenic response. This is an interesting potential avenue for future
experimental investigation.
4.5 Sensitivity Analysis
So far we have presented the equations that constitute the model, we have described
how the parameters of these equations have been optimized to best fit the data, and we
have presented the comparison between the model’s behaviour and the experimental
data for both steady-state and dynamic cases. In order to determine which of the
many parameters in the model have the greatest effect, and which have very little
effect, we now perform a sensitivity analysis on the model. Whereas the derivatives
of the objective function of the optimization with respect to the parameters, d
dp
from
eq. (4.4), give the sensitivity of the model output to the parameters at a specific
operating point, sensitivity analysis aims to evaluate the mean and variance of these
terms throughout the parameter space (i.e., for all sensible values of p). This approach
thus gives a better idea of the effects of parameter values over the whole parameter
domain of a strongly non-linear model such as ours.
4.5.1 Current Methods
We will look at the case where the output variable of which we are measuring the
sensitivity is the rms error between the model radius and the radius data for both
the Kuo flow and no-flow cases combined. This was the form of the model for the
fitting to the Kuo data described in § 4.3.2. In this case the model has 17 variable
parameters. In the parlance of sensitivity analysis, the derivative of the model output
(rms fitting error) with respect to a parameter is referred to as the elementary effect of
that parameter. It is the mean and variance of each elementary effect that sensitivity
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analysis aims to evaluate. Because the model is analytically intractable it is necessary
to infer the desired properties of the distribution of elementary effects from the samples
of their distribution, rather than to compute them directly. Due to limitations on
computational cost it is necessary that this sampling be relatively sparse. For instance,
to sample the elementary effect of only one parameter over a grid with 10 divisions
in each dimension of the parameter space would take 2.5 billion years, for just one
parameter (2 × 1017 × 0.4s). This has led to the development of techniques which
aim to sample the distribution of elementary effects with the fewest model evaluations
possible.
One group of such techniques is known as Morris Methods; briefly, the domain is
gridded evenly, then one vertex is chosen and the model evaluated there, the next
evaluation is made by stepping to an adjacent vertex of the grid, the dimension along
which this step is taken being chosen at random. A further step is then taken, again
along a randomly chosen dimension, providing that a step in that dimension has not
already been taken. This stepping continues until the number of steps taken is equal
to the number of dimensions, and so the elementary effects of all parameters have been
sampled once along the trajectory. For a system with k parameters, this path consists
of k + 1 model evaluations. Many such paths may be generated until a sufficiently
accurate approximation to the true distribution of elementary effects has been found.
By contrast, random selection of points for each sample of each elementary effect would
necessitate 2k evaluations of the model, one at each point and one after one parameter
had been incremented by the finite difference ∆, hence the great advantage of Morris’
method whereby the second evaluation in one dimension serves as the first evaluation
in the next dimension.
The separation of trajectories can be improved by using another sampling technique
for the selection of a starting point for each trajectory. Such a sampling technique is
the latin hypercube method, whereby n samples are taken from a k-dimensional space
by dividing each dimension into n divisions and ensuring that no two samples occupy
the same division in any dimension. Although the points are chosen at random within
these criteria, latin hypercube sampling does not guarantee an even, space filling,
distribution; the leading diagonal of a matrix, for example, satisfies the criteria of
the latin hypercube sampling method. It is common when employing latin hypercube
sampling, to generate several distributions and to choose the one with the greatest
mean separation between points. Even when the starting points are well distributed,
it is possible with a Morris method that two trajectories could become close if the
random direction and dimension of each step brings two trajectories together.
In order to resolve the problems of latin hypercube sampling and of Morris trajectories
converging, Campolongo et al. [14] proposed a scheme whereby a large number of
Morris trajectories are generated from random starting points and from that a subset
is chosen which has the maximum total distance between the trajectories, where the
distance between two trajectories is taken as the sum of the distances from each point
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in one trajectory to every point in the other trajectory:
dml =
k+1∑
i=1
k+1∑
j=1
√√√√ k∑
z=1
(
Xmi (z)−X lj(z)
)2
(4.9)
where k is the number of parameters and Xmi (z) is the zth coordinate of the ith point
on the mth Morris trajectory.
4.5.2 A Novel Method
The aim of the computationally intensive trajectory selection given in [14] is to achieve
an even, space-filling pattern of Morris trajectories; although this is achieved, it is not
the correct objective. The distributions being sampled are of derivatives, not of values,
so the location of the sample in the zth dimension lies midway between the points on
the Morris trajectory that are separated by a step in the zth dimension. Not only that
but when looking purely at elementary effects (as opposed to the combined effects of
two or more parameters) the distributions of each elementary effect are independent, so
the only relevant distance measure between two trajectories is the sum of the distances
between pairs of midpoints of steps in the same dimension. The distances between a
step in the zth dimension and all the steps in the non-z dimensions in another trajectory
are irrelevant. The illusion of optimal space filling is given by the idea of trajectories
weaving though the parameter space evenly, but for any given elementary effect, each
trajectory contains only one sample point. The reality is then that a lot of effort is
devoted to ensuring that k independent sets of points are well separated from each
other, for no reason.
The method proposed here is a much simpler one. We generate several sets of k-
dimensional points using the latin hypercube method, pick the one with the greatest
mean separation between points, evaluate the model at these points and at k additional
points per starting point, each separated from the starting point by a step in a different
dimension. The result is a ‘constellation’ of star-shaped experiments dotted throughout
the parameter space. Each elementary effect is sampled on an equally well spaced basis
and very little computational effort is required to design experiments, or to select a
subset thereof. The total number of model evaluations necessary for a star-shaped
experiment is equal to that of a Morris trajectory, but the unnecessary complexity of
choosing random directions in random, unexplored dimensions is removed.
The parameter space itself can be defined in many ways; some parameters might have
intrinsic bounds but for the rest there is some arbitrary choice of which values should
define the limits of the parameter space from which the sensitivity analysis samples are
to be drawn. Bounds for the parameters have already been set during the optimiza-
tion/fitting process, and these bounds can sensibly be used here for consistency with
chapter 3. Alternatively we can define the parameter space to extend some fixed per-
centage either side of the values found to give the best fit. This is perhaps a preferable
strategy as the definition of the bounds on each variable ensures that the parameter
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space is centred on a point where all of the mechanisms of the model are active. Con-
versely, if we change parameter values too much, we will find ourselves in regions of the
model where some sigmoid functions are effectively flat and so the related parameters
have no local effect. Here we conduct sensitivity analyses using the latin hypercube
‘constellation’ method detailed above on both an additive, absolute bounds parameter
space, and on a multiplicative, relative bounds parameter space.
The result of any sensitivity analysis such as this is a plot of variance, σ, versus mean,
µ, of the sensitivity of the output to variations in each parameter.
4.5.3 Additive Results
The bounds used to define the parameter space in the additive case were those bounds
which were used for the optimization of the fitting in § 4.3.2, given in table 4.6.
Parameter Lower Bound Optimal Value Upper Bound Units
hw 5× 10−15 38.0× 10−12 5× 10−10 m2/s
sw 0 346× 10−12 5× 10−7 M/s
γwb 1 7.27 100 –
rdb 0 89.5 200 1/s
rdw 0 47.6× 10−3 5× 10−2 1/s
kτ 1.65× 10−18 1.24× 10−15 5× 10−15 m2M/s
[NO]L 600× 10−12 780× 10−12 32× 10−9 M
[NO]U 32× 10−9 36.5× 10−9 40× 10−9 M
p[cGMP ]L -10 −9.57 -5 –
p[cGMP ]U -10 −8.29 -5 –
σL −4× 104 −0.816× 104 20× 104 N/m
σU 0 52.4× 103 20× 104 N/m
p[Ca2+]L -20 -8.50 -6.75 –
p[Ca2+]U -9 −6.94 -6 –
f1 0 9.34× 10−6 1× 10−2 Ns/m
λopt 1.3 1.49 2 –
η 10× 10−3 264× 10−3 500× 10−3 –
Table 4.6: Bounds placed on variables during optimization and used to define the limits of the
parameter space for additive sensitivity analysis. Optimal values shown are as per table 4.3,
‘Kuo’ column. These are the values used as the centre of the multiplicative sensitivity analysis
scheme.
The results of this analysis carried out with 1000 samples and using a finite difference
of 1 × 10−9 are shown in fig. 4.16. Aside from the arbitrary choice of bounds on the
parameter space, another major problem with performing sensitivity analysis in an
additive fashion is that the scale of the parameters scales both the mean and variance
of the sensitivities.
4.5.4 Multiplicative Results
To overcome some of the limitations of the additive scheme, another analysis was
carried out, this time with the parameter space being defined to extend ±10% or
±50% either side of the optimal values given in table 4.6. The finite difference used
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Figure 4.16: Results of sensitivity analysis using the additive scheme, variance of elementary
effects versus mean magnitude of elementary effects; axes are logarithmic to show detail.
to evaluate the main effects is also defined as a percentage of the value of the central
point, specifically 100 times smaller than the factor defining the width of the sample
space. The resulting sensitivities are then normalized by the baseline values of the
parameters, thus creating a dimensionless sensitivity which can be thought of as %/%,
or proportional change in output per proportional change in parameter. To give a
concrete example of the procedure for the ±10% case (in one dimension): if the optimal
value of a parameter, having been tuned to fit the data, is 6units, then the parameter
space over which samples are taken extends from 5.4units to 6.6units (±10%). Let
us suppose that one of the samples chosen by the latin hypercube method lies at
5.814units - the main effect for this sample will be found by evaluating the model
output both at 5.814units and at 5.1892units, this being an increment of 10%/100 =
0.1% of the sample point value. If the output values for the sample point value and the
incremented value are a and b respectively, then the dimensionless main effect is given
by ((b− a) /a) /0.001. Although dimensionless, this can be thought of as percentage
change in output per percent change in parameter. The results of this scheme are
shown in figs. 4.17 and 4.18.
4.5.5 Dynamic Results
We can also apply the same technique for sensitivity analysis in the dynamic case. We
measure the sensitivity of the model radius to variations in the dynamic parameters
at every time during the response. This analysis was done on the response of fig. 4.12
over a range of ±50% either side of the optimal values of the parameters v, f2, τCa, and
NOspeed, where NOspeed is a scaling factor applied to the four coefficients of eq. (3.4)
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Figure 4.17: Results of sensitivity analysis using the multiplicative scheme with a range of
±10%, variance of elementary effects versus mean magnitude of elementary effects; axes are
logarithmic to show detail, sensitivities are dimensionless.
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Figure 4.18: Results of sensitivity analysis using the multiplicative scheme with a range of
±50%, variance of elementary effects versus mean magnitude of elementary effects; axes are
logarithmic to show detail, sensitivities are dimensionless.
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as described in § 4.4. To ensure that we examine only the sensitivity of the dynamics
of the system, without changing the steady-state behaviour, we scale f1 inversely to
the scaling applied to v at each experimental location. The values of τCa for the two
phases of the response are treated as separate variables, τCa1 and τCa2. The 100 baseline
responses at which the 5 elementary effects were sampled are shown in fig. 4.19. The
mean and variance of the sensitivities are shown in fig. 4.20.
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Figure 4.19: The 100 different baseline dynamic responses used to evaluate the sensitivity of
the dynamic response. Parameters were varied ±50% around their optimal values.
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Figure 4.20: The mean and variance of the sensitivity of the dynamic response. Variance is
shown on a log y-axis to show detail. Sensitivity is dimensionless as the muliplicative scheme
yields %/% values.
It can be seen from fig. 4.20 to which parameters the response is sensitive in differ-
ent phases of the response: whilst the vessel is passively dilating in response to the
step increase in pressure, it is very sensitive to changes in the passive sliding friction
coefficient f2; during the slow active contraction the model is most sensitive to the
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Ca2+ time constant τCa1; sensitivity to f2 returns along with sensitivity to NOspeed
as the step in flow causes sudden dilation; finally the delayed drop in radius following
the cessation of flow is dominated by the speed of the NO response, as described in
§ 4.4.
4.5.6 Discussion
The two methods, additive and multiplicative, of sensitivity analysis yield quite dif-
ferent results. The additive scheme suggested that four parameters were over 100,000
times more influential than any others, whereas the multiplicative scheme shows that
there is not such a clear distinction. Two of the most important parameters in the
multiplicative results are the upper and lower levels of Ca2+ concentration in the myo-
genic response. Given that the myogenic response is the key driver in reducing the
vessel radius with increased pressure, this is not surprising. All of the NO system
parameters are relatively unimportant, with the exception of the saturation level of
[cGMP], suggesting that the system may have settled in a region of the parameter
space where the effect of NO is binary, i.e., NO is effectively ‘on’ or ‘off’. This could
only happen because the parameters were fitted to data in which there were only two
levels of flow.
Because the output of which we have measured the sensitivity is the goodness of fit
to experimental data, we can say that we have greatest confidence in the accuracy of
the parameters to which the model is most sensitive. In other words, we can be more
sure that we have realistic values for the myogenic response parameters than for the
NO model parameters. Of course with the caveat that this sensitivity analysis has
not included the parameters which were independently fitted to the data of [50] in
§ 4.2.1. In terms of the robustness of the physical system, our results suggest that a
perturbation of the Ca2+ levels would significantly affect the regulation of bloodflow by
the arterioles. Conversely an excess of NO would have very little effect on the radius
of the vessel without an accompanying rise in [cGMP], which would require additional
soluble guanylate cyclase (sGC) enzymes and/or additional guanylate triphosphate,
the substrate for the production of cGMP by sGC. It might be deduced that those
quantities which are limited by the availability of an enzyme are far less able to perturb
the system than those which are no so limited. For instance, an excess of NO introduced
by some external agent will not affect the equilibrium of a vessel through which blood
is flowing (because [cGMP] is already saturated) whereas a similar introduction of
Ca2+ would immediately upset the [Ca2+] in the cytoplasm of the VSMC (it being
able to diffuse across the cell membrane) and so the equilibrium of the vessel. There
is a point at which excess Ca2+ no longer has an effect on myosin phosphorylation,
fig. 4.1, but it is many times the equilibrium level. In this way the vessel is robust to
excess of NO in a way that it cannot be robust to an excess of Ca2+. Enzymes being
large molecules, unable to cross the cell membrane, must be produced by the cells
themselves and so some derangement of the cell’s biochemistry would be necessary to
alter the availability of an enzyme. In this sense enzymes limit the sensitivity of the
system to all but one (at a time) of the species which precede them in any pathway.
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While [NO] is below the saturation level, [cGMP] is sensitive only to [NO] and not to
[GTP] or [Mg2+], once NO is in excess, the system is insensitive to [NO] and becomes
sensitive to either [GTP], [Mg2+], or the capacity/availability of the sGC itself2.
4.6 Conclusions
In this chapter we have presented the data to which we have fitted our model, we have
explained the methods by which our model has been optimized to achieve the best fit
to the data, and we have presented the results of that optimization. The model closely
replicates the behaviour of an isolated arteriole both in the steady-state response to
changes in intramural pressure, and in its dynamic responses to step changes in pressure
and flow. The necessity of a varying myogenic Ca2+ time constant to fit the dynamic
data has been discussed, and possible physical mechanisms which could underlie this
process have been outlined. We have developed and implemented a novel technique for
sensitivity analysis and it has shown us a possible limitation in the way that our model
is tuned. Whilst the fit of the model responses to the data is not perfect, neither is our
model very complex. To achieve such a good correlation as we have to both the steady-
state and dynamic data with a model containing many simplifications (such as the
sigmoids) shows that the operation of the physical system could well be fundamentally
similar to that of our model. Although our model reproduces the behaviour of the
system at a high level and neglects to explicitly model the very complex biochemistry
of the VSMC.
2The production of cGMP by sGC requires activation by NO, catalysation by Mg2+, and guanosine
tri-phosphate (GTP) as the substrate [23].
Chapter 5
A Model of Autoregulation
5.1 Introduction
In the previous chapter we presented a model of an individual arteriole and showed that
its behaviour is representative of that of a real arteriole. In this chapter we integrate
that model of a single arteriole into a model of the vasculature of the whole brain. We
then examine the effect that our arteriolar model has within a larger vascular system.
The integration into a whole brain model also allows comparison of model results with
in-vivo data from humans. In-vivo flow data for single arterioles is not available for
humans, whereas data for the flow in the middle cerebral artery (MCA) and arterial
blood pressure in humans are readily available.
5.2 Integration of Arteriole Model Into Existing
Whole-Brain Model
The model of the cerebral vasculature which we will adapt to include our arteriolar
model is taken from [62]. A schematic of this vasculature model is reproduced from
[62] in fig. 5.1. The different levels of the vascular tree (large arteries, small arteries,
capillaries and small veins, and large veins) are each represented as a resistance in an
electrical equivalent circuit. Changes in volume of the arteriolar and venous compart-
ments are accommodated by two capacitors. Because it is the arterioles, or the small
arteries, which have the greatest effect in the autoregulation feedback loop, it is the
properties of this level of the vascular tree which change in response to haemodynamic
and metabolic stimuli. The work presented in [62] is concerned with the effects of
metabolic factors, whereas we do not wish to investigate feedback from neural activa-
tion, rather we wish to replace the variable components of the arterial compartment
with components whose properties are determined by the arteriolar model of chapter 3.
In this way we can examine the behaviour of our arteriolar model in the context of
the whole brain vasculature and compare the results to experimental data measured
in-vivo from humans.
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Figure 5.1: Schematic of the electrical equivalence model of the cerebral vasculature, re-
produced from [62]. Pa, systemic arterial pressure; Rla, resistance of non-regulating arterial
compartment; P1, Rsa, and Ca, pressure, resistance and compliance of regulating arterial com-
partment; Rsv, resistance of capillary compartment and small veins; Cv, venous compliance;
P2, venous pressure; Pv and Rlv, venous pressure and resistance of large veins, respectively;
Pic, intracranial pressure.
The arteriolar network in fig. 5.1 is represented by two resistive elements, each present-
ing half of the resistance of the whole arteriolar network, and a capacitance, accounting
for the blood volume which is stored or dispensed when the arterioles dilate or con-
tract respectively. To begin coupling our vessel model with this model we first define
the two intermediate pressures Pα and Pβ as the pressures immediately upstream and
downstream of the arteriolar level of the vascular tree, see fig. 5.2. We can relate the
resistance of the vessels to the radius via:
Rsa =
8µbL
pir4
· 1
nsa
(5.1)
where nsa is the effective number of parallel arterioles in the vascular tree. The volume
of blood in the arterioles at any time is given by:
Vsa = pir
2Lnsa (5.2)
from the volume of nsa cylinders of radius r, length L. This volume is equivalent to
the charge on the capacitor in the arterial compartment, and its derivative:
dVsa
dt
= V˙sa = 2pirLnsa
dr
dt
(5.3)
is equivalent to the current down that leg of the circuit, as shown in fig. 5.2. These
relationships are sufficient to combine the arteriolar model of chapter 3 with the vas-
culature model of [62].
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Figure 5.2: Schematic of the electrical equivalence model of the cerebral vasculature.
5.2.1 Solution in the Steady-State
In the steady-state the flows V˙sa and V˙v are zero. Conservation of mass then gives:
q1 = q2 = q3 = q =
Pa − Pv
Rla +Rsa +Rsv +Rlv
(5.4)
We then calculate Pα and Pβ from eq. (2.1):
Pα = Pa − qRla (5.5)
Pβ = Pα − qRsa (5.6)
The form of the arteriolar model in the steady-state is given in eq. (3.25), the inputs
for which can be calculated from Pα and Pβ as follows (to avoid confusion, here we
will refer to the mean intramural pressure as Pim, in chapter 3 this was referred to as
P ):
Pim =
Pα + Pβ
2
(5.7)
∆P = Pα − Pβ (5.8)
Our arteriolar model can now be used to close the algebraic loop by calculating r from
Pim and ∆P . The procedure employed for iteratively solving the steady-state of the
combined model is as follows (using k to denote iteration number and starting from an
initial value of rk = r0 = 60× 10−6m):
1. Calculate Rsa from rk, eq. (5.1).
2. Calculate q from Rsa, eq. (5.4).
3. Calculate Pα and Pβ, eqs. (5.5) and (5.6).
4. Convert to Pim and ∆P , eqs. (5.7) and (5.8).
5. Use arteriolar model to find λ¯ and hence r¯, eqs. (3.23) and (3.25).
6. Update estimated value of r using rk+1 = rk +
1
2
(r¯ − rk).
7. Repeat until rk+1 = rk to within some tolerance (1× 10−15m).
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This iterative process is itself repeated for different values of Pa to yield the steady-state
response of the model over a range of arterial pressures.
5.2.2 Solution in the Dynamic Case
The combined model has four states, the three states of the arteriolar model given in
eq. (3.25) and a fourth state from the vascular model, Vv, the volume of blood in the
venous compartment. Converting λ to r through eq. (3.23), we can write the form of
the combined model as:
x˙ =
d
dt

[Ca2+]
Cw
r
Vv
 = f(x, Pa(t)) (5.9)
The derivatives of the first three states are given by the arteriolar model as a function
of the states themselves and Pα and Pβ. The calculation of Pα and Pβ depends (in the
dynamic case) on the flows V˙sa and V˙v, which in turn depend on the state derivative
dr
dt
(eq. (5.3)), leaving us with an algebraic loop in the solution of the dynamic system.
Similarly to § 5.2.1, this can be solved using an iterative approach at each time step,
again using k to denote iteration number and starting with an initial value of V˙sak =
V˙sa0 = 0. From conservation of mass in the arterial compartment:
Pa − P1
R1
= V˙sak +
P1 − P2
R2
(5.10)
where R1 = Rla +
Rsa
2
and R2 =
Rsa
2
+Rsv. Rearranging for P1 gives:
P1 =
Pa
R1
− V˙sak + P2R2
1
R1
+ 1
R2
(5.11)
Equation (5) in [62] gives the venous compliance:
Cv =
1
kven (P2 − Pic − Pv1) (5.12)
where kven and Pv1 are constants. This leads to the following equation for venous
volume (eq. (6) in [62]):
Vv =
1
kven
ln(P2 − Pic − Pv1) + Vvn (5.13)
where the constant of integration, Vvn is chosen to given a suitable baseline venous vol-
ume fraction. Thus we can calculate P2 directly from the state Vv by rearranging:
P2 = e
(Vv−Vvn)kven + Pic + Pv1 (5.14)
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We can now calculate Pα and Pβ as follows:
Pα = Pa − Pa − P1
R1
Rla (5.15)
Pβ = P1 − P1 − P2
R2
Rsa
2
(5.16)
and from them use the dynamic form of the arteriolar model to yield dr
dt
. We then use
eq. (5.3) to find V˙saout , the inferred value of net bloodflow into the arteriolar compart-
ment. Finally we update our estimated value and iterate:
V˙sak+1 = V˙sak +
1
2
(
V˙saout − V˙sak
)
(5.17)
Once V˙sak+1 = V˙sak to within some tolerance, the derivatives of the first three states
have been found from the arteriolar model and the fourth state derivative can be found
from conservation of mass in the venous compartment:
dVv
dt
= V˙v =
P1 − P2
R2
− P2 − Pv
Rlv
(5.18)
With this iterative scheme solving for V˙sa at each time step, the dynamic system of
eq. (5.9) can be integrated to yield the dynamic response of the combined model.
5.3 Fitting and Analysis
In this section we will present the fitting of the combined model to experimental data
and examine the model’s behaviour, both static and dynamic, under a variety of con-
ditions.
5.3.1 Steady-State Response
Values of the parameters of the vasculature model were taken from [62]. The only
parameter not given in [62] and not already assigned a value in the fitting of the
arteriolar model is nsa, the effective number of arterioles in parallel in the arteriolar
level of the vascular tree. In order to simultaneously achieve a realistic resistance for
the arteriolar part of the network and a realistic volume in the arterial compartment,
it is necessary to change the value of vessel length, L, from that in chapter 4. It can be
seen from eqs. (5.1) and (5.2) that if Rsa and Vsa are given, and if r is to be maintained
at a value consistent with arteriolar radius, then two degrees of freedom are needed;
varying L provides this second degree of freedom (the first being nsa). Values of L and
nsa were thus found to achieve the correct resistance, matching the flow/pressure data
of [80], whilst also achieving an arteriolar radius of ≈ 60µm and an arterial volume
approximately one third of that of the venous compartment. Figure 5.3 shows data
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extracted from fig. 5B of [80] alongside the fitted steady-state response of the combined
model.
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Figure 5.3: The steady-state flow/pressure behaviour of the model shown alongside rat and
cat CBF data taken from [80] fig. 5B where they were presented as normalized around
100mmHg.
In [80] the data are presented as percentage deviations from the flow at 100mmHg, we
show them here multiplied by the model flow at 100mmHg. It can be seen that the
low pressure side of the curve is a very close fit to the data, the high pressure side less
so, possibly because it is much harder to collect high pressure data than low pressure
data. It should also be noted that in terms of investigation of pathological conditions
of bloodflow in the brain, we are much more interested in abnormally low, than ab-
normally high, values of blood pressure. Table 5.1 lists the parameter values used to
achieve this fit, parameters not listed take the values presented in chapter 3.
Parameter Description Value Units Source
Pv venous pressure 6 mmHg [62]
Pic intracranial pressure 10 mmHg [62]
Rla resistance of large arteries 0.4 mmHg s/mL [62]
Rsv resistance of small veins (inc. capillaries) 1.32 mmHg s/mL [62]
Rlv resistance of large veins 0.56 mmHg s/mL [62]
kven stiffness coefficient for venous compliance 0.186 1/mL [62]
Pv1 pressure offset for venous compliance -2.25 mmHg [62]
Vvn offset for venous volume 28 mL [62]
L characteristic length of arterioles 50× 10−3 m Fitting
nsa effective number of arterioles in parallel 16,000 – Fitting
Table 5.1: Parameters of the combined, whole-brain model.
Note that the values for L and nsa given in table 5.1 are not representative of actual
vessel length or number, rather they are the values which must be assumed in order
to match the volume and resistance of an actual arteriolar network whilst maintaining
the gross simplification that the network is a single level of identical arterioles arranged
in parallel. The implications of the values that these parameters must take will be dis-
cussed further in §5.3.4. The steady-state vessel radius which gives rise to this plateau
in the pressure/flow relationship of fig. 5.3 is shown in fig. 5.4 and the arteriolar volume
fraction Vsa
Vv
is shown in fig. 5.5; note that the x-axis shows systemic arterial pressure,
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Pa, whereas the x-axes of figs. 4.7 and 4.8 show pressure immediately upstream of the
arteriole, Pα in this combined model. The inset in fig. 5.4 shows the sigmoidal step
in vessel radius as the NO level rises and the cGMP concentration goes from its low
value to its saturation value. Arteriolar volume fraction is seen to vary with arteriolar
radius squared, with the exception of the lowest pressures where the collapse of venous
volume inflates the arteriolar volume in proportion to it.
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Figure 5.4: Steady-state arteriolar radius vs. arterial pressure.
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Figure 5.5: Steady-state arteriolar volume fraction, Vsa/Vv vs. arterial pressure.
5.3.2 Dynamic Responses
The dynamic behaviour of the system can be assessed through analysis of its responses
to variations in arterial pressure Pa. The response of the system to a 10% step decrease
in Pa from 80 to 72mmHg is shown in fig. 5.6 for a τCa value of 5s. It can be seen
from the flows dVa
dt
and dVv
dt
that the change in volume of the arterial compartment
is minimal compared to that of the venous compartment. It is the compliance of the
venous compartment which drives the overshoot of vessel radius, and so flow, past the
equilibrium value after the initial passive contraction of the vessels; this overshoot is not
pronounced when considering an isolated arteriole in the absence of venous compliance
(fig. 4.15).
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Figure 5.6: Response of the dynamic model to a 10% step decrease in arterial pressure Pa.
In the top pane, q1 and q2 are both shown but lie exactly atop one another.
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We next examine the response of the combined model to a pressure oscillation at 0.1Hz,
as this is the frequency which is most commonly used to characterise autoregulatory
influence. Figure 5.7 shows the model’s response to such an oscillatory driving pressure,
again with a value for τCa of 5s. The forcing function (bottom, blue) can be thought
of as the superposition of a 4mmHg step increase and a 4mmHg amplitude sine wave.
For comparison, the black dashed lines show the response to a 4mmHg step increase in
pressure (excluding the unresponsive dVsa
dt
). It can be seen that the response is nearly
linear in that it is close to a sine wave superposed on the step response. There is however
a phase lag between the driving pressure and the flows q1 and q2 (which remain almost
identical). This phase lag changes as we change the speed of the myogenic response by
varying τCa, as shown in fig. 5.8.
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Figure 5.7: Response of the dynamic model to the sudden onset of a sinusoidal oscillation in
pressure. In the top pane, q1 and q2 are both shown for each case but lie exactly atop one
another.
Altering the speed of the NO system, as described in § 4.4, has no effect on the phase
lag between pressure and flow. This is to be expected because of the saturation of
[cGMP] at relatively low levels of [NO]. The initial (and minimum) value of [NO] in
the sinusoidal pressure case is over 130 times greater than the [cGMP] saturation level
[NO]U .
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Figure 5.8: Phase difference between Pa and q1,2 for varying values of τCa. Positive φ indicates
flow lagging pressure.
5.3.3 Downstream Transport of NO and the Possibility of NO
Signalling
It has been postulated [25, 10] that the regulation of bloodflow in the brain in response
to metabolic factors may involve some signalling mechanism between the downstream
perfused tissue and the upstream regulating arterioles. Because it responds to flow
and diffuses easily through both tissue and blood, it is possible that NO may be the
medium for such signalling. In order to evaluate the feasibility of this hypothesis we
augment our combined model with equations describing the transport of NO through
the venous compartment and the equilibrium of NO concentrations between the tissue
surrounding the veins and the blood flowing through them. We begin by assuming
that the venous compartment is well-mixed, then conservation of mass gives:
d
dt
(CvVv) = q2Cin,v − q3Cv − rdbCv − hwv (Cv − CT ) (5.19)
where Cv is the NO concentration in the venous blood, CT is the NO concentration in
the tissue surrounding the veins, hwv is the transfer coefficient between the blood and
the tissue (across the wall), and Cin.v is the NO concentration in the blood entering
the venous compartment which can be found by evaluation of the solution to eq. (3.1)
at x = L:
Cin,v = Cb(L) =
(
hwCwe
hw + rdbAb
− Cin
)
·
(
1− e−(hw+rdbAb) LQ
)
+ Cin (5.20)
where all terms are as defined in §3.2.1 with the exception of Q which here is taken as
(q1 + q2)/2 in order to reconcile the singular flow of the arteriolar model with the split
arteriolar compartment of the combined model. As we have seen from figs. 5.6 and 5.7,
the two flows are nearly identical so this averaging has a negligible effect.
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The tissue compartment can be modelled similarly:
d
dt
(CTVT ) = hwv (Cv − CT )− rdwCT (5.21)
If we assume that the tissue volume is constant then we can multiply out both equations
to yield:
dCv
dt
=
1
Vv
(
q2Cin,v − q3Cv − rdbCv − hwv (Cv − CT )− Cv dVv
dt
)
(5.22)
dCT
dt
=
1
VT
(hwv (Cv − CT )− rdwCT ) (5.23)
If we assume that the ratio of volumes between the arterial and venous compartments
is approximately 1:3 and that the transfer coefficient between the tissue and the blood
is proportional to vessel circumference, and hence to the cube root of volume, then
hwv should be related to the known value for the arteriolar model, hw, by the relation
hwv = hw · 3
√
3. If we then assume that the volume of the tissue adjacent to the blood
in the venous compartment (which includes the capillary bed) is equal to that of all
brain tissue, and furthermore that the blood accounts for 3% of total brain volume,
then we have that VT = 97%/3% · Vv · 4/3. This approximation is completed with the
assumption of a nominal venous volume of Vv = 60mL. Thus we have found values for
the two parameters hitherto undefined, albeit very approximate ones, which will suffice
for the analysis presented here.
The steady-state solutions to eqs. (5.22) and (5.23), at which the states of our aug-
mented dynamic model will be initialized, are given by:
Cv0 =
q2Cin,v
q3 + rdb + hwv
(
1− hwv
hwv+rdw
) (5.24)
CT0 =
hwvCv0
hwv + rdw
(5.25)
Incorporating these two new states into our model we find that for an arterial pressure
of 80mmHg, the steady-state value of NO concentration in the venous blood is 1.4 ×
10−20M and that the steady-state concentration in the tissue is 1.6× 10−29M. Both of
these are extremely low, primarily due to the rapid rate of decay of NO in the blood,
rdb. Even if the decay rate in the blood is reduced to equal that in the tissue/vessel
wall, rdw, i.e., decreased by a factor of 1900, the initial concentration in the venous
blood rises to only 2.7 × 10−17M, and in the tissue to only 3.1 × 10−26M. Compare
this to the initial level of NO in the arteriole wall, 4.9 × 10−6M. Maintaining this
artificially reduced value of rdb, even after flow has increased (thus releasing more NO
from the arteriolar endothelial cells), in the sinusoidal pressure case of fig. 5.7 the peak
to trough amplitude of the variation in Cv is ≈ 3 × 10−17M. Given this evidence that
the downstream concentrations of NO in the blood are negligible, the possibility of NO
82 A Model of Autoregulation
being the medium of a signal from venous blood to upstream vessels appears remote.
When we consider that deoxyhaemoglobin takes up NO very readily and so realise that
the decay rate of NO in venous blood should in fact be higher than that in arterial
blood, it becomes evident that NO will not persist long enough in whole blood to
transmit signals of detectable magnitude.
An experiment, described in [45], where downstream endothelium-denuded vessels react
to NO transported from upstream intact vessels may be taken to suggest that this is not
the case, and that NO released from arteriolar endothelium can effect the dilation of
downstream vessels. However, this experiment was carried out using saline solution as
the intraluminal fluid, rather than whole blood, and since the NO scavenging capacity
of haemoglobin has such a profound effect on the lifetime of free NO molecules, this
experiment does not provide a sound basis for extrapolation to in-vivo processes (this
not being the purpose of the experiment in [45]).
5.3.4 Discussion
The integration of the isolated arteriole model of chapter 4 into a simple electrical
equivalent model of the whole-brain vasculature is not without some inconsistencies.
The first derives from the assumption that all the small arteries are identical, and
that they are all arranged in parallel. This leads to the misleading values of L =
50mm and nsa = 16, 000, when in fact the mean length of an arteriole of radius 70µm
is closer to the original value of 1mm and we might expect the actual number of
arterioles in the brain to be somewhere between 372,000 and 2,790,0001. How then do
we reconcile the short, low volume arterioles of chapter 4 with the volume of the arterial
compartment? We may suppose, for instance, that the arteriolar level is composed of
two generations of arterioles, the first being large, compliant, and passive, the second
being those of our earlier model – narrow and with an active myogenic response. This
arrangement would accommodate the volume required of the arterial compartment,
primarily in the first generation of larger arterioles. The resistance presented by the two
generations together would be only slightly greater than that of the second generation
alone. If we then generalise to a series of multiple generations, each smaller than
the last, then we might easily conceive that there is an arrangement which satisfies
simultaneously the requirements of number, resistance, and volume. The volume is
thus largely attributable to the earlier generations, the resistance largely to the later
generations, and the number being greatly increased.
Whilst, as stated above, it may be possible to match certain aspects of a more complex
arteriolar network with an equivalent single level of identical arterioles in parallel, there
are other properties of such a network which are not well represented. For example,
we would not expect the larger arteries to exhibit a strong myogenic response; in
fact we would expect the walls of such vessels to behave essentially purely elastically.
1It is estimated that there are ≈ 186 × 105 arterioles in the body [52]; if we assume arteriolar
density goes with mass density then we take 2% of this number for the brain’s proportion of body
mass [17], whereas if arteriolar density goes with density of oxygen-consumption then we take up to
15% of this number as the brain’s proportion of total cardiac output [3].
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This is supported by the data shown in fig. 3 of [62] which show arterial blood volume
increasing with blood flow, and by implication with arterial pressure. In our single layer
representation all arterioles show active contraction with increased blood flow, thus a
diminishing arterial blood volume. In order to capture this passive compliance of the
arterial compartment, another capacitative element must be added to the equivalent
circuit. This addition would also redress the balance between dVsa
dt
and dVv
dt
; currently
the former is negligible compared to the latter, causing q2 to follow q1 almost exactly.
Inclusion of the passive arterial compliance would partially decouple q2 and q1 and may
increase the phase lag between ABP and CBF significantly enough to bring it into line
with the ≈ 45◦ repeatedly observed in vivo [24, 11, 54].
The change in phase difference between ABP and CBF, shown in fig. 5.8, with varying
τCa can be explained in terms of the relative speeds of the passive, elastic, response
and the active myogenic response of the arteriole. When τCa is large the initial elas-
tic response of the arteriole is large, and persists for some time before the myogenic
response compensates and drives the system in the opposite direction, as we saw in
fig. 4.12. Conversely, when τCa is small and the myogenic response is fast, the initial
elastic response of the vessel is quickly reversed by the active myogenic response and
so is of much smaller magnitude and duration. With a driving pressure oscillation at
0.1Hz, the important factor for phase lag is the macro response of the vessel over a 10s
period – when τCa is large this is in the passive direction, when τCa is small, this is in
the active direction. The phase thus reverses, from lead to lag, when the speed of the
active response is just sufficient to balance the elastic reaction of the vessel over the
initial few seconds; this occurs at τCa ≈ 2.5s. Once the myogenic response is slower
than the driving oscillations, the phase ceases to change significantly, as seen on the
right of fig. 5.8 where τCa > 10s. This sensitivity of ABP-CBF phase difference to the
speed of the Ca2+ response suggests that it may be possible to diagnose pathological
conditions affecting the release/uptake of Ca2+ by measuring the ABP-CBF phase dif-
ference. If, as hypothesised in § 4.4.1, the quick response of the Ca2+ system is due to
Ca2+ release from the SR, then a pathological blockade of the Ca2+ channels of the SR
could lead to an observable phase shift between ABP and CBF, from lead to lag.
The insensitivity of the phase response to changes in the speed of the NO system may
be unrealistic. Whilst the effect of flow on equilibrium radius does saturate at higher
flow levels, it may be that our system saturates too early, and is thus insensitive to
variations in flow to which it should respond. There are some data on the response of
equilibrium radius to varying levels of flow in [45] but they are inconsistent with the
other data therein presented. Figure 3 in [45] presents the variation in vessel diameter
with flow for different levels of intramural pressure, however, these data, when plotted
alongside those shown in fig. 4.3, do not follow the same trend, and so it is difficult
to integrate them into the fitting procedure used here. The sigmoidal step in fig. 5.4
shows the range of pressures over which NO transitions to its saturation value. This
region of positive feedback between flow and radius, under the right conditions, could
lead to a minimum pressure below which the vessel ‘collapses’, or rather contracts fully,
to become completely occluded. Whilst this was not observed in either [45] or [26],
it is possible that the fluid surrounding the isolated vessels in these experiments was
at a lower pressure than that of the cerebral tissue. In their analysis of pressure-flow
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relationships in the cerebral vasculature Tzeng et al. [77] use the value of 33mmHg
for the arterial pressure at which vessels collapse and flow stops, taken from in-vivo
experiments presented in [7]. Our model exhibits no such sudden collapse, although
the on-off nature of the NO response does hint at it. Perhaps in reality this positive
feedback from the NO system contributes to this phenomenon. In our fitting of the
isolated arteriole model in chapter 4 we assume an extramural pressure of zero, there is
some inconsistency in this vasculature model as we present the arteriolar compliance as
reacting against an intracranial pressure of 10mmHg whilst calculating the wall stress
for the myogenic response assuming zero extramural pressure. This inconsistency will
be most noticeable at the lowest pressures. We should then perhaps not pay too much
attention to the behaviour of the model at this extreme end of the pressure range. The
effect of this inconsistency will be further reduced when we allow intracranial pressure
to vary with the introduction of cranial compliance in § 6.3.1.
Whilst the inclusion of the equations for downstream NO transport has shown that
there is a signal in the downstream NO concentration which reflects upstream condi-
tions, it has been assumed that this signal is too weak to have an effect on autoregula-
tion upstream. In numerical simulations such as ours it is possible to keep track of such
small numbers representing numbers of molecules, and in writing and solving equations
for exponential decay we do not make allowances for the true, stochastic nature of such
low concentrations. In reality it may be that the downstream NO concentration is
truly reduced to zero, or that at such low concentrations other effects which we have
not modelled become important. It should also be noted that we have not included
a discussion here of the sensitivity of any receptors to low concentrations of NO, the
only NO sensitive system we have approached in this text is that of cGMP production.
Without further investigation into the dynamics of low-concentration NO in blood and
possible highly sensitive receptors for downstream NO it is not possible to rule out NO
absolutely as a candidate for upstream metabolic signalling. However, on the basis of
these results it seems highly unlikely.
5.3.5 Conclusions
So far in this chapter we have integrated the single arteriole model from chapter 3
into a simple electrical equivalence model of the whole brain vasculature from [62].
The equilibrium behaviour of the combined model fits well with experimental data for
the variation of cerebral blood flow with arterial pressure. We have examined sev-
eral dynamic responses of the model and found that a phase difference exists between
pressure and flow, that this phase difference is largely caused by the venous compli-
ance, and that its magnitude and direction are dependent on the speed with which the
myogenic response overrides the passive response of the arterioles. We have identified
several shortcomings of this combined model and suggested possible improvements,
namely the inclusion of a passive arterial compliance to the represent the larger ar-
teries and the inclusion of a more complex vascular topology, better representing the
branching levels of the network. Lastly we have concluded, through our examination
of the downstream transport of NO, that the decay of NO in the blood is such that
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venous concentrations of NO are extremely low; consequently it is very unlikely that
NO is involved as the signalling medium for any large-scale autoregulatory feedback
loop.
5.4 Inclusion of Passive Arterial Compliance
In order to address the inconsistencies referred to in §5.3.4, the model of §5.2 has been
modified to include a capacitative element representing the passive elastic behaviour
of the larger, non-regulating arteries and arterioles. As well as adding this passive
arterial compliance, we neglect flow through the capacitative element associated with
regulating arterioles, noting from the results above that this flow is negligible. A
schematic for this modified model is shown in fig. 5.9.
Rsa/2 Rsa/2 Rsv Rlv
Pa PvP1
P2P P↵
dVv
dt
Rla
q1 q2 q3
Pic
dVa
dt
Figure 5.9: The modified electrical equivalent model of the vasculature; flow down the red
path is neglected.
The new arterial passive compliance is governed similarly to the venous compliance:
Ca =
1
kart (Pα − Pic − Pa1) (5.26)
The removal of dVsa
dt
from the model also removes the algebraic loop and so it is no
longer necessary to iteratively solve for the states of the arteriolar model at each time
step. Values for the parameters introduced in eq. (5.26) were found such that the
arterial to venous volume ratio was approximately 1:3 and such that this ratio too
increases slightly with increasing arterial pressure over the mid pressure range (as
opposed to the previous case where this ratio fell across the mid pressure range, see
fig. 5.5). The value for arterial stiffness was set at three times the stiffness of the venous
compartment, reflecting the relative stiffness of arterial walls relative to those of veins.
These values are given in table 5.2: note that the values of L and nsa have both been
reduced by a factor of fifty, thus reducing the characteristic length to a more realistic
value whilst maintaining overall resistance; again, the value for the number of arterioles
is not representative of the value found in a realistic network architecture.
The steady-state flow response of the modified model is identical to that of the original
model; the volume fraction response however is significantly altered and now exhibits
a slight upward trend through the central, autoregulatory, region; fig. 5.10. It should
be noted that whilst the flow related to the change in arteriolar volume ( dVsa
dt
in the
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Parameter Description Value Units Source
kart stiffness coefficient for arterial compliance 0.558 1/mL Fitting
Pa1 pressure offset for venous compliance -2.25 mmHg [62]
Van offset for venous volume 3 mL Fitting
L characteristic length of arterioles 1× 10−3 m Fitting
nsa effective number of arterioles in parallel 320 – Fitting
Table 5.2: Parameters of the modified whole-brain model.
original model) has been neglected, the actual change in volume of the arterioles has
been included in the calculation of arterial volume fraction, i.e., dVsa
dt
' 0 but ∆Vsa is
not. The discontinuities in the blue curve of fig. 5.10 are due to the points at which
the volume in the arteriolar and venous compartments reach zero, fig. 5.11 shows the
three volumes individually varying with arterial pressure.
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Figure 5.10: Arterial to venous volume fraction in the modified whole-brain model, variation
with arterial pressure. Dashed line shows Va/Vv = 1/3
The dynamic behaviour however is markedly different. In the previous model, the flow
into the arterial capacitative element, dVsa
dt
, was so small that q1 and q2 were effectively
identical. The passive compliance introduced in the modified model partially decouples
q1 and q2. Now that arterial volume fraction changes realistically with pressure, and
that q1 and q2 have been decoupled we can look at the responses of q1 and q2 to
variations in the frequency of the driving oscillation in Pa. As previously, the forcing
function used in this frequency response analysis is a 10% step in pressure coupled
with a 10% amplitude sine wave. Figures 5.12 and 5.13 show the magnitude and phase
respectively of the responses of the flows q1 and q2 to various frequencies of oscillation
in Pa.
The red and blue lines correspond to the cases where τCa = 1s and 10s respectively,
from a baseline of Pa = 80mmHg. There is a clear resonant peak in the red lines at
0.1Hz, interestingly this peak strengthens and moves to a lower frequency when the
calcium response is slowed. When the oscillation is applied about a point which is not
within the autoregulatory region of the system, Pa = 30mmHg, as in the case of the
black lines (τCa = 1s), the resonance is no longer present. The increasing values of q1
(solid lines) at higher frequencies culminates in another resonance with a magnitude of
1.2 around 60Hz – however it is not thought that the behaviour of the model at such
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Figure 5.11: Variation of the volumes of the veins, arteries and small arteries (reactive arte-
rioles) with arterial pressure.
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Figure 5.12: Magnitude of the response of the model flows to oscillations of various frequencies
in arterial pressure; y-axis shows oscillation amplitude relative to steady state value, legend
shows flow, τCa value, and baseline pressure for 10% oscillations in Pa.
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Figure 5.13: Phase of the response of the model flows to oscillations of various frequencies
in arterial pressure; y-axis shows phase lag of flow relative to driving pressure, legend shows
flow, τCa value, and baseline pressure for 10% oscillations in Pa.
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high frequencies is relevant to the real system, rather a mathematical feature of our
very simplified system architecture.
The phase of the flow relative to the pressure oscillations, fig. 5.13, tells a similar story:
when the calcium response is slowed by increasing τCa from 1s to 10s, the maximum
phase lag increases, moves to a lower frequency, and the transition from lead to lag
is compressed. The response at low pressure is tending towards the response of the
system in the absence of autoregulation – a zero phase shift in q2 and a transition from
0◦ to −90◦ for q1 as f increases. This is to be expected when the baseline pressure is so
close to the peak of the radius/pressure curve, fig. 5.4, where radius is least sensitive
to changes in pressure and so closest to presenting a fixed resistance.
5.4.1 Conclusions
The inclusion of a passive compliance in the arterial compartment has led to a more
realistic ratio of volumes between the arterial and venous compartments. The elastic
dilation of the arteries, in contrast to the active contraction of the arterioles, leads to the
volume ratio increasing slightly with Pa; this brings the model into closer agreement
with [62] and hence the data of [51]. We have also found that this modified model
exhibits a resonant peak and that this peak is found at a frequency around 0.1Hz
when the calcium response is fast, being lower and more pronounced as the calcium
response slows down. We also find that at lower frequencies, the phase lead of flow
is increased relative to the original model and achieves a maximum lead of nearly 70◦
at lower frequencies, being nearer 30◦ at 0.1Hz. As found in the original model, the
phase can invert at frequencies around 0.1Hz when the calcium system is slow. The
low pressure case (black line) shows that the resonance disappears at low perfusion
pressures, outside the active range of the arterioles. However, we also see that the
magnitude of the response at 1Hz is nearly twice as great at low pressure as it is at
higher pressure.
5.5 Conclusions
In this chapter we have integrated our well-fitted single arteriole model into a model
of the cerebral vasculature. We have shown that a realistic pressure/flow relationship
and pressure/volume-ratio can be achieved. Our results suggest that signalling through
tissue to upstream vessels is very unlikely to be possible using NO as a medium, due
to its rapid decay in the blood stream. By examining the response of the flows in
our model to sinusoidal variations in arterial pressure, we have found that the system
has a resonant peak, the frequency of which is sensitive to the speed of the myogenic
Ca2+ response. We have also found that the phase lag between pressure and flow is
sensitive to both frequency and Ca2+ response speed, and that this may have diagnostic
applications.
Chapter 6
Vasomotion and Spontaneous
Oscillations
6.1 Introduction
Now that we have produced a model of the cerebral vasculature including a well-fitted
(although simplified) model of the arteriole, we are in a position to investigate the
potential of the model to produce spontaneous oscillations in vascular tone, represen-
tative of vasomotion. We aim to gain an insight into the mechanism of vasomotion by
examining the requirements for its onset in our model.
6.2 Stability Analysis
Having identified an equilibrium radius for each value of arterial pressure for our mod-
ified whole-brain model, we can use a technique known as stability analysis to charac-
terise these equilibria – specifically to identify them as either stable nodes or possibly
unstable equilibria or oscillatory attractors. We perform this characterisation by evalu-
ating the Jacobian of the model at the equilibria and calculating the eigenvalues of this
matrix. A Jacobian is a matrix of all first order partial derivatives of a vector-valued
function; in our case the vector-valued function is the modified whole-brain model with
a fixed arterial pressure Pa:
x˙ = f (x) (6.1)
where x is the vector of state values for the modified model
x =

x1
x2
x3
x4
x5
 =

[Ca2+]
Cw
r
Vv
Va
 (6.2)
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The Jacobian matrix required for bifurcation analysis of our system is then:
J =
dx˙
dx
=

∂x˙1
∂x1
∂x˙1
∂x2
. . . ∂x˙1
∂x5
∂x˙2
∂x1
∂x˙2
∂x2
. . . ∂x˙2
∂x5
...
...
. . .
...
∂x˙5
∂x1
∂x˙5
∂x2
. . . ∂x˙5
∂x5
 (6.3)
The Jacobian tells us how the derivatives of the system will respond to a perturbation
in its state. If a small perturbation in the state will cause a bigger change in the
derivatives, or a change in the derivatives which pushes the system further in the same
direction as the purturbation, then the starting point is unstable. Any small perturba-
tion from such a point will quickly grow into a large perturbation and the system may
transition to another equilibrium, oscillate around an equilibrium, or continue in one
direction until it hits a limit of some kind. The eigenvalues of a matrix tell us by how
much, and in what direction, that matrix amplifies perturbations in various directions
(along the eigenvectors). The Jacobian can be compiled simply using finite differences:
having evaluated the model at the equilibrium point, we perturb each element, xi, of
x (each state) in turn, recording the change in x˙. We then divide each change in x˙
by the magnitude of the perturbation in xi to yield
∂x˙
∂xi
, each of which is a column of
the Jacobian. Having thus evaluated the Jacobian at an equilibrium point we proceed
to calculate the eigenvalues of this matrix, analysis of which reveals the nature of the
equilibrium.
In our case we find that all eigenvalues have negative real parts at all pressures, meaning
that all equilibria are stable. If we consider the iterative scheme which we used to solve
for the equilibria in the first place we realise that all equilibria found by such a scheme
must be stable, otherwise the iterative scheme would not have been able to converge
upon them. It is interesting to note that the eigenvalues for the highest and lowest
pressures, below 40mmHg and above 150mmHg, are all real whereas the equilibria of the
middle pressures all have two complex eigenvalues. Real negative eigenvalues indicate
an equilibrium to which the system will monotonically decay after a perturbatioin,
whereas complex eigenvalues with a negative real part indicate that the system will
oscillate about an equilibrium with an exponentially decaying amplitude. Thus we
have some indication that although the system is everywhere stable, it is closer to
displaying oscillatory behaviour in the regulatory pressure range than outside it. At the
point where venous volume reaches its minimum limit (see fig. 5.11) the discontinuity
in the sensitivity of dVv
dt
artificially magnifies ∂x˙4
∂x4
, and thus the fourth eigenvector,
λ4, enormously whilst reducing the other elements on the same row to zero. This is
because when one or more of the states (i.e., Vv) reaches a hard limit, its derivative is
no longer sensitive to perturbations in other states; however the discontinuity between
the baseline evaluation of x˙4, which returns zero, and the finite difference evaluation,
which returns a negative value, of that state derivative gives the misleading impression
that it is extremely sensitive to perturbations in its corresponding state. This is an
artefact of the numerical evaluation; it can be shown that if the finite difference step
used was in fact negative then the sensitivity would be zero, and the Jacobian matrix
would be rank-deficient.
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6.2.1 Discussion
The absence of any oscillatory behaviour in our model suggests that NO is not an
important factor in vasomotion. When we review the elements of the arteriolar model
we find that the absence of oscillatory behaviour is perhaps to be expected: the NO–
cGMP system is saturated at all but the very lowest levels of flow, and so plays no
part in the dynamics of the system in its normal pressure range; the Ca2+ dynamics of
the myogenic response are first order, and as such are over-damped and cannot drive
oscillation; and the mechanical model includes viscous friction terms which damp any
oscillation that might appear.
The saturation of the NO–cGMP system is of particular interest as it implies that
although NO is an important factor in determining the radius of the arteriole, it plays
virtually no role whatsoever in the dynamics of the vessel. From fig. 4.11 we can see that
the NO–cGMP sigmoid saturates quickly even with a pressure drop along the vessel
as low as 2.4mmHg. The arterial pressure in the whole brain model which creates this
pressure drop through the arterial component (in steady state) is only 9mmHg, which
is itself lower than the 10mmHg at which intracranial pressure is set. It is clear then
that unless a vessel is seriously occluded, or bloodflow is otherwise severely disrupted,
there is always sufficient flow through the arterioles to saturate the NO–cGMP pathway.
Given that sGC (the enzyme which produces cGMP) is the only proven receptor for NO
[23], once this pathway is saturated further increases in [NO] have no effect on the vessel
whatsoever. Furthermore, as long as the level of NO does not drop below saturation
level (which as we have seen would require a very large fall in arterial pressure), the
vessel is completely insensitive to oscillations in [NO]. Whilst [NO] may vary in response
to radius/flow dynamics, there is no feedback element. This has important implications
for interpreting the results of [40] – if NO plays no role in the dynamics of the system
except for a steady state dilatory component, then the blockade of eNOS by L-NMMA
would be expected to produce exactly the same effect as an α-adrenergic agonist such
as phenylephrine in terms of the correlation between ABP and CBF.
The saturation of the NO pathway is derived from fitting the arteriolar model to the
dynamic results of [45] as presented in §4.4, specifically the delay in vessel response to
the cessation of flow. However, there are conflicting results presented in the same paper
which suggest that, although the NO pathway does saturate, this does not happen at
such low flow levels. Figure 6.1 (reproduced from fig. 3 in [45]) presents data which
suggest that the vessel continues to show sensitivity to NO (or at least to flow) until
the pressure drop along the vessel is approximately 15mmHg, although as mentioned
in § 5.3.4, these results are themselves inconsistent with the data presented in fig. 4 of
the same paper and with the dynamic results of fig. 4.12.
It could be postulated that the saturation of the flow response manifested in the dy-
namic experiments was due to the use of saline solution as opposed to whole blood,
whereas if whole blood were used the response of [NO] within the vessel wall would
have been much reduced due to a far greater loss of NO into the blood, thus extending
the range in which the vessel was sensitive to flow induced NO. However, the results
presented in fig. 6.1 were also obtained using saline solution and not whole blood, so
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myogenic tone. As a result, the pressure-diameter rela- 
tionship was shifted upward (Fig. 4). With nitroprusside, 
all vessels behaved passively during luminal pressure 
changes (i.e., vessels distended and collapsed at high and 
low IPs, respectively). 
Protocol 2. Figure 5 shows the results of experiments 
designed to test whether the flow-induced dilation was 
caused by release of a transferable substance from the 
endothelium. Two vessels (one with an intact endothe- 
lium and the other one denuded mechanically) were 
connected in series and pressurized to 60 cmH20 using 
the dual-reservoir system. During perfusion from the 
intact to the denuded vessel, graded dilation as a function 
of flow was observed in both vessels. Generally, there 
was a delay for the denuded vessels to respond to an 
increase in flow (-10-E s compared with 5 s for the 
intact vessel), but the magnitude of the steady-state flow- 
induced dilation was not significantly different from that 
of the intact vessels (Fig. 5). However, when intact 
segments received flow from denuded segments, only the 
intact segments exhibited flow-induced responses. The 
diameter of the denuded donor vessels remained constant 
throughout the entire range of flow (Fig. 5). 
After the vessels were incubated with L-NMMA (10D5 
M) for 45 min, vascular tone significantly increased 
under no-flow conditions, and flow-induced dilations 
were completely inhibited (Fig. 7A). L-Arginine (3 mM) 
totally reversed the inhibitory effect of L-NMMA on 
flow-induced responses (Fig. 7A). Because L-NMMA 
caused a significant increase in resting tone, the flow- 
diameter relationship was also examined after enhance- 
ment of vascular tone by acetylcholine (2 x 10B7 M). 
Acetylcholine in the porcine coronary circulation is an 
endothelium-independent vasoconstrictor (22, 24), and 
this concentration constricted the vessels to the same 
extent as L-NMMA. In acetylcholine-preconstricted ves- 
sels, flow-induced responses were still observed. How- 
ever, the dilation associated with an increase in flow was 
significantly less (80% of the maximal diameter) than 
for control vessels that dilated to -92% of maximal 
diameter (Fig. 7A). In the absence of flow, the vasocon- 
striction caused by L-NMMA was completely reversed 
after the vessel was treated with L-arginine for 30 min 
(Fig. 7B). L-NMMA-treated vessels were tested to see if 
the endothelium was still capable of responding to bra- 
dykinin. The dilation to bradykinin (10m8 M) was similar 
in magnitude and was only slightly inhibited (P < 0.05) 
by L-NMMA (Fig. 7B). 
Protocol 3. To characterize the nature of the substance 
released from the endothelium by flow, pharmacological 
blockade of flow-induced responses was attempted. Fig- 
ure 6 shows that indomethacin (10m5 M) did not alter 
baseline diameter or flow-induced dilation in these ves- 
sels. There was no significant difference in the threshold 
or magnitude of the flow-induced response between con- 
trol and indomethacin-treated vessels (Fig. 6A). To dem- 
onstrate that indomethacin did inhibit prostanoid syn- 
thesis, the efficacy of blockade was challenged with ara- 
chidonic acid. Under control conditions, arachidonic acid 
produced a 40% vasodilation, which was completely in- 
hibited by indomethacin (Fig. 6B). Bradykinin (10m8 M) 
dilated the vessels in the presence and absence of indo- a mg. 7. 
In the double vessel setup, L-NMMA blocked flow- 
induced responses regardless of the direction of flow. 
This inhibition was completely reversed after subsequent 
treatment with L-arginine. Because the results from the 
intact vessels were similar to those in the single-vessel 
preparations, the data were combined and presented in 
no n 
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FIG. 4. Pressure-diameter relations of arterioles (n = 8) with or 
without flow. Average luminal diameters were 65 t 5 and 54 t 4 pm, 
respectively. With nitroprusside (10m4 M), vessels showed passive re- 
sponses to intraluminal pressure changes. Lumen diameters were nor- 
malized to diameters at intraluminal pressure of 60 cmHsO in presence 
of nitroprusside. Establishing flow or administration of nitroprusside 
caused significant vasodilation at all pressures (between groups). All 
diameters were significantly different (P < 0.05) from those at 60 
cmHnO intraluminal pressure (within groups). 
methacin, and the increase in diameter was not signifi- 
cantly different from that produced by nitroprusside 
(10D4 M) (Fig. 6B). 
Figure 6.1: Response of v ssel diameter to pressure dro along vessel. Reproduced from fig. 3
in [45].
the inconsistency remains unresolved. A better candidate explanation could lie in the
time domain: the results presented in fig. 6.1 are steady state results, and the satura-
tion seen in fig. 4.12 is observed only for about a minute, so it could be the case that
there is an initial fast response o NO which reaches satur tion quickly, and then a
much slower process continues to cause vasodilation until the final stead state radius
is reached. Although this explanation allows the possibility of consistency between the
dynamic results and the steady state results – it does not say in [45] how long it took
to reach a steady radius – it seems like an unlikely scenario. As far as we are aware,
there is no experimental evidence which suggests a dual-timescale NO response. N t
only that but if the second, slower, phase of the NO resp nse takes > 1min to manifest
itself then it makes little difference to our conclusions; the oscillations we are studying
are much too fast to be affected by such a slow response.
6.3 Replicating Vasomotion
Having concluded that the current model is incapable of spontaneous oscillations which
could represent vasomotion, w will now modify th model with the aim of investigating
the possibility of such oscillations occurring.
6.3.1 Adding Intracranial Compliance
Thus far intracranial pressure, Pic, has been fixed. If we model cranial compliance and
thus allow Pic to vary, we may find a resonance between the blood and intracranial fluid
volumes. To this end we introduce a third capacitative element to the model, coupling
the intracranial fluid to ground (outside the head), as found in [65] as a modification
to the original basis for our model from [62]. Figure 6.2 shows the schematic of the
electrical equivalent circuit.
This extra capacitative element represents the compliance of the cranium and other
meninges of the brain to accommodate changes in intracranial fluid pressure. In electri-
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Figure 6.2: The vasculature again modified to allow intracranial pressure to vary.
cal circuits capacitors are formed of two charge reservoirs (metal plates) separated by
an impermeable membrane (the dielectric), in hydraulic circuits capacitance is mani-
fested by two reservoirs of fluid separated by an impermeable membrane. The stiffness
of the membrane determines the equivalent capacitance of the coupling, a stiff mem-
brane deflects little and so has a low capacitance, the more flexible the membrane,
the more fluid can be accommodated by its deflection. The compliance of the extra
element is taken from [65] as:
Cic =
1
kicPic
(6.4)
where kic = 0.08/mL [65]. This is similar to the expressions for Ca and Cv but without
the pressure offsets. As with previous compliant elements, the expression for volume
is:
Vic =
1
kic
ln (Pic) (6.5)
In this case however the volume does not represent the total volume of intracranial
fluid, rather the change in volume of the cerebral cavity caused by the cranium and
other meninges deflecting in response to elevated intracranial pressure. If we assume
that the volume of cerebrospinal fluid remains constant then any increase in cerebral
blood volume must be matched by an equal increase in volume of the cerebral cavity,
thus we can write:
Va + Vv − Vic = Vb0 (6.6)
where Vb0 is a constant representing the cerebral blood volume at which cranial deflec-
tion would be zero. This expression completes a set of four equations which can be
solved in the steady state condition to yield values for the three volumes and Pic given
Pα, P2, and Vb0; these equations are:
Va =
1
kart
ln (Pα − Pic − Pa1) + Van (6.7)
Vv =
1
kven
ln (P2 − Pic − Pv1) + Vvn (6.8)
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Vic =
1
kic
ln (Pic) (6.9)
Va + Vv − Vic = Vb0 (6.10)
Vb0 can be determined by fixing the intracranial pressure at any particular arterial pres-
sure, in this case we fixed Pic = 10mmHg at Pa = 80mmHg. Having thus determined
the steady state values of all of the volumes at any given arterial pressure, we can then
integrate the system as before to reproduce its dynamic behaviour. The extra state,
Vic, is propagated by calculating Pic from Vic via eq. (6.5), using this to calculate flows
dVa
dt
and dVv
dt
, and then rearranging and differentiating eq. (6.6) to give:
dVic
dt
=
dVa
dt
+
dVv
dt
(6.11)
The variation of steady state volumes with arterial pressure is shown in fig. 6.3. Note
that because Pic is no longer fixed, and is allowed to vary alongside blood pressure, the
blood compartments no longer collapse at some non-zero arterial pressure, as they are
seen to do in the previous iteration of the model (fig. 5.11).
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Figure 6.3: Arterial, venous, and intracranial volumes with varying arterial pressure.
Despite this additional dynamic element, the model still exhibits no spontaneous os-
cillation at any arterial pressure. In fact its dynamic behaviour is very similar to that
of the previous iteration of the model. We therefore consider additional reactive com-
ponents, modelling more and more elements of the biological system, until such point
as we develop spontaneous oscillations under some conditions.
6.3.2 Adding Flow Inertia
Thus far the mass, and hence inertia, of the flow has been neglected, allowing instan-
taneous changes in flow velocity. In reality of course the blood flow does have mass
and so takes a finite time to accelerate and decelerate in response to changes in driving
pressure. We now add into the model the inertia of the blood in the small arteries
6.3 Replicating Vasomotion 95
(arterioles), starting from Newton’s first law:
f = ma (6.12)
we can write expressions for each of these quantities in terms of current parameters of
our model. The net force acting on the blood in the arterioles is equal to the pressure
difference between the upstream and downstream ends multiplied by the area upon
which it acts:
f = ∆Ppir2nsa (6.13)
The mass of the blood in the arterioles is given by:
m = ρbLpir
2nsa (6.14)
where ρb is the density of blood. The acceleration of that mass can be expressed
as:
a =
dvblood
dt
=
1
pir2nsa
dq2
dt
(6.15)
In combination then we have that:
∆Ppir2nsa = ρbLpir
2nsa
1
pir2nsa
dq2
dt
(6.16)
or, rearranging:
∆P =
ρbL
pir2nsa
dq2
dt
(6.17)
This is the hydraulic equivalent of an inductor. Figure 6.4 shows the revised electrical
equivalence circuit including this inductor. The pressure difference ∆P is equal to
Pβ − Pγ, and the parameters r, L, and nsa are taken from the arteriolar model of
chapter 4. The density of blood, ρb, is taken as 1.06kg/L [20].
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Figure 6.4: The vasculature further modified to include the inertia of the bloodflow.
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The addition of this inductance introduces another state, q2 into the model, the deriva-
tive of which is given by eq. (6.17). Steady state behaviour does not change and other
values are calculated much as before.
Although the addition of this inertia changes the phase behaviour of the system (by
partially decoupling pressure and flow) the stability of the system is unaltered and no
spontaneous oscillations are observed at any values of Pa and τCa. Considering the
literature on vasomotion, there is a clear consensus that vasomotive oscillations are
associated with Ca2+ oscillations in the VSMCs, therefore it is to the Ca2+ dynamics
of the system that we now turn.
6.3.3 Making Ca2+ Dynamics 2nd Order
The dynamics of the Ca2+ concentration in the VSMC have so far been determined
by eq. (3.15), a first order asymptotic approach to the steady state equilibrium value.
In an analysis of oscillations in vascular networks [78] Ursino et al. make reference to
both a static and a rate-dependent element of the myogenic response, as modelled in a
previous paper [79]. Whilst we do not replicate their model here we note the inclusion
of a rate-dependent term in the myogenic response in contrast to our existing model
which has no such term. To investigate the possible effect of a rate-dependent term we
modify our Ca2+ system to a simple second order response:
d2[Ca2+]
dt2
+ 2ζωn
d[Ca2+]
dt
+ ω2n[Ca
2+] = Gdcω
2
n[Ca
2+] (6.18)
In our case the DC-gain, Gdc, is unity since at equilibrium [Ca
2+] = [Ca2+]. We can
then write the new state equation:
d2[Ca2+]
dt2
= ω2n
(
[Ca2+]− [Ca2+]
)
− 2ζωn d[Ca
2+]
dt
(6.19)
The addition of the second derivative adds an extra state to the arteriole model in the
form of d[Ca
2+]
dt
. This appears both as a state and a state derivative. The arteriole
model now has the form:
x˙ =

x˙1
x¨1
x˙2
x˙3
 = ddt

[Ca2+]
d[Ca2+]
dt
Cw
λ
 = f (x) = f


x1
x˙1
x2
x3

 , (6.20)
and the whole brain model, which has gained several states since its inception, now
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has the state vector:
x =

[Ca2+]
Cw
r
Vv
Va
Vic
q2
d[Ca2+]
dt

(6.21)
Unlike the addition of the vasculature elements of §§ 5.4, 6.3.1 and 6.3.2, this change
in the Ca2+ dynamics affects the behaviour of the isolated arteriole model, albeit only
the dynamic behaviour and not the steady state results. In order then to preserve the
validity of this model we must re-tune the arteriole model with the new Ca2+ dynamics
to the dynamic results of [45]. Whereas previously we tuned the value of τCa for each
epoch of each experiment, table 4.5, we have now replaced the explicit time constant
τCa with the undamped natural frequency ωn and the damping factor ζ. It is these
then that we must tune in order to regain the fit previously obtained to the dynamic
arteriole experiments of [45]. Figures 6.5 to 6.8 show the fit that was obtained by this
tuning process (which was carried out manually as before), the corresponding values
of ωn and ζ for each epoch are given in table 6.1.
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Figure 6.5: Fit of model with 2nd order Ca2+ dynamics to the data of [45] fig. 2A.
The variation in values for ωn and ζ over the different epochs of the experiments is
similar to that of the first order system, given in table 4.5 with the most common fast
response being given by ωn = 1.5 and ζ = 0.5. A natural frequency of 1.5rad/s is
equivalent to approximately 0.24Hz. It should be noted that the values presented in
table 6.1 are not necessarily unique in their fit of the data; previously a similar fit was
achieved by tuning only one parameter, now that we have two to tune to the same data,
we cannot be sure that there do not exist other combinations of ωn and ζ which would
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Figure 6.6: Fit of model with 2nd order Ca2+ dynamics to the data of [45] fig. 2B.
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Figure 6.7: Fit of model with 2nd order Ca2+ dynamics to the data of [45] fig. 2C.
Experiment Start time (s) End time (s) ωn (rad/s) ζ ()
A 0 239 0.04 5.0
239 end 1.50 0.5
B 0 end 1.50 0.5
C 0 117 1.50 0.5
117 267 0.15 12.0
267 end 1.50 0.5
D 0 123 1.50 0.5
123 end 0.75 1.5
Table 6.1: Values of the myogenic response natural frequencies and damping factors, along
with corresponding epoch start and end times, used to obtain the model simulation results
presented in figs. 6.5 to 6.8.
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Figure 6.8: Fit of model with 2nd order Ca2+ dynamics to the data of [45] fig. 2D.
produce the same (or better) results. We have however shown that the new second-
order system is at least as capable as the previous, first-order, system of replicating
experimental behaviour. It should also be noted that all of the discussion of § 4.4.1
applies to this new system just as it did to the old. With this new Ca2+ dynamic, we are
aiming not to replicate exactly the Ca2+ behaviour of the cell, only to allow the system
a little freedom in that dimension, allowing us to explore the possible implications of
a more complex Ca2+ dynamic.
6.4 Analysis of Instability
The response of the system to the step onset of oscillatory arterial pressure (as in
fig. 5.7) is shown in fig. 6.9 and is similar to that of the first iteration of the system.
The response is a combination of a straightforward sinusoidal response with a phase
lead of flow w.r.t. pressure of 35◦ and a damped step response to the increase in mean
pressure. The dotted lines show the isolated step response while the solid lines show
the response to the combined step and sine-wave onset.
It is not necessarily discouraging that the modified system does not exhibit instability
in this response: vasomotion is only observed in vivo under strenuous conditions, such
as those of hypo-perfusion due to haemorrhage [72] or introduction of an adrenergic
stimulant [18]. Whilst our myogenic response model is not physiologically realistic
enough to directly model what effects these conditions might have on the biochemistry
of the VSMC, we can adjust the parameters of our Ca2+ dynamic (eq. (6.18)) and so
observe the range of possible effects. Figure 6.10 shows the response of the system to
a constant pressure of 80mmHg with ωn = pi/5 and ζ = 0.1 (
pi
5
rad/s = 0.1Hz).
The system can be seen to diverge from its initial equilibrium and to oscillate with
increasing amplitude, albeit still very low amplitude at 100s. As with any numerically
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Figure 6.9: Response of vasculature model to sinusoidal arterial pressure variations.
6.4 Analysis of Instability 101
0 10 20 30 40 50 60 70 80 90 100
7.395
7.4
7.405
7.41
flo
w 
(m
L/
s)
 
 
q1
q2
0 10 20 30 40 50 60 70 80 90 100−1
−0.5
0
0.5
1x 10
−4
flo
w 
(m
L/
s)
 
 dVa/dt
dVv/dt
0 10 20 30 40 50 60 70 80 90 10076.22
76.24
76.26
76.28
r (
µ m
)
0 10 20 30 40 50 60 70 80 90 10060
70
80
90
100
P a
 (m
m
Hg
)
time (s)
Figure 6.10: Initial response of vasculature model to constant arterial pressure when damping
is reduced (ζ = 0.1).
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solved system, the initial equilibrium was not exact, rather it was correct to within
1× 10−15m, thus no perturbation was needed in order to precipitate these oscillations.
If we integrate the system for a longer period we see that the growing oscillation settles
into a periodic limit cycle. Figure 6.11 shows the same trajectory as fig. 6.10 after it
has settled into this limit cycle. Figure 6.12 shows the the first 1000s of the evolution
in state-space, specifically [Ca2+] -r space. The spiral out from the point near the
centre corresponds to the slowly growing oscillations seen in fig. 6.10 whilst the heavily
traversed ovoid paths correspond to the ‘settled’ limit cycle behaviour seen in fig. 6.11.
Note that this limit-cycle behaviour is fundamentally different from the sinusoidal
response previously observed in the case of sinusoidal variation in arterial pressure –
in the case of a limit cycle there is a bound on the amplitude of any oscillation, but
each circuit of the state-space is different from the last.
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Figure 6.11: Response of vasculature model to constant arterial pressure when damping is
reduced (ζ = 0.1) – once limit cycle has been reached.
As can be seen from the flattening of the trajectories in on the left hand side of
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Figure 6.12: Initial 400s of the trajectory of the system through [Ca2+] -r state space under
reduced damping (ζ = 0.1).
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fig. 6.12, the cycle is limited by the impossibility of a negative Ca2+ concentration.
Once the concentration of Ca2+ has reached zero1 the vessel quickly dilates to the
passive radius of fig. 4.6, once this radius is reached the stress in the vessel wall has
increased sufficiently to cause [Ca2+] to rise again, and so cause the contraction of the
vessel which will in turn lower the stress in the wall and cause the return of [Ca2+] to
near zero, completing the cycle. The cycle is driven to continue by the interaction of
the slowness of vessel contraction and the ‘momentum’ of the Ca2+ response2.
6.4.1 Sensitivity to ζ
The oscillatory results so far presented have been at an arterial pressure of 80mmHg and
with a natural frequency and damping factor of 0.1Hz and 0.1 respectively. We know
that at some combinations of these parameters the system is stable, so it is naturally of
interest to define the boundary between stability and instability in the Pa–ωn–ζ space.
Firstly we look at the variation in the limits of vessel radius during oscillation at a fixed
value of ζ over the complete range of arterial pressure. Figure 6.13 shows the steady
state radii of the vessel under both active and passive ([Ca2+] = 0) conditions along
with the maximum and minimum radii of the vessel under spontaneous oscillation at
the given arterial pressure. The nature of limit cycles is such that the maximum value
achieved in the 1000s integration time of the simulations that went into this graph are
not necessarily consistent, hence the ‘noise’ in the envelope of oscillatory range.
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Figure 6.13: Variation of oscillatory range with arterial pressure. Maxima and minima taken
over first 1000s of integration starting at equilibrium. Arterial pressure was constant through-
out each integration (ζ = 0.1).
We can see that with a damping factor of 0.1 the system is only unstable in the
autoregulatory range of arterial pressure. It is also obvious that the passive radius acts
1Actually marginally above zero to prevent numerical singularities in the integration.
2During integration, d[Ca
2+]
dt is set to zero the instant that [Ca
2+] reaches its lower limit, effectively
losing all ‘momentum’.
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as an effective upper bound on oscillatory radius; given that [Ca2+] is limited to be non-
negative, and the passive equilibrium is achieved at zero [Ca2+] , this is to be expected.
Any dilation of the vessel beyond the passive equilibrium radius for the given arterial
pressure must be due to a transient pressure fluctuation increasing the mean pressure
in the arteriolar compartment above the steady state value. As damping is reduced,
the range of arterial pressures at which spontaneous oscillations occur increases, the
instability spreading to higher and lower arterial pressures. Conversely, as damping
factor is increased the range of arterial pressures in which oscillation occurs is narrowed.
This is shown in fig. 6.14 where the envelope of oscillation has been plotted for a range
of values of ζ.
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Figure 6.14: Variation of oscillatory range with arterial pressure for various values of ζ.
Maxima and minima taken over first 1000s of integration starting at equilibrium. Arterial
pressure was constant throughout each integration (ωn = 0.1Hz).
The steeper region of the steady state active radius curve, where autoregulation is
strongest, seems to be able to sustain spontaneous oscillations at higher damping factors
than the less steep regions. However there are pressures at which the equilibrium
response of radius is to increase with increasing pressure, i.e., outside the autoregulatory
range, which do in fact exhibit spontaneous oscillations when damping is reduced far
enough.
6.4.2 Sensitivity to ωn
A similar set of simulations reveals that the pressure region over which oscillation occurs
varies not only with ζ but also with ωn. Figure 6.15 shows this variation of oscillatory
range, and amplitude, with arterial pressure and undamped natural frequency, ωn. The
pressure range over which oscillation is observed is greatest at a frequency of 0.025Hz
– an oscillatory period of 40s. At frequencies of 0.2Hz and higher no oscillation is
seen, similarly at frequencies below 0.005Hz the oscillatory pressure range narrows to
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nothing. As well as this change in oscillatory pressure range with frequency, we can
observe a decrease in minimum radius during the oscillation. At 0.01Hz, 100mmHg,
the minimum radius seems to reach a minimum, with the vessel oscillating between
r = 105µm and r = 22µm. It is possible that 0.025Hz is the frequency at which the
Ca2+ dynamics cause the greatest resonance with the speeds of the mechanical model,
hence the greatest range of pressures over which oscillation is observed, but lower
frequencies afford the mechanical model more time to respond to the elevated levels of
Ca2+ and so achieve a smaller minimum radius (greater contraction). The apparent
decrease in oscillation magnitude at 0.005Hz may be illusory, at such low frequencies
it is possible that the 1000s integration time is not sufficient for the oscillation to fully
develop.
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Figure 6.15: Variation of oscillatory range with arterial pressure for various values of ωn.
Maxima and minima taken over first 1000s of integration starting at equilibrium. Arterial
pressure was constant throughout each integration (ζ = 0.1).
6.4.3 Role of Non-regulating Vasculature
Spontaneous oscillatory behaviour has been discovered only after incorporation of the
arteriole model into the whole-brain vasculature model, and subsequent to the modi-
fication of this vasculature model in search of vasomotion like oscillations. However,
since the final modification (which made oscillations possible) was to the Ca2+ dy-
namics within the arteriole model, it is worth investigating the possibility that the
isolated arteriole model may now be capable of vasomotion-like oscillations in and of
itself, without the peripheral elements of the vasculature model. To this end we set
ωn = 0.1Hz and ζ = 0.1 (as in the cases of figs. 6.10 to 6.12) and we fix the upstream
and downstream pressures to match those of the vasculature model (Pα, Pβ) with an
arterial pressure of 80mmHg. Figure 6.16 shows the resulting oscillation in radius of
this single, isolated arteriole.
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Figure 6.16: Oscillation in radius of an isolated arteriole. P = 48.5mmHg, ∆P = 75mmHg,
ωn = 0.1Hz, ζ = 0.1.
This oscillation is similar in character to that of the whole-brain model, we can see
from the[Ca2+] -r phase plane shown in fig. 6.17 that the trajectory is a similar shape
to that of fig. 6.12, however, it is much more regular than in the case of the whole-
brain model. The oscillations exhibited by this single arteriole are in fact so regular
that it is difficult to say whether any irregularity is due to the nature of the system or
the inaccuracies of its integration. Either way the result is that the oscillatory regime
into which the single arteriole settles is considerably more regular and predictable than
when the arteriole is coupled to the whole-brain vasculature model.
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Figure 6.17: Oscillation in radius of an isolated arteriole shown in the [Ca2+] -r state space.
P = 48.5mmHg, ∆P = 75mmHg, ωn = 0.1Hz, ζ = 0.1.
It appears then that the irregularity in the oscillations of the whole-brain model are
borne of variations in pressure upstream and downstream of the arteriolar bed, because
we can see from the results above that if the arteriole experiences constant pressures
at both upstream and downstream ends then it will oscillate in a regular fashion.
The irregularity in the whole-brain oscillations can then be thought of as a result of
interference between the frequency of the driving arteriolar oscillation and the natural
frequencies of the surrounding vasculature model.
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6.4.4 Effect on Flow
So far we have examined primarily the sensitivity of the range of vessel radius under
oscillation to the parameters of the Ca2+ system. A prominent hypothesis for the
evolutionary benefit (to avoid using ‘purpose’) of vasomotion is that it increases oxygen
perfusion in pathological conditions, where the tissue would otherwise become hypoxic.
In [32] it is found that symmetrical oscillations in radius about its steady state value
can increase oxygen perfusion into the surrounding tissue. In our results however, we
find that the oscillation has a very non-symmetrical nature at 0.1Hz; from a steady
state radius of 77µm, the oscillation causes the vessel to dilate as far as 103µm but
only to contract to 60µm. At higher frequencies this bias towards dilation becomes
even more pronounced (fig. 6.15). The effect that this has on the response of flow to
arterial pressure is pronounced. Figure 6.18 shows the steady state response of the
vasculature model in blue (at higher damping), and the response under the oscillatory
regime (reduced damping) in red. The flows shown for the oscillatory regime are the
time-averaged flows once oscillations have settled into the fully developed limit cycle.
The greatly increased flows under oscillation are partly the result of an asymmetric
oscillation in radius, and partly the result of the fourth power of radius in the Poiseuille
equation (eq. (2.1)).
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Figure 6.18: Effect of oscillation on average flow. ωn = 0.125Hz, ζ = 0.1.
6.4.5 Comparison to Vasomotion
We have found that large oscillations in vessel radius are possible with second-order
Ca2+ dynamic only if damping factor is below 0.2, whereas in fitting the new Ca2+ dy-
namics to the dynamic vessel response data of [45] we required damping factors of 0.5
and higher. As mentioned in § 6.4, this discrepancy is perhaps to be expected given
that vasomotion is not often observed under normal physiological conditions. The
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physiological analogy to our system would be that under normal physiological con-
ditions damping factor is high but in conditions under which vasomotion is observed
(hypo-perfusion or adrenergic stimulation) damping factor is reduced and oscillations
ensue. We should be careful here not to suggest that our second order model is the
correct one, or that work should be carried out to identify the cause of this reduction
in ‘damping factor’ as such. Rather a more general view should be taken; we should
note that self sustaining oscillations in Ca2+ are not necessary for large oscillations in
radius to occur, some amount of damping of the Ca2+ system (such that the Ca2+ sys-
tem in isolation would quickly settle to a stable equilibrium) is tolerable, more so in the
more myogenically active regions of the pressure range. We should note also that some
change in the character of the Ca2+ response is likely to take place between normal
physiological conditions and those in which vasomotion is observed.
The true nature of Ca2+ dynamics within the VSMC is probably much closer to those
found in [41], where the cell membrane channels and sarcoplasmic reticulum are repre-
sented in enough detail to allow CICR to drive self-sustaining Ca2+ oscillations in the
cell, under some conditions3. Our simple second order Ca2+ dynamic is useful because
it sets a lower bound on the propensity of the Ca2+ concentration in the cytoplasm to
oscillate which is necessary to allow large, whole-vessel radius oscillations.
6.5 Discussion
If we reflect upon the components of the model we may be surprised to find any
circumstances under which self-sustained oscillations might occur: the Ca2+ dynamics,
although less damped than when fitted to the Kuo data, are positively damped such
that without some external forcing the Ca2+ oscillations would decay quickly; changes
in the length of the mechanical muscle model are damped proportionally to the number
of attached cross bridges; and the NO system, although it does exhibit positive feedback
at very low pressures, is all but inactive in the mid-range of arterial pressure. With
these damping elements dissipating energy during any state transition, there must be
some mechanism putting the energy back into the system to propagate the oscillations
which we have observed. This mechanism is the contraction of the vessel against the
pressure of the blood within it, driven by the cycling of phosphorylated cross bridges to
cause contraction of the VSMC. The energy thus expended doing work on the fluid is
then released into the mechanical damping elements as the vessel dilates back towards
its passive radius. This is only possible because we have implicitly assumed in our 4-
state kinetic model (§3.2.4) that there is always enough ATP present to phosphorylate
myosin heads to whatever degree is permitted by the Ca2+/NO balance. The fact that
the oscillation can withstand the greatest degree of damping when arterial pressure
places the system at the regions of greatest negative gradient on the radius/pressure
curve (most active autoregulation) is consistent with this view. The centre of the
autoregulatory range, and so the centre of the myogenic response curve, is the point at
3Stimulation by IP3, which is part of the adrenergic stimulation pathway. Source: implementation
and refinement of the model of [41] in communication with the author (Jens Jacobsen), results not
presented here.
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which changes in stress cause the greatest change in Ca2+ concentrations. Accordingly
it is also the point at which the feedback between stress in the vessel wall and energy
usage in vessel contraction is strongest. It is this energy uptake from ATP and its use
in vessel contraction which drives the oscillation against the various damping elements
removing energy from the system.
We can see from fig. 6.14 that the oscillation can exist outside the range of pressures
within which the response of radius to increased pressure is negative. At zero damping
for instance the oscillation extends to arterial pressures as low as 25mmHg, where the
vessel in its steady state dilates slightly to positive changes in pressure. This is however
not in contradiction to what has already been said about the contractive energy use of
the VSMC driving oscillation, for while the net change in radius at these low pressures
is positive, it is not as positive as it would have been in the absence of the myogenic
response – some phosphorylation of muscle has taken place even if it wasn’t enough to
cause a net contraction. We can compare the gradients of the passive and active steady
state equilibrium curves of fig. 6.14 and see that the point at which the oscillations
become sustainable is the point at which the gradient of the active curve diverges from
that of the passive curve (i.e., the first point at which the active curve becomes less
steep than the passive curve). It may be highlighted that at the high pressure end the
active curve is steeper than that of the passive curve and yet oscillations persist, this
is not contradictory either; the active curve may be steeper than the passive curve at
their respective equilibrium radii but if the stiffness of the passive curve at the radius of
the active curve were to be plotted it would produce a far steeper line than that of the
active response. The stiffness of the passive response is exponentially increasing with
extension, such that the gradients of the two lines are only meaningfully comparable
where they are close in radius, as is the case at the low end of the pressure range.
6.6 Conclusions
The capability of exhibiting self-sustaining oscillations in radius under constant exter-
nal conditions (P and ∆P ) is an important feature of our arteriole model. Whilst the
addition of intracranial compliance and flow inertia undoubtedly make our vasculature
model more realistic, and so possibly more useful for future comparisons with in-vivo
data, we have shown that they are not necessary for vasomotion-like oscillations in
arteriolar radius. The sufficiency of a damped Ca2+ dynamic to produce oscillations
in radius suggests that the self-sustaining Ca2+ fluctuations of CICR are not neces-
sary (although certainly sufficient) to instigate vasomotion. In fact vasomotion may be
initiated by some influence on the VSMC which causes reduced damping of Ca2+ fluc-
tuations, perhaps by upsetting the buffering of Ca2+ in the cytoplasm, and the resulting
feedback from the mechanical system, via the myogenic response, could initiate whole-
cell Ca2+ waves and CICR. Thus our model shows that self-sustaining Ca2+ waves in
the VSMC are not a prerequisite for vasomotion, in fact they may be a consequence of
it. The only prerequisites for vasomotion in our model are an active myogenic response
and a lightly damped Ca2+ dynamic.
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We have also found that the upper bound on vessel radius during vasomotion-like
oscillations is that of the passive equilibrium. In most cases this means that the upper
bound on radius will be further from the steady state equilibrium than the lower bound,
and so the mean radius greater under oscillation than in the steady state. Flow is thus
much greater during vasomotion than in the steady state equilibrium at the same
pressure, more so than if the oscillation were symmetric around the equilibrium radius.
This is consistent with the view that vasomotion is instigated by the sympathetic
nervous system as a response to hypo-perfusion because it increases mean blood flow
and so perfusion of the distressed tissue.
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Chapter 7
Conclusions and Future Work
In this chapter we will summarise the results of our work before discussing its implica-
tions and limitations. We will conclude with a discussion of future work which could
build on that presented here and provide further insight into the regulation of blood
flow in cerebral arterioles.
7.1 Summary of Results
In chapter 4 we found, through optimization, a set of parameters for the equations pre-
sented in chapter 3 which provide a very good fit to both the static and dynamic data
found in the experimental literature. We saw that the combined models of the mechan-
ics and biochemistry of the arteriole can create an active response to increased pressure
through the stress-induced release of Ca2+ in the VSMC, and that the flow-induced
production of NO in the endothelium is antagonistic to this contraction. In the dy-
namic cases we found that a fixed time constant in the Ca2+ myogenic response model
is not sufficient to reproduce the results observed experimentally. Rather than intro-
duce extra complexity at such an early stage by trying to explicitly model the changes
in Ca2+ speed we simply found the variation in time constant necessary to fit the data
and hypothesised about possible mechanisms which could replicate these changes in-
nately. It was also noted at this point that the level of flow at which [NO] reaches
saturation is necessarily very low, leading to an almost binary NO state. Although
further data are available on the response of vessel radius to variations in flow, it is
not consistent with radius-pressure data and so we decided not to attempt a combined
fitting of these datasets.
On finding limitations with current methods of sensitivity analysis we contrived a novel
implementation of the technique and used it to analyse our model. Consistent with our
observations on NO saturation, the sensitivity analysis revealed that the key parameters
were those influencing the myogenic response, and not the NO system.
After integrating our arteriole model into a representation of the vasculature of the
whole brain we found that we could match the pressure-flow data from rats and cats
found in [80]. After some modification we also reproduced the approximate arterial
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to venous volume ratio and its variation with ABP at the end of chapter 5. The
frequency response of this combined arteriolar and non-regulating vasculature model
was found to have a resonant peak close to 0.1Hz and to exhibit a phase difference
between ABP and flow similar to that observed in vivo. The variation of this phase
difference with Ca2+ time constant is significant and the possibility of this being used
as a diagnostic measure was discussed. We also used this model to investigate the
potential for the involvement of NO in the proposed mechanism of chemical signalling
from downstream to upstream through the brain tissue. It was found that the decay
rate of NO in the blood is far too high for any detectable traces of NO to remain in
the venous blood.
In chapter 6 the possibility of replicating oscillations in vessel radius characteristic of
vasomotion was investigated. We first used bifurcation analysis to confirm what we
had already suspected from running simulations; that the model as it was would not
produce spontaneous oscillations. After adding two more dynamic elements to the
non-regulating vasculature part of the model without causing oscillatory behaviour, we
changed the dynamics of the Ca2+ equilibrium in the arteriolar model to second-order.
This being a change that affected previous dynamic results, we first found parameters of
the new dynamic equation which create as good a fit to the dynamic experiments of [45]
as did the previous first-order parameter τCa. This was done and the resulting system
(with the parameters as fitted to the Kuo data) was stable, however, if the damping
factor of the new second-order Ca2+ response was reduced, spontaneous oscillations
resulted. Having mapped the extent and range of these oscillations over the pressure-
damping-frequency space we examined the stability of the arteriole model in isolation
and found that it exhibited vasomotion-like oscillations in the absence of the rest of the
vasculature model. We also found that the mean radius under oscillation was higher
than the equilibrium radius at which it would settle if damping were higher.
7.2 Discussion and Conclusions
7.2.1 The Role of NO
Our fitting to the flow and no-flow data of [45] in chapter 4 shows that NO does play a
significant role in determining the radius of the arteriole. However, because the effect
of NO saturates at such low levels of flow, the change in radius due to NO is a constant
offset at all physiological levels of flow. The NO pathway has virtually no effect on the
dynamic behaviour of the system, either in response to an oscillatory arterial pressure
or as part of the spontaneous oscillations the vessel has been found to exhibit, as long
as flow remains above a very low minimum level. Because the saturation of the NO
pathway occurs due to the exhaustion of cGMP, and not the exhaustion of NO itself,
there are interesting delays in the response to the complete cessation of flow, as seen in
chapter 4. These delays could serve as a useful hysteresis to allow the brief cessation of
flow without closing the arteriole down and possibly exacerbating pathological hypo-
perfusion.
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7.2.2 The Role of Ca2+
Whilst we may have found that the role of NO is somewhat less interesting than an-
ticipated, we have found the converse to be true of Ca2+. Firstly we established that
a variable Ca2+ time constant was necessary to replicate the dynamic isolated vessel
experiments of [45]. We then found that the Ca2+ dynamic itself was critical to the
possibility of spontaneous oscillations. The fact that some ‘momentum’ or hysteresis
must be associated with the Ca2+ concentration before the system becomes unstable
is interesting in two ways; firstly that the system of inductances and capacitances cou-
pled with a very non-linear arteriole model does not oscillate otherwise is notable, the
arteriole model must provide significant damping and be everywhere stable; secondly
it is very interesting that all that is necessary is an underdamped Ca2+ dynamic –
much work has focussed on the mechanism by which whole-cell calcium waves (caused
by CICR) in one VSMC might become coordinated with the surrounding cells and so
initiate vasomotion. We have found that feedback between the mechanical and bio-
chemical aspects of the myogenic response can amplify an arbitrarily small deviation
from equilibrium into a limit cycle oscillation. Although we have implicitly assumed
coordination throughout all VSMCs in our model, we have not put in place an elec-
trochemical model of the cell which is capable of generating whole-cell calcium waves
in and of itself. Our view of vasomotion in light of these results is that although
whole-cell calcium waves are a very likely result of vasomotion (given a sufficiently able
electrochemical model), they are in no way a necessary precursor to vasomotion.
7.2.3 Interpretation of Ide Results
Let us return to our hypotheses from chapter 3, and to the question which instigated
these investigations: we sought an explanation as to why the ABP-CBFV correlation
was not different between the two conditions of eNOS blockade and stimulation with
phenylephrine. We can now verify, at least partly, two of our hypotheses:
Number 1 was that NO is not involved in cerebral autoregulation at all; whilst NO is
indeed involved in autoregulation its effect is that of a DC component. The negligible
role that NO plays in the dynamics of autoregulation suggests that eNOS blockade
might well have no measurable effect on ABP-CBF correlation. The vasoconstriction
and consequent rise in ABP caused by eNOS blockade must move the equilibrium
of the system to a new operating point, about which its dynamics may differ. We
might therefore expect eNOS blockade to alter ABP-CBFV correlation in comparison
to the normal ABP baseline. However, when the comparison is made to a condition
with the same ABP, we can expect to see no discernible difference in the ABP-CBFV
correlation.
Hypothesis number 3 was that the two conditions being compared were in fact two
different methods of achieving the same thing; in one case NO was absent, in the other
it was ineffective. We can also partially substantiate this hypothesis from our fitting
of the 4-state kinetic model of § 4.2.1. The relative phosphorylation curve shown in
fig. 4.1 shows that cGMP only has influence over the mid-range of Ca2+ concentrations.
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Where [Ca2+] is greater than 10−4.5 the dotted lines of differing [cGMP] converge.
It is quite possible (although we have not investigated this explicitly here) that the
action of phenylephrine in releasing Ca2+ from the SR via IP3 raises the concentration
of Ca2+ above the level at which cGMP has an effect on phosphorylation of myosin
heads.
7.3 Future Work
The model developed here will doubtless/hopefully be valuable in analysing and pre-
dicting the behaviour of arterioles and in interpreting experimental results of future
experiments. In terms of its future development, it is clear that the first part which
should be ‘upgraded’ is the myogenic response model. The inclusion of a more com-
plete electrochemical model of the VSMC, such as that of Jacobsen or Stalhand [41, 75],
would greatly increase the ability of this model to replicate observed behaviour and to
further elucidate the interactions between flow, pressure, Ca2+ , and NO. The stress-
sensitivity critical for an effective model of the myogenic response would probably take
the form of a stress-sensitive Ca2+ channel in the cell membrane, although a stress sen-
sitive channel for a species which then stimulated Ca2+ release from the SR may also
be viable. Ideally such a model would be innately capable of changing the speed with
which the Ca2+ concentration reaches equilibrium, thus fitting the dynamic results of
[45] without, as we did, resorting to manual manipulation of parameters over different
epochs.
The second most promising development of the model would seem to require some
experimental results exposing in more detail the relationship between flow and NO
production/vasodilation. As mentioned previously, Kuo [45] presents some such results
but the inconsistency between them and the primary dataset makes it hard to integrate
them into any model. New investigation and clarification of this issue would enable
more precise validation of the NO model and greater confidence in the conclusions
that we have drawn from it. Of course if such experiments could be carried out with
whole-blood, or with surrounding tissue, or even in vivo, then so much the better.
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